GSK3B
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| E9PAV3 | T2022 | SIGNOR|EPSD|PSP | NACA | AAEKFKVQGEAVsNIQENtQtPtVQEEsEEEEVDEtGVEVK |
| O00213 | T579 | EPSD|PSP | APBB1 FE65 RIR | VDVINGALESVLSSSSREQWtPSHVSVAPATLTILHQQTEA |
| O00327 | S17 | SIGNOR|EPSD|PSP | BMAL1 ARNTL BHLHE5 MOP3 PASD3 | ____MADQRMDISSTISDFMsPGPtDLLSSSLGTSGVDCNR |
| O00327 | T21 | SIGNOR|EPSD|PSP | BMAL1 ARNTL BHLHE5 MOP3 PASD3 | MADQRMDISSTISDFMsPGPtDLLSSSLGTSGVDCNRKRKG |
| O00429 | S40 | SIGNOR|EPSD|PSP | DNM1L DLP1 DRP1 | ADIIQLPQIVVVGTQSSGKSsVLEsLVGRDLLPRGTGIVTR |
| O00429 | S44 | SIGNOR|EPSD|PSP | DNM1L DLP1 DRP1 | QLPQIVVVGTQSSGKSsVLEsLVGRDLLPRGTGIVTRRPLI |
| O00429 | S616 | PSP | DNM1L DLP1 DRP1 | SKAEELLAEEKsKPIPIMPAsPQKGHAVNLLDVPVPVARKL |
| O00429 | S693 | SIGNOR|EPSD|PSP | DNM1L DLP1 DRP1 | FLVNHVKDTLQSELVGQLyKsSLLDDLLtESEDMAQRRKEA |
| O14965 | S283 | SIGNOR | AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 | LLGsAGELKIADFGWsVHAPssRRttLCGTLDYLPPEMIEG |
| O15033 | T783 | SIGNOR|EPSD | AREL1 KIAA0317 | PGGFAALCPSFQIIAAPTHStLPTAHTCFNQLCLPTYDSYE |
| O15067 | S1062 | Sugiyama | PFAS KIAA0361 | SYCLPPTFPKAsVPREPGGPsPRVAILREEGSNGDREMADA |
| O15085 | S1457 | Sugiyama | ARHGEF11 KIAA0380 | NRLKDMELAHRELLKsLGGEssGGttPVGSFHTEAARWTDG |
| O15085 | S1458 | Sugiyama | ARHGEF11 KIAA0380 | RLKDMELAHRELLKsLGGEssGGttPVGSFHTEAARWTDGs |
| O15169 | S486 | SIGNOR | AXIN1 AXIN | NPEsILDEHVQRVLRtPGRQsPGPGHRsPDSGHVAKMPVAL |
| O15169 | S614 | iPTMNet|EPSD | AXIN1 AXIN | HSGKVGVACKRNAKKAESGKsASTEVPGASEDAEKNQKIMQ |
| O15169 | T481 | SIGNOR | AXIN1 AXIN | DAHEENPEsILDEHVQRVLRtPGRQsPGPGHRsPDSGHVAK |
| O15273 | S157 | SIGNOR|PSP | TCAP | TKQLPPVVPVSKPGALRRSLsRSMsQEAQRG__________ |
| O15273 | S161 | PSP | TCAP | PPVVPVSKPGALRRSLsRSMsQEAQRG______________ |
| O15294 | S3 | SIGNOR|EPSD|PSP | OGT | __________________MAssVGNVADSTEPTKRMLsFQG |
| O15294 | S4 | SIGNOR|EPSD|PSP | OGT | _________________MAssVGNVADSTEPTKRMLsFQGL |
| O15516 | S427 | SIGNOR|EPSD|PSP | CLOCK BHLHE8 KIAA0334 | GsDNRINTVSLKEALERFDHsPTPsASsRSsRKssHtAVsD |
| O43432 | S1409 | Sugiyama | EIF4G3 | EGEDVHNFLLEQKLDFIEsDsPCssEALSKKELSAEELYKR |
| O43602 | S332 | SIGNOR | DCX DBCN LISX | NDQDANGTSSSQLStPKsKQsPIstPtsPGSLRKHKDLYLP |
| O43623 | S100 | EPSD|PSP | SNAI2 SLUG SLUGH | SSSLGRVsPPPPsDTSsKDHsGSEsPIsDEEERLQSKLSDP |
| O43623 | S104 | EPSD|PSP | SNAI2 SLUG SLUGH | GRVsPPPPsDTSsKDHsGSEsPIsDEEERLQSKLSDPHAIE |
| O43623 | S92 | EPSD|PSP | SNAI2 SLUG SLUGH | GLSPLSGYSSSLGRVsPPPPsDTSsKDHsGSEsPIsDEEER |
| O43623 | S96 | EPSD|PSP | SNAI2 SLUG SLUGH | LSGYSSSLGRVsPPPPsDTSsKDHsGSEsPIsDEEERLQSK |
| O43765 | S77 | Sugiyama | SGTA SGT SGT1 | TLPEIFEAAATGKEMPQDLRsPARtPPsEEDsAEAERLKTE |
| O43765 | T81 | Sugiyama | SGTA SGT SGT1 | IFEAAATGKEMPQDLRsPARtPPsEEDsAEAERLKTEGNEQ |
| O43852 | T196 | Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O60341 | S683 | EPSD|PSP | KDM1A AOF2 KDM1 KIAA0601 LSD1 | VLCFDRVFWDPSVNLFGHVGsTTAsRGELFLFWNLYKAPIL |
| O60346 | S1359 | SIGNOR|EPSD|PSP | PHLPP1 KIAA0606 PHLPP PLEKHE1 SCOP | TRILGYTFLHPSVVPRPHVQsVLLtPQDEFFILGSKGLWDs |
| O60346 | S1379 | EPSD|PSP | PHLPP1 KIAA0606 PHLPP PLEKHE1 SCOP | sVLLtPQDEFFILGSKGLWDsLsVEEAVEAVRNVPDALAAA |
| O60346 | S1381 | EPSD|PSP | PHLPP1 KIAA0606 PHLPP PLEKHE1 SCOP | LLtPQDEFFILGSKGLWDsLsVEEAVEAVRNVPDALAAAKK |
| O60346 | T1363 | SIGNOR|EPSD|PSP | PHLPP1 KIAA0606 PHLPP PLEKHE1 SCOP | GYTFLHPSVVPRPHVQsVLLtPQDEFFILGSKGLWDsLsVE |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60701 | T185 | Sugiyama | UGDH | EGTAIKDLKNPDRVLIGGDEtPEGQRAVQALCAVYEHWVPR |
| O60716 | S252 | SIGNOR|iPTMNet|EPSD|Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60716 | T310 | SIGNOR|iPTMNet|EPSD | CTNND1 KIAA0384 | GyDDLDyGMMsDyGtARRtGtPsDPRRRLRsyEDMIGEEVP |
| O75030 | S405 | GPS6|SIGNOR | MITF BHLHE32 | NRHLLLRIQELEMQARAHGLsLIPsTGLCsPDLVNRIIKQE |
| O75116 | S425 | Sugiyama | ROCK2 KIAA0619 | GNQLPFIGFTYYRENLLLsDsPSCRETDSIQSRKNEESQEI |
| O75122 | S499 | EPSD|PSP | CLASP2 KIAA0627 | GVQRVLVNsAsAQKRSKIPRsQGCsREAsPSRLSVARSSRI |
| O75122 | S503 | EPSD|PSP | CLASP2 KIAA0627 | VLVNsAsAQKRSKIPRsQGCsREAsPSRLSVARSSRIPRPs |
| O75122 | S507 | EPSD|PSP | CLASP2 KIAA0627 | sAsAQKRSKIPRsQGCsREAsPSRLSVARSSRIPRPsVsQG |
| O75122 | S533 | SIGNOR|EPSD|PSP | CLASP2 KIAA0627 | VARSSRIPRPsVsQGCsREAsRESsRDTsPVRSFQPLASRH |
| O75122 | S537 | SIGNOR|EPSD|PSP | CLASP2 KIAA0627 | SRIPRPsVsQGCsREAsRESsRDTsPVRSFQPLASRHHSRS |
| O75385 | S405 | GPS6 | ULK1 KIAA0722 | SGSSLVASAGLESHGRtPsPsPPCsssPsPsGRAGPFSsSR |
| O75385 | S415 | GPS6 | ULK1 KIAA0722 | LESHGRtPsPsPPCsssPsPsGRAGPFSsSRCGASVPIPVP |
| O75533 | T223 | Sugiyama | SF3B1 SAP155 | tADQtPGAtPKKLssWDQAEtPGHtPsLRWDEtPGRAKGsE |
| O75533 | T227 | Sugiyama | SF3B1 SAP155 | tPGAtPKKLssWDQAEtPGHtPsLRWDEtPGRAKGsEtPGA |
| O75581 | S1490 | SIGNOR|iPTMNet|EPSD|PSP | LRP6 | SSSSssTKGtYFPAILNPPPsPAtERsHYTMEFGYSsNsPs |
| O75581 | S1607 | iPTMNet|EPSD | LRP6 | CPPsPYTERSYSHHLYPPPPsPCTDss______________ |
| O75581 | T1572 | iPTMNet|EPSD | LRP6 | TAKGYTSDLNyDSEPVPPPPtPRSQYLSAEENyESCPPsPY |
| O75925 | S13 | SIGNOR|PSP | PIAS1 DDXBP1 | ________MADSAELKQMVMsLRVsELQVLLGYAGRNKHGR |
| O75925 | S17 | SIGNOR|PSP | PIAS1 DDXBP1 | ____MADSAELKQMVMsLRVsELQVLLGYAGRNKHGRKHEL |
| O75952 | S155 | SIGNOR|iPTMNet|EPSD|PSP | CABYR CBP86 FSP2 | EAVGGLsSKPAtPKTTtPPssPPPTAVSPEFAYVPADPAQL |
| O75952 | T151 | SIGNOR|iPTMNet|EPSD|PSP | CABYR CBP86 FSP2 | TEQTEAVGGLsSKPAtPKTTtPPssPPPTAVSPEFAYVPAD |
| O94979 | S188 | Sugiyama | SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 | PEDISCIAWNRQVQHILAsAsPsGRATVWDLRKNEPIIKVS |
| O94979 | S190 | Sugiyama | SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 | DISCIAWNRQVQHILAsAsPsGRATVWDLRKNEPIIKVSDH |
| O94979 | S799 | Sugiyama | SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 | IMQLRDRLCRAQGEPVAGHEsPKIPyEKQQLPKGRPGPVAG |
| O95271 | S978 | EPSD|PSP | TNKS PARP5A PARPL TIN1 TINF1 TNKS1 | PEALPTCFKPQATVVSASLIsPAStPSCLsAASsIDNLTGP |
| O95271 | S987 | EPSD|PSP | TNKS PARP5A PARPL TIN1 TINF1 TNKS1 | PQATVVSASLIsPAStPSCLsAASsIDNLTGPLAELAVGGA |
| O95271 | S991 | EPSD|PSP | TNKS PARP5A PARPL TIN1 TINF1 TNKS1 | VVSASLIsPAStPSCLsAASsIDNLTGPLAELAVGGASNAG |
| O95271 | T982 | EPSD|PSP | TNKS PARP5A PARPL TIN1 TINF1 TNKS1 | PTCFKPQATVVSASLIsPAStPSCLsAASsIDNLTGPLAEL |
| O95757 | T35 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | IAVARsGGIETIANEySDRCtPACIsLGSRTRAIGNAAKSQ |
| O95863 | S100 | SIGNOR|EPSD|PSP | SNAI1 SNAH | QEsPRVAELTSLsDEDsGKGsQPPsPPsPAPsSFSsTSVsS |
| O95863 | S104 | GPS6|SIGNOR|ELM|EPSD|PSP | SNAI1 SNAH | RVAELTSLsDEDsGKGsQPPsPPsPAPsSFSsTSVsSLEAE |
| O95863 | S107 | GPS6|SIGNOR|ELM|EPSD|PSP | SNAI1 SNAH | ELTSLsDEDsGKGsQPPsPPsPAPsSFSsTSVsSLEAEAYA |
| O95863 | S111 | SIGNOR|EPSD|PSP | SNAI1 SNAH | LsDEDsGKGsQPPsPPsPAPsSFSsTSVsSLEAEAYAAFPG |
| O95863 | S115 | SIGNOR|EPSD|PSP | SNAI1 SNAH | DsGKGsQPPsPPsPAPsSFSsTSVsSLEAEAYAAFPGLGQV |
| O95863 | S119 | SIGNOR|EPSD|PSP | SNAI1 SNAH | GsQPPsPPsPAPsSFSsTSVsSLEAEAYAAFPGLGQVPKQL |
| O95863 | S96 | SIGNOR|EPSD|PSP | SNAI1 SNAH | SLRLQEsPRVAELTSLsDEDsGKGsQPPsPPsPAPsSFSsT |
| O95997 | S183 | SIGNOR|PSP | PTTG1 EAP1 PTTG TUTR1 | PPsPVKMPsPPWESNLLQsPssILSTLDVELPPVCCDIDI_ |
| O95997 | S184 | SIGNOR|PSP | PTTG1 EAP1 PTTG TUTR1 | PsPVKMPsPPWESNLLQsPssILSTLDVELPPVCCDIDI__ |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00966 | Y163 | Sugiyama | ASS1 ASS | APWRMPEFYNRFKGRNDLMEyAKQHGIPIPVtPKNPWSMDE |
| P01106 | S77 | PSP | MYC BHLHE39 | PPAPSEDIWKKFELLPtPPLsPsRRsGLCsPSyVAVTPFsL |
| P01106 | T73 | iPTMNet|PSP | MYC BHLHE39 | SELQPPAPSEDIWKKFELLPtPPLsPsRRsGLCsPSyVAVT |
| P01112 | S183 | PSP | HRAS HRAS1 | IRQHKLRKLNPPDESGPGCMsCKCVLS______________ |
| P01112 | T144 | EPSD|PSP | HRAS HRAS1 | TVESRQAQDLARSyGIPYIEtSAKtRQGVEDAFytLVREIR |
| P01112 | T148 | EPSD|PSP | HRAS HRAS1 | RQAQDLARSyGIPYIEtSAKtRQGVEDAFytLVREIRQHKL |
| P03372 | S102 | GPS6|SIGNOR|ELM|EPSD|PSP | ESR1 ESR NR3A1 | PGSEAAAFGSNGLGGFPPLNsVsPsPLMLLHPPPQLsPFLQ |
| P03372 | S104 | GPS6|SIGNOR|ELM|EPSD|PSP | ESR1 ESR NR3A1 | SEAAAFGSNGLGGFPPLNsVsPsPLMLLHPPPQLsPFLQPH |
| P03372 | S106 | GPS6|SIGNOR|ELM|EPSD|PSP | ESR1 ESR NR3A1 | AAAFGSNGLGGFPPLNsVsPsPLMLLHPPPQLsPFLQPHGQ |
| P03372 | S118 | GPS6|SIGNOR|ELM|EPSD|PSP | ESR1 ESR NR3A1 | PPLNsVsPsPLMLLHPPPQLsPFLQPHGQQVPYYLENEPSG |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04150 | S404 | SIGNOR|EPSD|PSP | NR3C1 GRL | PGRTVFSNGYssPSMRPDVssPPSSSStATTGPPPKLCLVC |
| P04198 | T58 | PSP | MYCN BHLHE37 NMYC | GGPDSTPPGEDIWKKFELLPtPPLsPsRGFAEHSSEPPSWV |
| P04637 | S33 | SIGNOR|ELM|iPTMNet|EPSD | TP53 P53 | PLsQEtFsDLWKLLPENNVLsPLPsQAMDDLMLsPDDIEQW |
| P04637 | S376 | EPSD|PSP | TP53 P53 | GKEPGGSRAHssHLKsKKGQstsRHKKLMFKtEGPDsD___ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05067 | T743 | GPS6|SIGNOR|ELM|EPSD | APP A4 AD1 | LKKKQYtsIHHGVVEVDAAVtPEERHLSKMQQNGyENPtyK |
| P05187 | S114 | Sugiyama | ALPP PLAP | DRFPYVALSKTYNVDKHVPDsGAtATAYLCGVKGNFQTIGL |
| P05412 | S243 | GPS6|SIGNOR|EPSD|PSP | JUN | QALKEEPQtVPEMPGEtPPLsPIDMEsQERIKAERKRMRNR |
| P05412 | S249 | GPS6|SIGNOR|EPSD | JUN | PQtVPEMPGEtPPLsPIDMEsQERIKAERKRMRNRIAASKC |
| P05412 | T239 | GPS6|SIGNOR|ELM|EPSD|PSP | JUN | HPRLQALKEEPQtVPEMPGEtPPLsPIDMEsQERIKAERKR |
| P05787 | S274 | Sugiyama | KRT8 CYK8 | LDMDsIIAEVKAQyEDIANRsRAEAEsMyQIKyEELQsLAG |
| P06401 | S554 | SIGNOR | PGR NR3C3 | LPQVYPPYLNYLRPDsEAsQsPQYsFEsLPQKICLICGDEA |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | S40 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGK |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06744 | S455 | Sugiyama | GPI | ALMRGKSTEEARKELQAAGKsPEDLERLLPHKVFEGNRPTN |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S70 | Sugiyama | LDHB | ALVDVLEDKLKGEMMDLQHGsLFLQtPKIVADKDysVtANS |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07195 | T75 | Sugiyama | LDHB | LEDKLKGEMMDLQHGsLFLQtPKIVADKDysVtANSKIVVV |
| P07437 | S168 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | GTLLISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLS |
| P07437 | S172 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | ISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLSVHQL |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S263 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EEKEKEEKEsEDKPEIEDVGsDEEEEKKDGDKKKKKKIKEK |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S726 | PSP | HSP90AA1 HSP90A HSPC1 HSPCA | DDtsAAVtEEMPPLEGDDDtsRMEEVD______________ |
| P07900 | T725 | PSP | HSP90AA1 HSP90A HSPC1 HSPCA | ADDtsAAVtEEMPPLEGDDDtsRMEEVD_____________ |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07942 | T1141 | Sugiyama | LAMB1 | FWGDPDVECRACDCDPRGIEtPQCDQSTGQCVCVEGVEGPR |
| P08047 | S728 | PSP | SP1 TSFP1 | HQNKKGGPGVALsVGtLPLDsGAGsEGSGtAtPSALITTNM |
| P08047 | S732 | PSP | SP1 TSFP1 | KGGPGVALsVGtLPLDsGAGsEGSGtAtPSALITTNMVAME |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | S718 | PSP | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EEPNAAVPDEIPPLEGDEDAsRMEEVD______________ |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08865 | T97 | Sugiyama | RPSA LAMBR LAMR1 | IssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQAAFR |
| P09104 | S37 | Sugiyama | ENO2 | NPtVEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRY |
| P09104 | S40 | Sugiyama | ENO2 | VEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGK |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0DMV8 | T636 | PSP | HSPA1A HSP72 HSPA1 HSX70 | GPGPGGFGAQGPKGGsGsGPtIEEVD_______________ |
| P10070 | S820 | SIGNOR | GLI2 THP | SQLQERRDsstsTVSSAYTVsRRssGISPYFSsRRssEAsP |
| P10070 | S832 | SIGNOR | GLI2 THP | TVSSAYTVsRRssGISPYFSsRRssEAsPLGAGRPHNAssA |
| P10070 | S863 | SIGNOR | GLI2 THP | AGRPHNAssADSYDPISTDAsRRsSEASQCSGGSGLLNLTP |
| P10636 | S214 | GPS6 | MAPT MAPTL MTBT1 TAU | GDLHQEGPPLKGAGGKERPGsKEEVDEDRDVDESsPQDsPP |
| P10636 | S235 | GPS6 | MAPT MAPTL MTBT1 TAU | KEEVDEDRDVDESsPQDsPPsKAsPAQDGRPPQTAAREATS |
| P10636 | S396 | GPS6|SIGNOR|EPSD | MAPT MAPTL MTBT1 TAU | ARMVSKSKDGtGSDDKKAKTsTRSsAKtLKNRPCLsPKHPT |
| P10636 | S400 | GPS6|SIGNOR|EPSD | MAPT MAPTL MTBT1 TAU | SKSKDGtGSDDKKAKTsTRSsAKtLKNRPCLsPKHPTPGSs |
| P10636 | S46 | EPSD|PSP | MAPT MAPTL MTBT1 TAU | QGGytMHQDQEGDtDAGLKEsPLQtPTEDGsEEPGsETSDA |
| P10636 | S501 | EPSD | MAPT MAPTL MTBT1 TAU | GQANATRIPAKtPPAPKtPPsSGEPPKsGDRsGyssPGsPG |
| P10636 | S512 | SIGNOR|EPSD | MAPT MAPTL MTBT1 TAU | tPPAPKtPPsSGEPPKsGDRsGyssPGsPGtPGsRsRtPsL |
| P10636 | S515 | SIGNOR|EPSD | MAPT MAPTL MTBT1 TAU | APKtPPsSGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtP |
| P10636 | S516 | SIGNOR|EPSD | MAPT MAPTL MTBT1 TAU | PKtPPsSGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtPP |
| P10636 | S519 | SIGNOR|EPSD | MAPT MAPTL MTBT1 TAU | PPsSGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtPPTRE |
| P10636 | S525 | EPSD | MAPT MAPTL MTBT1 TAU | PPKsGDRsGyssPGsPGtPGsRsRtPsLPtPPTREPKKVAV |
| P10636 | S531 | SIGNOR | MAPT MAPTL MTBT1 TAU | RsGyssPGsPGtPGsRsRtPsLPtPPTREPKKVAVVRtPPK |
| P10636 | S552 | GPS6|ELM|EPSD | MAPT MAPTL MTBT1 TAU | LPtPPTREPKKVAVVRtPPKsPssAKSRLQTAPVPMPDLKN |
| P10636 | S575 | GPS6|ELM|EPSD | MAPT MAPTL MTBT1 TAU | sAKSRLQTAPVPMPDLKNVKsKIGstENLKHQPGGGKVQII |
| P10636 | S579 | GPS6|SIGNOR|ELM|EPSD | MAPT MAPTL MTBT1 TAU | RLQTAPVPMPDLKNVKsKIGstENLKHQPGGGKVQIINKKL |
| P10636 | S713 | GPS6|SIGNOR|ELM|EPSD | MAPT MAPTL MTBT1 TAU | LTFRENAKAKTDHGAEIVyKsPVVsGDtsPRHLsNVsstGs |
| P10636 | S717 | SIGNOR|EPSD | MAPT MAPTL MTBT1 TAU | ENAKAKTDHGAEIVyKsPVVsGDtsPRHLsNVsstGsIDMV |
| P10636 | S721 | GPS6|SIGNOR|ELM|EPSD | MAPT MAPTL MTBT1 TAU | AKTDHGAEIVyKsPVVsGDtsPRHLsNVsstGsIDMVDsPQ |
| P10636 | S730 | EPSD | MAPT MAPTL MTBT1 TAU | VyKsPVVsGDtsPRHLsNVsstGsIDMVDsPQLAtLADEVS |
| P10636 | T123 | iPTMNet|EPSD | MAPT MAPTL MTBT1 TAU | AEEAGIGDtPSLEDEAAGHVtQEPESGKVVQEGFLREPGPP |
| P10636 | T173 | iPTMNet | MAPT MAPTL MTBT1 TAU | MPGAPLLPEGPREATRQPsGtGPEDTEGGRHAPELLKHQLL |
| P10636 | T498 | SIGNOR|EPSD | MAPT MAPTL MTBT1 TAU | GQKGQANATRIPAKtPPAPKtPPsSGEPPKsGDRsGyssPG |
| P10636 | T50 | EPSD|PSP | MAPT MAPTL MTBT1 TAU | tMHQDQEGDtDAGLKEsPLQtPTEDGsEEPGsETSDAKstP |
| P10636 | T522 | SIGNOR|EPSD | MAPT MAPTL MTBT1 TAU | SGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtPPTREPKK |
| P10636 | T529 | SIGNOR|EPSD | MAPT MAPTL MTBT1 TAU | GDRsGyssPGsPGtPGsRsRtPsLPtPPTREPKKVAVVRtP |
| P10636 | T534 | SIGNOR|EPSD | MAPT MAPTL MTBT1 TAU | yssPGsPGtPGsRsRtPsLPtPPTREPKKVAVVRtPPKsPs |
| P10636 | T548 | GPS6|SIGNOR|ELM|EPSD | MAPT MAPTL MTBT1 TAU | RtPsLPtPPTREPKKVAVVRtPPKsPssAKSRLQTAPVPMP |
| P10696 | S111 | Sugiyama | ALPG ALPPL ALPPL2 | DRFPYVALSKTYSVDKHVPDsGAtATAYLCGVKGNFQTIGL |
| P10809 | S225 | Sugiyama | HSPD1 HSP60 | KtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVL |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P10809 | T455 | Sugiyama | HSPD1 HSP60 | GIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLKIP |
| P10914 | S184 | PSP | IRF1 | YTVPGYMQDLEVEQALtPALsPCAVSSTLPDWHIPVEVVPD |
| P10914 | T180 | PSP | IRF1 | DHSSYTVPGYMQDLEVEQALtPALsPCAVSSTLPDWHIPVE |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11308 | T180 | SIGNOR|PSP | ERG | FQNIDGKELCKMTKDDFQRLtPSyNADILLSHLHYLRETPL |
| P11388 | S1361 | SIGNOR|EPSD|PSP | TOP2A TOP2 | EKtDDEDFVPsDAsPPKtKTsPKLsNKELKPQKsVVsDLEA |
| P11586 | S129 | Sugiyama | MTHFD1 MTHFC MTHFD | INTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCtP |
| P11831 | S224 | PSP | SRF | PMITSETGKALIQtCLNsPDsPPRsDPttDQRMSATGFEET |
| P12036 | S503 | SIGNOR|EPSD|PSP | NEFH KIAA0845 NFH | GKEEEGGEEEEAEGGEEEtKsPPAEEAAsPEKEAKsPVKEE |
| P12524 | S38 | EPSD|PSP | MYCL BHLHE38 LMYC MYCL1 | DFYRSTAPSEDIWKKFELVPsPPTsPPWGLGPGAGDPAPGI |
| P12524 | S42 | EPSD|PSP | MYCL BHLHE38 LMYC MYCL1 | STAPSEDIWKKFELVPsPPTsPPWGLGPGAGDPAPGIGPPE |
| P12830 | S847 | SIGNOR|iPTMNet|EPSD | CDH1 CDHE UVO | YDSLLVFDYEGsGsEAAsLSsLNssEsDKDQDYDYLNEWGN |
| P12931 | S43 | SIGNOR|PSP | SRC SRC1 | NVHGAGGGAFPAsQtPsKPAsADGHRGPsAAFAPAAAEPKL |
| P12931 | S493 | GPS6|SIGNOR|PSP | SRC SRC1 | EVLDQVERGYRMPCPPECPEsLHDLMCQCWRKEPEERPTFE |
| P12931 | S51 | GPS6|PSP | SRC SRC1 | AFPAsQtPsKPAsADGHRGPsAAFAPAAAEPKLFGGFNssD |
| P12931 | Y419 | PSP | SRC SRC1 | ENLVCKVADFGLARLIEDNEytARQGAKFPIKWTAPEAALy |
| P13051 | S64 | SIGNOR|EPSD|PSP | UNG DGU UNG1 UNG15 | AAIPAKKAPAGQEEPGtPPssPLsAEQLDRIQRNKAAALLR |
| P13051 | T60 | SIGNOR|EPSD|PSP | UNG DGU UNG1 UNG15 | SGDAAAIPAKKAPAGQEEPGtPPssPLsAEQLDRIQRNKAA |
| P13489 | T176 | Sugiyama | RNH1 PRI RNH | AASCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKD |
| P13688 | S508 | PSP | CEACAM1 BGP BGP1 | MNEVtysTLNFEAQQPTQPTsASPsLTATEIIySEVKKQ__ |
| P13807 | S641 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GYS1 GYS | FTYEPNEADAAQGyRyPRPAsVPPsPsLsRHssPHQsEDEE |
| P13807 | S645 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | GYS1 GYS | PNEADAAQGyRyPRPAsVPPsPsLsRHssPHQsEDEEDPRN |
| P13807 | S649 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | GYS1 GYS | DAAQGyRyPRPAsVPPsPsLsRHssPHQsEDEEDPRNGPLE |
| P13807 | S653 | SIGNOR|iPTMNet|EPSD|PSP | GYS1 GYS | GyRyPRPAsVPPsPsLsRHssPHQsEDEEDPRNGPLEEDGE |
| P13929 | S37 | Sugiyama | ENO3 | NPtVEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRY |
| P13929 | S40 | Sugiyama | ENO3 | VEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGK |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | T328 | EPSD|PSP | PKM OIP3 PK2 PK3 PKM2 | LAQKMMIGRCNRAGKPVICAtQMLEsMIKKPRPTRAEGsDV |
| P14866 | S101 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | GAAGGGGGGENyDDPHKtPAsPVVHIRGLIDGVVEADLVEA |
| P14921 | S269 | SIGNOR|PSP | ETS1 EWSR2 | QDsFEsIEsYDSCDRLtQsWssQssFNsLQRVPsyDsFDsE |
| P14921 | T265 | SIGNOR|PSP | ETS1 EWSR2 | KLGGQDsFEsIEsYDSCDRLtQsWssQssFNsLQRVPsyDs |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15559 | S82 | Sugiyama | NQO1 DIA4 NMOR1 | DPANFQYPAESVLAYKEGHLsPDIVAEQKKLEAADLVIFQF |
| P15924 | S2845 | EPSD|PSP | DSP | sRsGsRsGsRSGsRsGsRsGsRRGsFDAtGNssYsYSYSFS |
| P15924 | S2849 | EPSD|PSP | DSP | sRsGsRSGsRsGsRsGsRRGsFDAtGNssYsYSYSFSsssI |
| P15941 | S1227 | GPS6|SIGNOR|ELM|EPSD|PSP | MUC1 PUM | sEyPtyHtHGRyVPPsstDRsPyEKVsAGNGGssLsytNPA |
| P16220 | S115 | PSP | CREB1 | EDsQEsVDsVTDsQKRREILsRRPsYRKILNDLssDAPGVP |
| P16220 | S129 | SIGNOR|ELM|iPTMNet|EPSD | CREB1 | KRREILsRRPsYRKILNDLssDAPGVPRIEEEKsEEETSAP |
| P16278 | S433 | Sugiyama | GLB1 ELNR1 | YGFVLYRTTLPQDCSNPAPLssPLNGVHDRAyVAVDGIPQG |
| P16401 | T11 | GPS6|SIGNOR|EPSD|PSP | H1-5 H1F5 HIST1H1B | __________MsEtAPAEtAtPAPVEKsPAKKKATKKAAGA |
| P16615 | S663 | SIGNOR | ATP2A2 ATP2B | QDEDVTSKAFtGREFDELNPsAQRDACLNARCFARVEPSHK |
| P17275 | S251 | SIGNOR|EPSD|PSP | JUNB | GLGRGASTFKEEPQtVPEARsRDAtPPVsPINMEDQERIKV |
| P17275 | T255 | SIGNOR|EPSD|PSP | JUNB | GASTFKEEPQtVPEARsRDAtPPVsPINMEDQERIKVERKR |
| P17661 | S28 | PSP | DES | sQRVssYRRtFGGAPGFPLGsPLssPVFPRAGFGsKGssss |
| P17661 | S32 | PSP | DES | ssYRRtFGGAPGFPLGsPLssPVFPRAGFGsKGssssVTSR |
| P17676 | S223 | EPSD|PSP | CEBPB TCF5 PP9092 | FPYALRAYLGYQAVPsGssGsLstsssssPPGtPsPADAKA |
| P17676 | S231 | SIGNOR | CEBPB TCF5 PP9092 | LGYQAVPsGssGsLstsssssPPGtPsPADAKAPPTACyAG |
| P17676 | T226 | SIGNOR | CEBPB TCF5 PP9092 | ALRAYLGYQAVPsGssGsLstsssssPPGtPsPADAKAPPT |
| P17676 | T235 | SIGNOR | CEBPB TCF5 PP9092 | AVPsGssGsLstsssssPPGtPsPADAKAPPTACyAGAAPA |
| P17812 | S571 | SIGNOR|PSP | CTPS1 CTPS | LSHYLQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD |
| P17812 | S573 | Sugiyama | CTPS1 CTPS | HYLQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD__ |
| P17812 | S574 | SIGNOR|Sugiyama | CTPS1 CTPS | YLQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD___ |
| P17812 | S575 | SIGNOR | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P17947 | S140 | SIGNOR|PSP | SPI1 | QYPSLSPAQPSSDEEEGERQsPPLEVSDGEADGLEPGPGLL |
| P17947 | S41 | SIGNOR|PSP | SPI1 | VPYDTDLYQRQTHEYYPYLSsDGESHSDHYWDFHPHHVHSE |
| P18669 | S23 | Sugiyama | PGAM1 PGAMA CDABP0006 | AYKLVLIRHGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQ |
| P18669 | S31 | Sugiyama | PGAM1 PGAMA CDABP0006 | HGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALRDAGyE |
| P18669 | Y26 | Sugiyama | PGAM1 PGAMA CDABP0006 | LVLIRHGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALR |
| P19544 | S208 | SIGNOR | WT1 | LGEQQYSVPPPVYGCHTPTDsCTGSQALLLRTPYSSDNLYQ |
| P19793 | S49 | SIGNOR|EPSD|PSP | RXRA NR2B1 | AAPsLHPSLGPGIGSPGQLHsPISTLSSPINGMGPPFsVIS |
| P19793 | S66 | SIGNOR|EPSD|PSP | RXRA NR2B1 | QLHsPISTLSSPINGMGPPFsVISSPMGPHSMsVPTtPTLG |
| P19793 | S78 | SIGNOR|EPSD|PSP | RXRA NR2B1 | INGMGPPFsVISSPMGPHSMsVPTtPTLGFSTGSPQLSSPM |
| P19838 | S903 | GPS6|SIGNOR|ELM|EPSD | NFKB1 | EAIEVIQAAssPVKTtsQAHsLPLsPAstRQQIDELRDSDs |
| P19838 | S907 | GPS6|SIGNOR|ELM|EPSD | NFKB1 | VIQAAssPVKTtsQAHsLPLsPAstRQQIDELRDSDsVCDs |
| P20393 | S55 | SIGNOR|EPSD|PSP | NR1D1 EAR1 HREV THRAL | DNSNGSFQSLTQGCPTYFPPsPTGsLTQDPARSFGSIPPSL |
| P20393 | S59 | SIGNOR|EPSD|PSP | NR1D1 EAR1 HREV THRAL | GSFQSLTQGCPTYFPPsPTGsLTQDPARSFGSIPPSLSDDG |
| P21796 | S13 | PSP | VDAC1 VDAC | ________MAVPPTYADLGKsARDVFTKGyGFGLIKLDLKt |
| P21796 | T107 | PSP | VDAC1 VDAC | VEDQLARGLKLtFDssFsPNtGKKNAKIKTGYKREHINLGC |
| P22234 | S27 | Sugiyama | PAICS ADE2 AIRC PAIS | LNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAGNAARK |
| P22314 | S816 | Sugiyama | UBA1 A1S9T UBE1 | VPEFtPKsGVKIHVsDQELQsANAsVDDsRLEELKATLPsP |
| P22314 | S820 | Sugiyama | UBA1 A1S9T UBE1 | tPKsGVKIHVsDQELQsANAsVDDsRLEELKATLPsPDKLP |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22415 | S186 | SIGNOR|PSP | USF1 BHLHB11 USF | PQEVLQGGSQRSIAPRTHPYsPKSEAPRTTRDEKRRAQHNE |
| P22415 | T153 | SIGNOR|PSP | USF1 BHLHB11 USF | SGSTAAVVTTQGSEALLGQAtPPGTGQFFVMMSPQEVLQGG |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P22626 | Y347 | Sugiyama | HNRNPA2B1 HNRPA2B1 | MGGPyGGGNyGPGGsGGsGGyGGRsRy______________ |
| P22670 | S120 | EPSD|PSP | RFX1 | YIVVTVSEGAMRAsEtVsEAsPGstAsQtGVPTQVVQQVQG |
| P22670 | T124 | EPSD|PSP | RFX1 | TVSEGAMRAsEtVsEAsPGstAsQtGVPTQVVQQVQGTQQR |
| P23246 | T687 | SIGNOR|EPSD|PSP | SFPQ PSF | FGQGGAGPVGGQGPRGMGPGtPAGyGRGREEYEGPNKKPRF |
| P24071 | S284 | SIGNOR|PSP | FCAR CD89 | AEPSWSQQMCQPGLTFARTPsVCK_________________ |
| P24385 | T286 | SIGNOR|ELM|iPTMNet|EPSD|PSP | CCND1 BCL1 PRAD1 | MDPKAAEEEEEEEEEVDLACtPtDVRDVDI___________ |
| P24864 | S73 | EPSD|PSP | CCNE1 CCNE | ARDQCGSQPWDNNAVCADPCsLIPtPDKEDDDRVYPNsTCK |
| P24864 | T395 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CCNE1 CCNE | AKKAMLsEQNRAsPLPsGLLtPPQsGKKQSSGPEMA_____ |
| P24864 | T77 | SIGNOR|EPSD|PSP | CCNE1 CCNE | CGSQPWDNNAVCADPCsLIPtPDKEDDDRVYPNsTCKPRII |
| P25054 | S1501 | iPTMNet|EPSD|PSP | APC DP2.5 | VLPDADTLLHFATESTPDGFsCsssLsALsLDEPFIQKDVE |
| P25054 | S1503 | iPTMNet|EPSD|PSP | APC DP2.5 | PDADTLLHFATESTPDGFsCsssLsALsLDEPFIQKDVELR |
| P25205 | T722 | Sugiyama | MCM3 | GDsyDPyDFsDtEEEMPQVHtPKTADsQEtKEsQKVELsES |
| P25786 | Y6 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______________MFRNQyDNDVtVWsPQGRIHQIEYAM |
| P26358 | S714 | PSP | DNMT1 AIM CXXC9 DNMT | MAMKEADDDEEVDDNIPEMPsPKKMHQGKKKKQNKNRIsWV |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27824 | S362 | Sugiyama | CANX | WDEDMDGEWEAPQIANPRCEsAPGCGVWQRPVIDNPNyKGK |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P29401 | T287 | Sugiyama | TKT | AEQIIQEIysQIQsKKKILAtPPQEDAPsVDIANIRMPsLP |
| P29692 | S71 | Sugiyama | EEF1D EF1D | ARARENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVEN |
| P30043 | Y194 | Sugiyama | BLVRB FLR SCAN | RVISKHDLGHFMLRCLttDEyDGHstyPsHQyQ________ |
| P30101 | S443 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LsKDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLN |
| P30279 | T280 | SIGNOR|EPSD|PSP | CCND2 | QYRQDQRDGsKsEDELDQAstPTDVRDIDL___________ |
| P30281 | T283 | GPS6|SIGNOR|ELM|EPSD|PSP | CCND3 | ssPAPKAPRGsssQGPsQtstPtDVtAIHL___________ |
| P30291 | S211 | SIGNOR|EPSD|PSP | WEE1 | PKSLLSKARGIDSSSVKLRGssLFMDtEKSGKREFDVRQTP |
| P30304 | S76 | SIGNOR|EPSD|PSP | CDC25A | GSDyEQPLEVKNNSNLQRMGsSEstDsGFCLDsPGPLDSKE |
| P30405 | S191 | SIGNOR|PSP | PPIF CYP3 | FGHVKEGMDVVKKIESFGSKsGRTSKKIVItDCGQLs____ |
| P31645 | S48 | PSP | SLC6A4 HTT SERT | QKVVPTPGDKVESGQISNGysAVPSPGAGDDtRHsIPATTT |
| P31943 | S104 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | EVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P31943 | T100 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | HRyVEVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPF |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P32929 | S56 | Sugiyama | CTH | AVVPPISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVA |
| P33076 | S373 | SIGNOR|EPSD|PSP | CIITA MHC2TA | PAGPDGILVEVDLVQARLERsSSKSLERELATPDWAERQLA |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | S31 | Sugiyama | HSPA4 APG2 HSPH2 | QSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGAA |
| P34932 | S40 | Sugiyama | HSPA4 APG2 HSPH2 | AGGIETIANEysDRCtPACIsFGPKNRSIGAAAKSQVISNA |
| P34932 | T35 | Sugiyama | HSPA4 APG2 HSPH2 | VAVARAGGIETIANEysDRCtPACIsFGPKNRSIGAAAKSQ |
| P34932 | T538 | Sugiyama | HSPA4 APG2 HSPH2 | EEEKMQVDQEEPHVEEQQQQtPAENKAEsEEMEtsQAGsKD |
| P34932 | Y30 | Sugiyama | HSPA4 APG2 HSPH2 | FQSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGA |
| P35222 | S23 | GPS6|EPSD | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | tQADLMELDMAMEPDRKAAVsHWQQQsyLDsGIHsGATtTA |
| P35222 | S29 | GPS6|EPSD | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | ELDMAMEPDRKAAVsHWQQQsyLDsGIHsGATtTAPsLsGK |
| P35222 | S33 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | AMEPDRKAAVsHWQQQsyLDsGIHsGATtTAPsLsGKGNPE |
| P35222 | S37 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | DRKAAVsHWQQQsyLDsGIHsGATtTAPsLsGKGNPEEEDV |
| P35222 | T41 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | AVsHWQQQsyLDsGIHsGATtTAPsLsGKGNPEEEDVDTsQ |
| P35579 | S1714 | Sugiyama | MYH9 | RAKRQAQQERDELADEIANssGKGALALEEKRRLEARIAQL |
| P35612 | S613 | EPSD|PSP | ADD2 ADDB | PAKsAPAsPVQsPAKEAEtKsPLVsPsKSLEEGTKKTETSK |
| P35612 | S693 | EPSD|PSP | ADD2 ADDB | ADtDVDTSKDKTESVTSGPMsPEGsPsKsPsKKKKKFRTPs |
| P35659 | T67 | SIGNOR | DEK | EKEKsLIVEGKREKKKVERLtMQVssLQREPFTIAQGKGQK |
| P35869 | S436 | SIGNOR|PSP | AHR BHLHE76 | ATNPFPAIMDPLPLRTKNGTsGKDsATTsTLSKDSLNPSSL |
| P35869 | S440 | SIGNOR|PSP | AHR BHLHE76 | FPAIMDPLPLRTKNGTsGKDsATTsTLSKDSLNPSSLLAAM |
| P35869 | S444 | SIGNOR|PSP | AHR BHLHE76 | MDPLPLRTKNGTsGKDsATTsTLSKDSLNPSSLLAAMMQQD |
| P35869 | S689 | SIGNOR|PSP | AHR BHLHE76 | PQQYNVFTDLHGISQEFPYKsEMDsMPYtQNFISCNQPVLP |
| P35869 | S693 | SIGNOR|PSP | AHR BHLHE76 | NVFTDLHGISQEFPYKsEMDsMPYtQNFISCNQPVLPQHSK |
| P35869 | S723 | SIGNOR|PSP | AHR BHLHE76 | CNQPVLPQHSKCTELDYPMGsFEPsPYPtTSSLEDFVTCLQ |
| P35869 | S727 | SIGNOR|PSP | AHR BHLHE76 | VLPQHSKCTELDYPMGsFEPsPYPtTSSLEDFVTCLQLPEN |
| P35869 | T697 | SIGNOR|PSP | AHR BHLHE76 | DLHGISQEFPYKsEMDsMPYtQNFISCNQPVLPQHSKCTEL |
| P35869 | T731 | SIGNOR|PSP | AHR BHLHE76 | HSKCTELDYPMGsFEPsPYPtTSSLEDFVTCLQLPENQKHG |
| P35998 | T193 | Sugiyama | PSMC2 MSS1 | TYSDVGGCKEQIEKLREVVEtPLLHPERFVNLGIEPPKGVL |
| P36956 | S430 | SIGNOR|EPSD|PSP | SREBF1 BHLHD1 SREBP1 | TDVLMEGVKTEVEDTLtPPPsDAGsPFQSsPLSLGSRGsGs |
| P36956 | S434 | SIGNOR|EPSD|PSP | SREBF1 BHLHD1 SREBP1 | MEGVKTEVEDTLtPPPsDAGsPFQSsPLSLGSRGsGsGGsG |
| P36956 | T426 | SIGNOR|EPSD|PSP | SREBF1 BHLHD1 SREBP1 | SGGNTDVLMEGVKTEVEDTLtPPPsDAGsPFQSsPLSLGSR |
| P37802 | S145 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | VQRTLMNLGGLAVARDDGLFsGDPNWFPKKSKENPRNFsDN |
| P37840 | S129 | EPSD|PSP | SNCA NACP PARK1 | QEGILEDMPVDPDNEAyEMPsEEGyQDyEPEA_________ |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T87 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKR |
| P38936 | S114 | GPS6|SIGNOR|ELM|EPSD|PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | RPGtsPALLQGTAEEDHVDLsLSCTLVPRsGEQAEGsPGGP |
| P38936 | T57 | GPS6|ELM|EPSD|PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | LMAGCIQEARERWNFDFVtEtPLEGDFAWERVRGLGLPKLy |
| P40337 | S68 | EPSD|PSP | VHL | LGAEEEMEAGRPRPVLRSVNsREPsQVIFCNRsPRVVLPVW |
| P40763 | S727 | PSP | STAT3 APRF | KTKFICVtPttCsNtIDLPMsPRTLDSLMQFGNNGEGAEPS |
| P40763 | T714 | PSP | STAT3 APRF | HPEADPGsAAPyLKTKFICVtPttCsNtIDLPMsPRTLDSL |
| P41091 | T109 | Sugiyama | EIF2S3 EIF2G | YKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLVRH |
| P41236 | T73 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PPP1R2 IPP2 | LAtyHPADKDyGLMKIDEPstPYHsMMGDDEDACsDtEAtE |
| P46013 | S1131 | Sugiyama | MKI67 | tPGPsEEsMtDEKTTKIACKsPPPEsVDtPtstKQWPKRSL |
| P46777 | Y226 | Sugiyama | RPL5 MSTP030 | DyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAA |
| P46937 | T114 | Sugiyama | YAP1 YAP65 | sFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssPAsLQL |
| P46937 | T119 | Sugiyama | YAP1 YAP65 | PEPKsHsRQAstDAGtAGALtPQHVRAHssPAsLQLGAVsP |
| P47736 | S525 | GPS6|ELM|EPSD | RAP1GAP KIAA0474 RAP1GA1 | NIQEVQEKREsPPAGQKtPDsGHVSQEPKSENSStQssPEM |
| P48436 | T236 | EPSD|PSP | SOX9 | SGMSEVHsPGEHsGQsQGPPtPPtTPKTDVQPGKADLKREG |
| P49327 | T1999 | Sugiyama | FASN FAS | LLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFVVF |
| P49327 | T2204 | Sugiyama | FASN FAS | LRKLQELSSKADEAsELACPtPKEDGLAQQQtQLNLRSLLV |
| P49715 | T226 | SIGNOR|iPTMNet|EPSD | CEBPA CEBP | LQFQIAHCGQTTMHLQPGHPtPPPtPVPsPHPAPALGAAGL |
| P49715 | T230 | SIGNOR|iPTMNet|EPSD | CEBPA CEBP | IAHCGQTTMHLQPGHPtPPPtPVPsPHPAPALGAAGLPGPG |
| P49716 | S167 | EPSD|PSP | CEBPD | VSLAAAGQPTPPTSPEPPRSsPRQtPAPGPAREKSAGKRGP |
| P49716 | T171 | PSP | CEBPD | AAGQPTPPTSPEPPRSsPRQtPAPGPAREKSAGKRGPDRGs |
| P49768 | S353 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PSEN1 AD3 PS1 PSNL1 | DGGFsEEWEAQRDsHLGPHRstPEsRAAVQELsssILAGED |
| P49768 | S357 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PSEN1 AD3 PS1 PSNL1 | sEEWEAQRDsHLGPHRstPEsRAAVQELsssILAGEDPEER |
| P49768 | S397 | GPS6 | PSEN1 AD3 PS1 PSNL1 | RGVKLGLGDFIFYSVLVGKAsATASGDWNTTIACFVAILIG |
| P49840 | S282 | Sugiyama | GSK3A | CDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTSSID |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | S13 | Sugiyama | GSK3B | ________MSGRPRttsFAEsCKPVQQPsAFGsMKVSRDKD |
| P49841 | S219 | Sugiyama | GSK3B | CDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTSSID |
| P49841 | S389 | Sugiyama | GSK3B | SNPPLATILIPPHARIQAAAstPtNATAASDANTGDRGQTN |
| P49841 | S9 | Sugiyama | GSK3B | ____________MSGRPRttsFAEsCKPVQQPsAFGsMKVS |
| P49841 | T390 | Sugiyama | GSK3B | NPPLATILIPPHARIQAAAstPtNATAASDANTGDRGQTNN |
| P49841 | Y216 | SIGNOR|EPSD|PSP|Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P50219 | S77 | SIGNOR | MNX1 HLXB9 | sCsPASSEPPAAPADRLRAEsPsPPRLLAAHCALLPKPGFL |
| P50219 | S79 | SIGNOR | MNX1 HLXB9 | sPASSEPPAAPADRLRAEsPsPPRLLAAHCALLPKPGFLGA |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P50895 | S596 | EPSD|PSP | BCAM LU MSK19 | GPCCRQRREKGAPPPGEPGLsHsGsEQPEQtGLLMGGAsGG |
| P50990 | T398 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | RGstDNLMDDIERAVDDGVNtFKVLTRDKRLVPGGGAtEIE |
| P52565 | T160 | Sugiyama | ARHGDIA GDIA1 | DKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYsIKSR |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P52630 | S381 | SIGNOR|PSP | STAT2 | VSIDRNPPQLQGFRKFNILTsNQKtLtPEKGQsQGLIWDFG |
| P52630 | S393 | SIGNOR|PSP | STAT2 | FRKFNILTsNQKtLtPEKGQsQGLIWDFGYLtLVEQRSGGS |
| P52630 | T385 | SIGNOR|PSP | STAT2 | RNPPQLQGFRKFNILTsNQKtLtPEKGQsQGLIWDFGYLtL |
| P52789 | T514 | Sugiyama | HK2 | EMERGLSKETHASAPVKMLPtYVCAtPDGTEKGDFLALDLG |
| P52789 | T519 | Sugiyama | HK2 | LSKETHASAPVKMLPtYVCAtPDGTEKGDFLALDLGGTNFR |
| P52945 | S268 | SIGNOR | PDX1 IPF1 STF1 | VPPAAPVAAREGRLPPGLSAsPQPssVAPRRPQEPR_____ |
| P52945 | S272 | SIGNOR | PDX1 IPF1 STF1 | APVAAREGRLPPGLSAsPQPssVAPRRPQEPR_________ |
| P52945 | S61 | SIGNOR | PDX1 IPF1 STF1 | QPPPPPPHPFPGALGALEQGsPPDIsPYEVPPLADDPAVAH |
| P52945 | S66 | SIGNOR | PDX1 IPF1 STF1 | PPHPFPGALGALEQGsPPDIsPYEVPPLADDPAVAHLHHHL |
| P52948 | S623 | Sugiyama | NUP98 ADAR2 | KNLNNsNLFsPVNRDsENLAsPsEyPENGERFsFLSKPVDE |
| P53396 | S451 | SIGNOR|ELM|iPTMNet|EPSD | ACLY | AAHTANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAK |
| P53396 | S457 | Sugiyama | ACLY | FLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMPQD |
| P53396 | T447 | SIGNOR|ELM|iPTMNet|EPSD | ACLY | QPPTAAHTANFLLNAsGststPAPsRtAsFsEsRADEVAPA |
| P53805 | S163 | SIGNOR|iPTMNet|EPSD|PSP | RCAN1 ADAPT78 CSP1 DSC1 DSCR1 | TLHIGSSHLAPPNPDKQFLIsPPAsPPVGWKQVEDAtPVIN |
| P54132 | S175 | SIGNOR | BLM RECQ2 RECQL3 | DDMDDFDTSETSKsFVtPPQsHFVRVStAQKSKKGKRNFFK |
| P54132 | T171 | SIGNOR|EPSD|PSP | BLM RECQ2 RECQL3 | INDWDDMDDFDTSETSKsFVtPPQsHFVRVStAQKSKKGKR |
| P54252 | S256 | GPS6|SIGNOR|ELM|EPSD|PSP | ATXN3 ATX3 MJD MJD1 SCA3 | sRQEIDMEDEEADLRRAIQLsMQGssRNIsQDMtQtsGTNL |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55060 | S342 | Sugiyama | CSE1L CAS XPO2 | ASVCERPHYKNLFEDQNtLtsICEKVIVPNMEFRAADEEAF |
| P55795 | S104 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | EVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P55795 | T100 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | HRyVEVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPF |
| P56524 | S298 | SIGNOR|EPSD|PSP | HDAC4 KIAA0288 | TALKKRPLDVTDSACSSAPGsGPSsPNNSSGSVSAENGIAP |
| P56524 | S302 | SIGNOR|EPSD|PSP | HDAC4 KIAA0288 | KRPLDVTDSACSSAPGsGPSsPNNSSGSVSAENGIAPAVPS |
| P56537 | S235 | GPS6|PSP | EIF6 EIF3A ITGB4BP OK/SW-cl.27 | LSVVESVFKLNEAQPstIAtsMRDsLIDsLt__________ |
| P56537 | S239 | GPS6|PSP | EIF6 EIF3A ITGB4BP OK/SW-cl.27 | ESVFKLNEAQPstIAtsMRDsLIDsLt______________ |
| P56537 | S243 | GPS6|PSP | EIF6 EIF3A ITGB4BP OK/SW-cl.27 | KLNEAQPstIAtsMRDsLIDsLt__________________ |
| P56537 | T231 | GPS6|PSP | EIF6 EIF3A ITGB4BP OK/SW-cl.27 | TSTELSVVESVFKLNEAQPstIAtsMRDsLIDsLt______ |
| P57059 | T182 | GPS6|EPSD | SIK1 SIK SNF1LK | DIKLADFGFGNFYKSGEPLStWCGsPPYAAPEVFEGKEYEG |
| P58012 | S33 | EPSD|PSP | FOXL2 | GALLAPETGRTVKEPEGPPPsPGKGGGGGGGTAPEKPDPAQ |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60484 | S362 | GPS6|ELM|EPSD|PSP | PTEN MMAC1 TEP1 | KVKLYFTKTVEEPSNPEASSsTSVtPDVsDNEPDHyRYsDt |
| P60484 | T366 | GPS6|SIGNOR|ELM|EPSD|PSP | PTEN MMAC1 TEP1 | YFTKTVEEPSNPEASSsTSVtPDVsDNEPDHyRYsDttDsD |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61978 | S77 | Sugiyama | HNRNPK HNRPK | VIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIETI |
| P61981 | S38 | Sugiyama | YWHAG | ERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKNVVGARRS |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62195 | T109 | Sugiyama | PSMC5 SUG1 | VHPEGKFVVDVDKNIDINDVtPNCRVALRNDsytLHKILPN |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62942 | S9 | Sugiyama | FKBP1A FKBP1 FKBP12 | ____________MGVQVEtIsPGDGRtFPKRGQtCVVHytG |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P84022 | T66 | SIGNOR | SMAD3 MADH3 | GQLDELEKAITTQNVNTKCItIPRSLDGRLQVSHRKGLPHV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P98170 | T180 | SIGNOR|EPSD|PSP | XIAP API3 BIRC4 IAP3 | MYSEEARLKSFQNWPDYAHLtPRELASAGLYYTGIGDQVQC |
| Q00613 | S303 | SIGNOR|ELM|EPSD|PSP | HSF1 HSTF1 | SIDERPLSSsPLVRVKEEPPsPPQsPRVEEAsPGRPssVDt |
| Q00653 | S222 | EPSD|PSP | NFKB2 LYT10 | DGSFSLPLKPVISQPIHDsKsPGASNLKISRMDKTAGSVRG |
| Q00653 | S707 | EPSD|PSP | NFKB2 LYT10 | LLKAGADIHAENEEPLCPLPsPPTsDsDsDsEGPEKDtRss |
| Q00653 | S711 | EPSD|PSP | NFKB2 LYT10 | GADIHAENEEPLCPLPsPPTsDsDsDsEGPEKDtRssFRGH |
| Q01094 | S403 | EPSD|PSP | E2F1 RBBP3 | LLEHVREDFSGLLPEEFISLsPPHEALDYHFGLEEGEGIRD |
| Q01094 | T433 | EPSD|PSP | E2F1 RBBP3 | FGLEEGEGIRDLFDCDFGDLtPLDF________________ |
| Q01201 | S573 | EPSD|PSP | RELB | VGSNMFPNHYREAAFGGGLLsPGPEAT______________ |
| Q01518 | S308 | SIGNOR|PSP | CAP1 CAP | AQSGPVRsGPKPFsAPKPQtsPsPKRATKKEPAVLELEGKK |
| Q01518 | S310 | SIGNOR|PSP | CAP1 CAP | SGPVRsGPKPFsAPKPQtsPsPKRATKKEPAVLELEGKKWR |
| Q01974 | S864 | SIGNOR | ROR2 NTRKR2 | MQMAPQQVPPQMVPKPssHHsGsGststGYVTTAPSNTSMA |
| Q02156 | S346 | SIGNOR|EPSD|PSP | PRKCE PKCE | GAEsPQPAsGssPsEEDRsKsAPtsPCDQEIKELENNIRKA |
| Q02543 | T24 | Sugiyama | RPL18A | SGTLREYKVVGRCLPTPKCHtPPLYRMRIFAPNHVVAKSRF |
| Q04206 | S468 | GPS6|SIGNOR|ELM|EPSD|PSP | RELA NFKB3 | EDLGALLGNSTDPAVFTDLAsVDNsEFQQLLNQGIPVAPHT |
| Q04206 | T254 | SIGNOR | RELA NFKB3 | EARGsFSQADVHRQVAIVFRtPPYADPsLQAPVRVsMQLRR |
| Q04637 | S1430 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | GQDIGAFVAEQKVEyTLGEEsEAPGQRALPsEELNRQLEKL |
| Q04721 | S2070 | SIGNOR|iPTMNet|EPSD | NOTCH2 | ARDRMHHDIVRLLDEyNVtPsPPGtVLtSALsPVICGPNRs |
| Q04721 | S2093 | SIGNOR|iPTMNet|EPSD | NOTCH2 | GtVLtSALsPVICGPNRsFLsLKHtPMGKKSRRPSAKSTMP |
| Q04721 | T2068 | SIGNOR|iPTMNet|EPSD | NOTCH2 | DVARDRMHHDIVRLLDEyNVtPsPPGtVLtSALsPVICGPN |
| Q04721 | T2074 | SIGNOR|iPTMNet|EPSD | NOTCH2 | MHHDIVRLLDEyNVtPsPPGtVLtSALsPVICGPNRsFLsL |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q07021 | T165 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | GEEEPSQGQKVEEQEPELtstPNFVVEVIKNDDGKKALVLD |
| Q07812 | S163 | SIGNOR|EPSD|PSP | BAX BCL2L4 | FLRERLLGWIQDQGGWDGLLsYFGtPTWQtVtIFVAGVLTA |
| Q07817 | S62 | EPSD|PSP | BCL2L1 BCL2L BCLX | ESEMEtPsAINGNPSWHLADsPAVNGATGHSSSLDAREVIP |
| Q07820 | S121 | PSP | MCL1 BCL2L3 | PTRRAAPLEEMEAPAADAIMsPEEELDGYEPEPLGKRPAVL |
| Q07820 | S159 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MCL1 BCL2L3 | AVLPLLELVGEsGNNtstDGsLPstPPPAEEEEDELYRQSL |
| Q07820 | T163 | iPTMNet|EPSD|PSP | MCL1 BCL2L3 | LLELVGEsGNNtstDGsLPstPPPAEEEEDELYRQSLEIIS |
| Q07960 | S51 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | KNWPsDEMPDFPKsDDsKsssPELVtHLKWDDPyyDIARHQ |
| Q08J23 | S743 | Sugiyama | NSUN2 SAKI TRM4 | AstGQPDNDVtEGQRAGEPNsPDAEEANsPDVtAGCDPAGV |
| Q12778 | S325 | iPTMNet|EPSD | FOXO1 FKHR FOXO1A | DDFDNWSTFRPRtssNAstIsGRLsPIMtEQDDLGEGDVHS |
| Q12931 | S568 | Sugiyama | TRAP1 HSP75 HSPC5 | ISVETDIVVDHYKEEKFEDRsPAAECLSEKETEELMAWMRN |
| Q13131 | S486 | EPSD|PSP | PRKAA1 AMPK1 | DsRTYLLDFRsIDDEItEAKsGtAtPQRsGsVsNYRSCQRs |
| Q13131 | T482 | PSP | PRKAA1 AMPK1 | LYQVDsRTYLLDFRsIDDEItEAKsGtAtPQRsGsVsNYRS |
| Q13131 | T490 | EPSD|PSP | PRKAA1 AMPK1 | YLLDFRsIDDEItEAKsGtAtPQRsGsVsNYRSCQRsDsDA |
| Q13136 | S666 | Sugiyama | PPFIA1 LIP1 | IQEEKENTEQRAEEIESRVGsGsLDNLGRFRSMssIPPYPA |
| Q13144 | S535 | SIGNOR|ELM|iPTMNet|EPSD | EIF2B5 EIF2BE | WGLKINMEEEsEsESEQSMDsEEPDsRGGsPQMDDIKVFQN |
| Q13144 | S540 | SIGNOR|iPTMNet|EPSD | EIF2B5 EIF2BE | NMEEEsEsESEQSMDsEEPDsRGGsPQMDDIKVFQNEVLGT |
| Q13144 | S544 | iPTMNet|EPSD | EIF2B5 EIF2BE | EsEsESEQSMDsEEPDsRGGsPQMDDIKVFQNEVLGTLQRG |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13451 | T46 | Sugiyama | FKBP5 AIG6 FKBP51 | TsKKDRGVLKIVKRVGNGEEtPMIGDKVyVHYKGKLSNGKK |
| Q13485 | T265 | SIGNOR|PSP | SMAD4 DPC4 MADH4 | QPGQQQNGFTGQPATYHHNStTTWtGSRtAPYtPNLPHHQN |
| Q13485 | T269 | SIGNOR|PSP | SMAD4 DPC4 MADH4 | QQNGFTGQPATYHHNStTTWtGSRtAPYtPNLPHHQNGHLQ |
| Q13485 | T273 | SIGNOR|PSP | SMAD4 DPC4 MADH4 | FTGQPATYHHNStTTWtGSRtAPYtPNLPHHQNGHLQHHPP |
| Q13509 | S168 | Sugiyama | TUBB3 TUBB4 | GTLLISKVREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLS |
| Q13509 | S172 | Sugiyama | TUBB3 TUBB4 | ISKVREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLSIHQL |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13541 | S65 | EPSD|PSP | EIF4EBP1 | ttPGGtRIIyDRKFLMECRNsPVtKtPPRDLPtIPGVtsPs |
| Q13541 | T37 | SIGNOR|EPSD|PSP | EIF4EBP1 | ATRRVVLGDGVQLPPGDysttPGGtLFsttPGGtRIIyDRK |
| Q13541 | T46 | SIGNOR|EPSD|PSP | EIF4EBP1 | GVQLPPGDysttPGGtLFsttPGGtRIIyDRKFLMECRNsP |
| Q13541 | T70 | EPSD|PSP | EIF4EBP1 | tRIIyDRKFLMECRNsPVtKtPPRDLPtIPGVtsPssDEPP |
| Q13765 | T159 | GPS6|ELM | NACA HSD48 | AAEKFKVQGEAVsNIQENTQtPTVQEEsEEEEVDEtGVEVK |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q13887 | S303 | SIGNOR|EPSD|PSP | KLF5 BTEB2 CKLF IKLF | PCTYTMPSQFLPQQATYFPPsPPSSEPGSPDRQAEMLQNLt |
| Q14103 | S83 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | HNRNPD AUF1 HNRPD | SEGAKIDAsKNEEDEGHsNssPRHsEAAtAQREEWKMFIGG |
| Q14103 | T193 | Sugiyama | HNRNPD AUF1 HNRPD | KAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVESIEL |
| Q14194 | S518 | SIGNOR | CRMP1 DPYSL1 ULIP3 | MYDGPVyEVPAtPKYAtPAPsAKssPsKHQPPPIRNLHQSN |
| Q14194 | T509 | SIGNOR | CRMP1 DPYSL1 ULIP3 | FGLQGVSRGMYDGPVyEVPAtPKYAtPAPsAKssPsKHQPP |
| Q14194 | T514 | SIGNOR | CRMP1 DPYSL1 ULIP3 | VSRGMYDGPVyEVPAtPKYAtPAPsAKssPsKHQPPPIRNL |
| Q14195 | S518 | SIGNOR|EPSD|PSP | DPYSL3 CRMP4 DRP3 ULIP ULIP1 | MYDGPVFDLtttPKGGtPAGsARGsPTRPNPPVRNLHQSGF |
| Q14195 | S522 | SIGNOR | DPYSL3 CRMP4 DRP3 ULIP ULIP1 | PVFDLtttPKGGtPAGsARGsPTRPNPPVRNLHQSGFSLSG |
| Q14195 | T509 | SIGNOR|EPSD|PSP | DPYSL3 CRMP4 DRP3 ULIP ULIP1 | ADLHAVPRGMYDGPVFDLtttPKGGtPAGsARGsPTRPNPP |
| Q14195 | T514 | SIGNOR|EPSD|PSP | DPYSL3 CRMP4 DRP3 ULIP ULIP1 | VPRGMYDGPVFDLtttPKGGtPAGsARGsPTRPNPPVRNLH |
| Q14249 | S288 | PSP | ENDOG | ESIERASGLLFVPNILARAGsLKAITAGSK___________ |
| Q14249 | T128 | PSP | ENDOG | GDRRECDFREDDSVHAYHRAtNADYRGSGFDRGHLAAAANH |
| Q14449 | S358 | SIGNOR|PSP | GRB14 | RLLKYGMQLYQNYMHPYQGRsGCSsQSIsPMRsIsENSLVA |
| Q14449 | S362 | SIGNOR|PSP | GRB14 | YGMQLYQNYMHPYQGRsGCSsQSIsPMRsIsENSLVAMDFS |
| Q14449 | S366 | SIGNOR|PSP | GRB14 | LYQNYMHPYQGRsGCSsQSIsPMRsIsENSLVAMDFSGQKS |
| Q14449 | S370 | PSP | GRB14 | YMHPYQGRsGCSsQSIsPMRsIsENSLVAMDFSGQKSRVIE |
| Q14449 | S419 | PSP | GRB14 | AVEEGLAWRKKGCLRLGTHGsPtAsSQSSATNMAIHRSQPW |
| Q14449 | S423 | PSP | GRB14 | GLAWRKKGCLRLGTHGsPtAsSQSSATNMAIHRSQPWFHHK |
| Q14494 | S379 | SIGNOR|EPSD|PSP | NFE2L1 HBZ17 NRF1 TCF11 | QNVSLHQASLGGCSQDFLLFsPEVESLPVASSSTLLPLAPS |
| Q14534 | S83 | PSP | SQLE ERG1 | FALFSDILSGLPFIGFFWAKsPPEsENKEQLEARRRRKGTN |
| Q14534 | S87 | PSP | SQLE ERG1 | SDILSGLPFIGFFWAKsPPEsENKEQLEARRRRKGTNISET |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14596 | T586 | SIGNOR|PSP | NBR1 1A13B KIAA0049 M17S2 MIG19 | LDINIVQELERVPHNtPVDVtPCMsPLPHDsPLIEKPGLGQ |
| Q14653 | S123 | PSP | IRF3 | PHKIYEFVNSGVGDFSQPDTsPDTNGGGSTSDtQEDILDEL |
| Q14653 | S173 | PSP | IRF3 | PDPGPPSLAVAPEPCPQPLRsPsLDNPtPFPNLGPsENPLK |
| Q14653 | T180 | PSP | IRF3 | LAVAPEPCPQPLRsPsLDNPtPFPNLGPsENPLKRLLVPGE |
| Q14896 | S133 | EPSD|PSP | MYBPC3 | ATGAPGEAPAPAAELGESAPsPKGSSSAALNGPTPGAPDDP |
| Q14896 | S304 | PSP | MYBPC3 | sDSHEDTGILDFSSLLKKRDsFRTPRDsKLEAPAEEDVWEI |
| Q15208 | S6 | SIGNOR|EPSD|PSP | STK38 NDR1 | _______________MAMTGstPCssMSNHTKERVTMTKVT |
| Q15208 | T7 | EPSD|PSP | STK38 NDR1 | ______________MAMTGstPCssMSNHTKERVTMTKVTL |
| Q15293 | T71 | Sugiyama | RCN1 RCN | EDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRI |
| Q15293 | T76 | Sugiyama | RCN1 RCN | FQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGD |
| Q15691 | S155 | PSP | MAPRE1 | tAVAPsLVAPALNKPKKPLtsssAAPQRPIstQRTAAAPKA |
| Q15691 | S156 | PSP | MAPRE1 | AVAPsLVAPALNKPKKPLtsssAAPQRPIstQRTAAAPKAG |
| Q15746 | S16 | ELM | MYLK MLCK MLCK1 MYLK1 | _____MGDVKLVASSHIsKTsLsVDPSRVDSMPLTEAPAFI |
| Q15746 | S1776 | EPSD|PSP | MYLK MLCK MLCK1 MYLK1 | GRLssMAMISGLSGRKsstGsPtsPLNAEKLEsEEDVsQAF |
| Q15773 | S240 | Sugiyama | MLF2 | GGRRAEGPPRLAIQGPEDsPsRQsRRYDW____________ |
| Q15797 | T202 | EPSD|PSP | SMAD1 BSP1 MADH1 MADR1 | HPFPHsPNSSYPNsPGSSSStYPHsPTSSDPGsPFQMPADT |
| Q15853 | S155 | EPSD|PSP | USF2 BHLHB12 | PGPAAPFPLAVIQNPFSNGGsPAAEAVSGEARFAYFPASSV |
| Q15853 | T230 | EPSD|PSP | USF2 BHLHB12 | TQRTIAPRTHPYsPKIDGTRtPRDERRRAQHNEVERRRRDK |
| Q15910 | S363 | EPSD|PSP | EZH2 KMT6 | IKtPPKRPGGRRRGRLPNNssRPstPtINVLEsKDtDsDRE |
| Q15910 | T367 | EPSD|PSP | EZH2 KMT6 | PKRPGGRRRGRLPNNssRPstPtINVLEsKDtDsDREAGtE |
| Q16204 | S240 | Sugiyama | CCDC6 D10S170 TST1 | RMDKLEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMR |
| Q16204 | S244 | Sugiyama | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q16236 | S344 | EPSD|PSP | NFE2L2 NRF2 | LCKAFNQNHPESTAEFNDSDsGIsLNTsPSVAsPEHSVESS |
| Q16236 | S347 | EPSD|PSP | NFE2L2 NRF2 | AFNQNHPESTAEFNDSDsGIsLNTsPSVAsPEHSVESSSYG |
| Q16555 | S518 | GPS6|SIGNOR|ELM|EPSD|PSP | DPYSL2 CRMP2 ULIP2 | LyDGPVCEVsVtPKtVtPAssAKtsPAKQQAPPVRNLHQsG |
| Q16555 | T509 | GPS6|SIGNOR|ELM|EPSD|PSP | DPYSL2 CRMP2 ULIP2 | AELRGVPRGLyDGPVCEVsVtPKtVtPAssAKtsPAKQQAP |
| Q16555 | T514 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | DPYSL2 CRMP2 ULIP2 | VPRGLyDGPVCEVsVtPKtVtPAssAKtsPAKQQAPPVRNL |
| Q16584 | S789 | SIGNOR|PSP | MAP3K11 MLK3 PTK1 SPRK | PsPLRSRIDPWsFVSAGPRPsPLPsPQPAPRRAPWTLFPDS |
| Q16584 | S793 | SIGNOR|PSP | MAP3K11 MLK3 PTK1 SPRK | RSRIDPWsFVSAGPRPsPLPsPQPAPRRAPWTLFPDSDPFW |
| Q16630 | T157 | Sugiyama | CPSF6 CFIM68 | SKKLMDLLPKRELHGQNPVVtPCNKQFLsQFEMQSRKTTQS |
| Q16665 | S551 | GPS6|EPSD | HIF1A BHLHE78 MOP1 PASD8 | FKLELVEKLFAEDTEAKNPFsTQDtDLDLEMLAPYIPMDDD |
| Q16665 | S589 | GPS6|EPSD | HIF1A BHLHE78 MOP1 PASD8 | DDDFQLRsFDQLSPLESSSAsPESASPQSTVTVFQQTQIQE |
| Q16665 | T555 | GPS6|EPSD | HIF1A BHLHE78 MOP1 PASD8 | LVEKLFAEDTEAKNPFsTQDtDLDLEMLAPYIPMDDDFQLR |
| Q16881 | T413 | Sugiyama | TXNRD1 GRIM12 KDRF | HGIKFIRQFVPIKVEQIEAGtPGRLRVVAQSTNSEEIIEGE |
| Q2M1Z3 | T789 | SIGNOR | ARHGAP31 CDGAP KIAA1204 | VEVGGPGNLsPPLPPAPPPPtPLEESTPVLLSKGGPEREDS |
| Q53GS7 | S88 | PSP | GLE1 GLE1L | ETSPSSTSASALDQPSFVPKsPDAssAFsPAsPAtPNGTKG |
| Q53GS7 | S92 | PSP | GLE1 GLE1L | SSTSASALDQPSFVPKsPDAssAFsPAsPAtPNGTKGKDES |
| Q53GS7 | S93 | PSP | GLE1 GLE1L | STSASALDQPSFVPKsPDAssAFsPAsPAtPNGTKGKDESQ |
| Q53GS7 | S99 | PSP | GLE1 GLE1L | LDQPSFVPKsPDAssAFsPAsPAtPNGTKGKDESQHTESMV |
| Q53GS7 | T102 | PSP | GLE1 GLE1L | PSFVPKsPDAssAFsPAsPAtPNGTKGKDESQHTESMVLQS |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q5R3I4 | S362 | Sugiyama | TTC38 | GAHDPQTTQELLTTLRDASEsPGENCQHLLARDVGLPLCQA |
| Q5T4S7 | S178 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | AKLPQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLT |
| Q6IA17 | T372 | GPS6|PSP | SIGIRR UNQ301/PRO342 | PEGDLGVRGPVFGEPSAPPHtsGVsLGEsRssEVDVSDLGS |
| Q6P3X3 | T302 | Sugiyama | TTC27 | VAQLILDVRREGDVLSNCEFtPAPtPQEHLTKNLELNDDTI |
| Q6P3X3 | T306 | Sugiyama | TTC27 | ILDVRREGDVLSNCEFtPAPtPQEHLTKNLELNDDTILNDI |
| Q6PGQ7 | S274 | SIGNOR|EPSD|PSP | BORA C13orf34 | IQASAKKYSLGSITsPsPIssPTFsPIEFQIGETPLSEQRK |
| Q6PGQ7 | S278 | SIGNOR|EPSD|PSP | BORA C13orf34 | AKKYSLGSITsPsPIssPTFsPIEFQIGETPLSEQRKFtVH |
| Q6R327 | S1235 | EPSD|PSP | RICTOR KIAA1999 | IRsQsFNtDtttSGIssMsssPsRETVGVDATTMDTDCGSM |
| Q6R327 | T1695 | SIGNOR|EPSD|PSP | RICTOR KIAA1999 | ELFQDVQFLQMHEEAEAVLAtPPKQPIVDTSAEs_______ |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6U7Q0 | S391 | SIGNOR|EPSD|PSP | ZNF322 ZNF322A ZNF388 ZNF489 | TVHIGEKPFVCNVSEKGLELsPPHAsEAsQMS_________ |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMU5 | S255 | PSP | TRIM72 MG53 | TEFLMKYCLVTSRLQKILAEsPPPARLDIQLPIISDDFKFQ |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q7KZF4 | T240 | Sugiyama | SND1 TDRD11 | TVMLSGIKCPTFRREADGsEtPEPFAAEAKFFTESRLLQRD |
| Q7KZI7 | S212 | SIGNOR|EPSD|PSP | MARK2 EMK1 | ADFGFSNEFTFGNKLDtFCGsPPYAAPELFQGKKYDGPEVD |
| Q8IWX8 | S817 | Sugiyama | CHERP DAN26 SCAF6 | QSRSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDS |
| Q8IWX8 | T819 | Sugiyama | CHERP DAN26 SCAF6 | RSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDSRL |
| Q8IZQ8 | S451 | SIGNOR|iPTMNet|EPSD | MYOCD MYCD | PNYQSSSSTSALSNGFYHFGsTSSsPPIsPASsDLSVAGSL |
| Q8IZQ8 | S455 | SIGNOR|iPTMNet|EPSD | MYOCD MYCD | SSSSTSALSNGFYHFGsTSSsPPIsPASsDLSVAGSLPDTF |
| Q8IZQ8 | S459 | SIGNOR|iPTMNet|EPSD | MYOCD MYCD | TSALSNGFYHFGsTSSsPPIsPASsDLSVAGSLPDTFNDAS |
| Q8IZQ8 | S463 | SIGNOR | MYOCD MYCD | SNGFYHFGsTSSsPPIsPASsDLSVAGSLPDTFNDASPSFG |
| Q8IZQ8 | S626 | SIGNOR|iPTMNet|EPSD | MYOCD MYCD | LQPLGNAHCVESSDQTNVLSsTFLsPQCsPQHsPLGAVKSP |
| Q8IZQ8 | S630 | SIGNOR|iPTMNet|EPSD | MYOCD MYCD | GNAHCVESSDQTNVLSsTFLsPQCsPQHsPLGAVKSPQHIS |
| Q8IZQ8 | S634 | SIGNOR|iPTMNet|EPSD | MYOCD MYCD | CVESSDQTNVLSsTFLsPQCsPQHsPLGAVKSPQHISLPPS |
| Q8IZQ8 | S638 | SIGNOR | MYOCD MYCD | SDQTNVLSsTFLsPQCsPQHsPLGAVKSPQHISLPPSPNNP |
| Q8N122 | S722 | EPSD|PSP | RPTOR KIAA1303 RAPTOR | GGSLtPVRDsPCtPRLRsVssYGNIRAVATARSLNKSLQNL |
| Q8N122 | S792 | EPSD|PSP | RPTOR KIAA1303 RAPTOR | PENEEHILSFETIDKMRRAssYSSLNSLIGVSFNSVYTQIW |
| Q8N122 | S859 | EPSD|PSP | RPTOR KIAA1303 RAPTOR | YKATVNARPQRVLDtssLtQsAPAsPtNKGVHIHQAGGsPP |
| Q8N122 | S863 | EPSD|PSP | RPTOR KIAA1303 RAPTOR | VNARPQRVLDtssLtQsAPAsPtNKGVHIHQAGGsPPAsst |
| Q8N122 | S877 | EPSD|PSP | RPTOR KIAA1303 RAPTOR | tQsAPAsPtNKGVHIHQAGGsPPAsstssssLtNDVAKQPV |
| Q8N1F7 | S430 | Sugiyama | NUP93 KIAA0095 | TEDYLWLKLNQVCFDDDGTssPQDRLTLsQFQKQLLEDYGE |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8NBJ5 | S607 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | DRAKSQKMREQQALSREAKNsDVLQsPLDsAARDEL_____ |
| Q8NBJ5 | S612 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | QKMREQQALSREAKNsDVLQsPLDsAARDEL__________ |
| Q8NHW3 | S49 | SIGNOR|PSP | MAFA | FEVKKEPPEAERFCHRLPPGsLSStPLStPCSsVPSsPSFC |
| Q8NHW3 | S61 | SIGNOR|PSP | MAFA | FCHRLPPGsLSStPLStPCSsVPSsPSFCAPSPGTGGGGGA |
| Q8NHW3 | T53 | SIGNOR|PSP | MAFA | KEPPEAERFCHRLPPGsLSStPLStPCSsVPSsPSFCAPSP |
| Q8NHW3 | T57 | SIGNOR|PSP | MAFA | EAERFCHRLPPGsLSStPLStPCSsVPSsPSFCAPSPGTGG |
| Q92837 | S188 | SIGNOR|EPSD|PSP | FRAT1 | CRRGWLRGAAASRRLQQRRGsQPETRTGDDDPHRLLQQLVL |
| Q92908 | S37 | SIGNOR|EPSD|PSP | GATA6 | AGADASDSRAFPAREPSTPPsPISSSSSSCSRGGERGPGGA |
| Q92915 | S226 | SIGNOR | FGF14 FHF4 | YREPSLHDVGETVPKPGVTPsKsTsASAIMNGGKPVNKSKT |
| Q92993 | S86 | SIGNOR|EPSD|PSP | KAT5 HTATIP TIP60 | KKIQFPKKEAKTPTKNGLPGsRPGsPEREVPASAQASGKTL |
| Q92993 | S90 | EPSD|PSP | KAT5 HTATIP TIP60 | FPKKEAKTPTKNGLPGsRPGsPEREVPASAQASGKTLPIPV |
| Q969R2 | S762 | PSP | OSBP2 KIAA1664 ORP4 OSBPL4 | AHYVLSGSWDEQMECSKVMHssPssPsSDGKQKTVYQTLSA |
| Q969R2 | S763 | PSP | OSBP2 KIAA1664 ORP4 OSBPL4 | HYVLSGSWDEQMECSKVMHssPssPsSDGKQKTVYQTLSAK |
| Q969R2 | S766 | PSP | OSBP2 KIAA1664 ORP4 OSBPL4 | LSGSWDEQMECSKVMHssPssPsSDGKQKTVYQTLSAKLLW |
| Q969R2 | S768 | PSP | OSBP2 KIAA1664 ORP4 OSBPL4 | GSWDEQMECSKVMHssPssPsSDGKQKTVYQTLSAKLLWKK |
| Q96A49 | S269 | Sugiyama | SYAP1 PRO3113 | PPVVIKSQLKtQEDEEEIstsPGVsEFVsDAFDACNLNQED |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96D15 | T72 | Sugiyama | RCN3 UNQ239/PRO272 | FQYDHEAFLGREVAKEFDQLtPEEsQARLGRIVDRMDRAGD |
| Q96EK9 | S184 | Sugiyama | KTI12 SBBI81 | GSAQADVPKELEREEsGAAEsPALVtPDSEKSAKHGsGAFy |
| Q96EK9 | T189 | Sugiyama | KTI12 SBBI81 | DVPKELEREEsGAAEsPALVtPDSEKSAKHGsGAFysPELL |
| Q96F46 | T780 | SIGNOR|EPSD|PSP | IL17RA IL17R | LSCQAQGGCSRPAMVLTDPHtPYEEEQRQSVQsDQGyIsRs |
| Q96G01 | S585 | SIGNOR|iPTMNet|EPSD | BICD1 | RRGVssPVETRTSSEPVAKEsTEASKEPsPtKtPtIsPVIT |
| Q96G01 | T597 | SIGNOR|iPTMNet|EPSD | BICD1 | SSEPVAKEsTEASKEPsPtKtPtIsPVITAPPssPVLDtsD |
| Q96IG2 | S139 | PSP | FBXL20 FBL2 | IEVLNLNGCTKTTDATCTSLsKFCsKLRHLDLASCTSITNM |
| Q96IG2 | S143 | PSP | FBXL20 FBL2 | NLNGCTKTTDATCTSLsKFCsKLRHLDLASCTSITNMSLKA |
| Q96IG2 | S251 | PSP | FBXL20 FBL2 | CLQITDEGLITICRGCHKLQsLCAsGCSNITDAILNALGQN |
| Q96IG2 | S255 | PSP | FBXL20 FBL2 | TDEGLITICRGCHKLQsLCAsGCSNITDAILNALGQNCPRL |
| Q96IG2 | S421 | PSP | FBXL20 FBL2 | RTHLPNIKVHAyFAPVtPPPsVGGsRQRFCRCCIIL_____ |
| Q96IG2 | S425 | PSP | FBXL20 FBL2 | PNIKVHAyFAPVtPPPsVGGsRQRFCRCCIIL_________ |
| Q96IG2 | T417 | PSP | FBXL20 FBL2 | IKRLRTHLPNIKVHAyFAPVtPPPsVGGsRQRFCRCCIIL_ |
| Q96K76 | S910 | Sugiyama | USP47 | DGDNGDssKstEtsDFENIEsPLNERDsSAsVDNRELEQHI |
| Q96KS0 | S401 | EPSD|PSP | EGLN2 EIT6 | AAAKDKYQLASGQKGVQVPVsQPPtPT______________ |
| Q96KS0 | T405 | EPSD|PSP | EGLN2 EIT6 | DKYQLASGQKGVQVPVsQPPtPT__________________ |
| Q96R06 | S974 | SIGNOR|EPSD|PSP | SPAG5 | sMVSLQPAETPGMEESLAEMsIMTtELQSLCSLLQESKEEA |
| Q96R06 | T111 | SIGNOR|EPSD|PSP | SPAG5 | ETCQHEsDEQPLDPIPQIsstPKTsEEAVDPLGNyMVKtIV |
| Q96R06 | T937 | SIGNOR|EPSD|PSP | SPAG5 | NDRTFLGSILTAVADEEPEStPVPLLGsDKSAFTRVAsMVS |
| Q96R06 | T978 | SIGNOR|EPSD|PSP | SPAG5 | LQPAETPGMEESLAEMsIMTtELQSLCSLLQESKEEAIRTL |
| Q96RR4 | S129 | SIGNOR | CAMKK2 CAMKKB KIAA0787 | LAAGGsLDMNGRCICPsLPysPVssPQssPRLPRRPTVESH |
| Q96RR4 | S133 | SIGNOR | CAMKK2 CAMKKB KIAA0787 | GsLDMNGRCICPsLPysPVssPQssPRLPRRPTVESHHVSI |
| Q96RR4 | S137 | SIGNOR | CAMKK2 CAMKKB KIAA0787 | MNGRCICPsLPysPVssPQssPRLPRRPTVESHHVSITGMQ |
| Q99250 | T1966 | SIGNOR | SCN2A HBA NAC2 SCN2A1 SCN2A2 | KEDTLIDKLNENSTPEKTDMtPstTSPPSYDSVTKPEKEKF |
| Q99459 | T385 | Sugiyama | CDC5L KIAA0432 PCDC5RP | EAQNLMALtNVDtPLKGGLNtPLHEsDFsGVtPQRQVVQtP |
| Q99626 | S283 | SIGNOR|EPSD|PSP | CDX2 CDX3 | PPPQPPQPQPGPLRSVPEPLsPVSsLQAsVPGsVPGVLGPT |
| Q99626 | S287 | SIGNOR|EPSD | CDX2 CDX3 | PPQPQPGPLRSVPEPLsPVSsLQAsVPGsVPGVLGPTGGVL |
| Q99626 | S291 | SIGNOR|EPSD | CDX2 CDX3 | QPGPLRSVPEPLsPVSsLQAsVPGsVPGVLGPTGGVLNPTV |
| Q99626 | S295 | SIGNOR|EPSD | CDX2 CDX3 | LRSVPEPLsPVSsLQAsVPGsVPGVLGPTGGVLNPTVTQ__ |
| Q99684 | S94 | SIGNOR|PSP | GFI1 ZNF163 | sCEGSVCERSSEFEDFWRPPsPsAsPAsEKSMCPSLDEAQP |
| Q99684 | S98 | SIGNOR|PSP | GFI1 ZNF163 | SVCERSSEFEDFWRPPsPsAsPAsEKSMCPSLDEAQPFPLP |
| Q9BPU6 | T516 | SIGNOR|PSP | DPYSL5 CRMP5 ULIP6 | VAVVVHPGKKEMGtPLADtPtRPVTRHGGMRDLHEssFsLS |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BXF6 | S188 | PSP | RAB11FIP5 GAF1 KIAA0857 RIP11 | FTRNNLsAsMFDLSMKDKPRsPFSKIRDKMKGKKKyDLEsA |
| Q9BXF6 | T276 | PSP | RAB11FIP5 GAF1 KIAA0857 RIP11 | stLSSASGSLAYQGPGAELLtRsPsRssWLsTEGGRDsAQs |
| Q9BYG3 | S230 | GPS6|ELM|EPSD|PSP | NIFK MKI67IP NOPP34 | LRKKKKKVsGtLDtPEKtVDsQGPtPVCtPtFLERRKsQVA |
| Q9BYG3 | T234 | GPS6|SIGNOR|ELM|EPSD|PSP | NIFK MKI67IP NOPP34 | KKKVsGtLDtPEKtVDsQGPtPVCtPtFLERRKsQVAELND |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9BZS1 | S270 | SIGNOR|EPSD|PSP | FOXP3 IPEX JM2 | KEKLSAMQAHLAGKMALTKAsSVAsSDKGSCCIVAAGSQGP |
| Q9BZS1 | S274 | SIGNOR|EPSD|PSP | FOXP3 IPEX JM2 | SAMQAHLAGKMALTKAsSVAsSDKGSCCIVAAGSQGPVVPA |
| Q9GZV5 | S58 | SIGNOR | WWTR1 TAZ | PKPSSWRKKILPESFFKEPDsGsHsRQsstDSsGGHPGPRL |
| Q9GZV5 | S62 | SIGNOR | WWTR1 TAZ | SWRKKILPESFFKEPDsGsHsRQsstDSsGGHPGPRLAGGA |
| Q9H0B6 | S608 | EPSD|PSP | KLC2 | KsVEEPTQPGGTGLsDsRtLssssMDLsRRssLVG______ |
| Q9H0Z9 | S195 | SIGNOR|EPSD|PSP | RBM38 RNPC1 SEB4 | ASPAYAQYPPATYDQYPYAAsPATAASFVGYSYPAAVPQAL |
| Q9H6T3 | T491 | Sugiyama | RPAP3 | ATGTTSKKNssQDDLFPTsDtPRAKVLKIEEVsDTssLQPQ |
| Q9NP62 | S322 | EPSD|PSP | GCM1 GCMA | ALGRNHLADNCYSNYPFPLTsWPCsFSPSQNSSEPFYQQLP |
| Q9NQX3 | S270 | SIGNOR | GPHN GPH KIAA1385 | SRGVQVLPRDTAsLsttPsEsPRAQAtsRLstAsCPtPKVQ |
| Q9NRD5 | S342 | EPSD|PSP | PICK1 PRKCABP | LDQKHVQDIVFQLQRLVsTMsKYYNDCYAVLRDADVFPIEV |
| Q9NRD5 | S415 | EPSD|PSP | PICK1 PRKCABP | PSRDTRGAAGPLDKGGsWCDs____________________ |
| Q9NRR4 | S300 | SIGNOR|EPSD|PSP | DROSHA RN3 RNASE3L RNASEN | SYERSRERERERHRHRDNRRsPsLERSYKKEYKRSGRSYGL |
| Q9NRR4 | S302 | SIGNOR|EPSD|PSP | DROSHA RN3 RNASE3L RNASEN | ERSRERERERHRHRDNRRsPsLERSYKKEYKRSGRSYGLSV |
| Q9NW38 | T178 | PSP | FANCL PHF9 | YPAESPDYFVDFPVPFCASWtPQSSLISIYSQFLAAIESLK |
| Q9NXG6 | S485 | Sugiyama | P4HTM PH4 | ARQALFQQEMARLAREGGtDsQPEWALDRAYRDARVEL___ |
| Q9NYF8 | S531 | EPSD|PSP | BCLAF1 BTF KIAA0164 | ysPPLHKNLDAREKstFREEsPLRIKMIAsDSHRPEVKLKM |
| Q9NZ72 | S60 | SIGNOR|PSP | STMN3 SCLIP | MEVKQLDKRAsGQsFEVILKsPSDLsPEsPMLssPPKKKDt |
| Q9NZN8 | S242 | Sugiyama | CNOT2 CDC36 NOT2 HSPC131 MSTP046 | VTGLDLSDFPALADRNRREGsGNPtPLINPLAGRAPYVGMV |
| Q9NZN8 | T246 | Sugiyama | CNOT2 CDC36 NOT2 HSPC131 MSTP046 | DLSDFPALADRNRREGsGNPtPLINPLAGRAPYVGMVTKPA |
| Q9NZQ7 | S184 | SIGNOR|PSP | CD274 B7H1 PDCD1L1 PDCD1LG1 PDL1 | EVIWTSSDHQVLSGKTtTTNsKREEKLFNVtsTLRINTTTN |
| Q9NZQ7 | T180 | SIGNOR|PSP | CD274 B7H1 PDCD1L1 PDCD1LG1 PDL1 | YPKAEVIWTSSDHQVLSGKTtTTNsKREEKLFNVtsTLRIN |
| Q9P0L2 | S219 | GPS6|EPSD | MARK1 KIAA1477 MARK | ADFGFSNEFTVGNKLDtFCGsPPYAAPELFQGKKYDGPEVD |
| Q9UHD2 | S172 | PSP | TBK1 NAK | VyKLtDFGAARELEDDEQFVsLyGtEEyLHPDMYERAVLRK |
| Q9UKA4 | T1136 | SIGNOR|EPSD|PSP | AKAP11 AKAP220 KIAA0629 | DIKKLTKKLKGELAKEFAPAtPPstPHNSSVGSLSENEQNT |
| Q9UKA4 | T1140 | EPSD|PSP | AKAP11 AKAP220 KIAA0629 | LTKKLKGELAKEFAPAtPPstPHNSSVGSLSENEQNTIEKE |
| Q9UKC9 | T404 | PSP | FBXL2 FBL2 FBL3 | IKRMRAQLPHVKVHAYFAPVtPPTAVAGSGQRLCRCCVIL_ |
| Q9UKT5 | S12 | SIGNOR|EPSD|PSP | FBXO4 FBX4 | _________MAGSEPRsGtNsPPPPFSDWGRLEAAILSGWK |
| Q9UKT6 | T33 | SIGNOR|PSP | FBXL21P FBL21 FBL3 FBXL21 FBXL3B FBXL3P | VQLSGAAKQPKVGFYSSLNQtHTHTVLLDWGSLPHHVVLQI |
| Q9UKT9 | S378 | PSP | IKZF3 ZNFN1A3 | ELEKKSIHLPEKSVPSERGLsPNNsGHDstDtDsNHEERQN |
| Q9UMX1 | S342 | GPS6|EPSD|PSP | SUFU UNQ650/PRO1280 | PVLPPINPQRQNGLAHDRAPsRKDsLEsDsstAIIPHELIR |
| Q9UNE7 | S19 | Sugiyama | STUB1 CHIP PP1131 | __MKGKEEKEGGARLGAGGGsPEKsPsAQELKEQGNRLFVG |
| Q9UNE7 | S23 | Sugiyama | STUB1 CHIP PP1131 | GKEEKEGGARLGAGGGsPEKsPsAQELKEQGNRLFVGRKYP |
| Q9UPN3 | S7222 | SIGNOR|PSP | MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251 | FILPEGASQGMtPFRSRGRRsKPSsRAAsPtRssssASQSN |
| Q9UPN3 | S7226 | PSP | MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251 | EGASQGMtPFRSRGRRsKPSsRAAsPtRssssASQSNHsCT |
| Q9UPN3 | S7230 | SIGNOR|PSP | MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251 | QGMtPFRSRGRRsKPSsRAAsPtRssssASQSNHsCTSMPs |
| Q9UPN3 | S7234 | SIGNOR|PSP | MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251 | PFRSRGRRsKPSsRAAsPtRssssASQSNHsCTSMPssPAT |
| Q9UPN3 | S7310 | SIGNOR|PSP | MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251 | sssPAsTGAKTNRADPKKSAsRPGsRAGsRAGsRASsRRGs |
| Q9UPN3 | S7314 | SIGNOR|PSP | MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251 | AsTGAKTNRADPKKSAsRPGsRAGsRAGsRASsRRGsDAsD |
| Q9UPN3 | S7318 | SIGNOR|PSP | MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251 | AKTNRADPKKSAsRPGsRAGsRAGsRASsRRGsDAsDFDLL |
| Q9UPN3 | S7322 | SIGNOR|PSP | MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251 | RADPKKSAsRPGsRAGsRAGsRASsRRGsDAsDFDLLEtQs |
| Q9UPN3 | S7326 | SIGNOR|PSP | MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251 | KKSAsRPGsRAGsRAGsRASsRRGsDAsDFDLLEtQsACsD |
| Q9UPN3 | S7330 | SIGNOR|PSP | MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251 | sRPGsRAGsRAGsRASsRRGsDAsDFDLLEtQsACsDTSES |
| Q9UQD0 | T1938 | SIGNOR | SCN8A MED | KKTTSNKLENGGTHREKKEStPSTASLPSYDSVTKPEKEKQ |
| Q9Y266 | S139 | Sugiyama | NUDC | IDQKKDAENHEAQLKNGsLDsPGKQDtEEDEEEDEKDKGKL |
| Q9Y266 | T145 | Sugiyama | NUDC | AENHEAQLKNGsLDsPGKQDtEEDEEEDEKDKGKLKPNLGN |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2X9 | S638 | SIGNOR|EPSD|PSP | ZNF281 GZP1 ZBP99 | SEsQKEDPFNIAEPRVDLHtsGEHsELVQEENLsPGtQtPS |
| Q9Y448 | T294 | PSP | KNSTRN C15orf23 SKAP TRAF4AF1 HSD11 | QALKVKLEMKEERVRFLEQQtLCNNQVNDLTTALKEMEQLL |
| Q9Y4K3 | T266 | SIGNOR|PSP | TRAF6 RNF85 | TFGCHEKMQRNHLARHLQENtQSHMRMLAQAVHSLSVIPDS |
| Q9Y696 | S226 | Sugiyama | CLIC4 | RNFDIPKEMTGIWRYLtNAysRDEFtNtCPsDKEVEIAysD |
| Q9Y6H5 | S556 | SIGNOR|EPSD|PSP | SNCAIP | RVTLQNQLQQFLEAQKSEGKsLPSSPSSPSSPASRKSQWKS |
| Q9Y6K9 | S17 | EPSD|PSP | IKBKG FIP3 NEMO | ____MNRHLWKsQLCEMVQPsGGPAADQDVLGEEsPLGKPA |
| Q9Y6K9 | S31 | EPSD|PSP | IKBKG FIP3 NEMO | CEMVQPsGGPAADQDVLGEEsPLGKPAMLHLPsEQGAPETL |
| Q9Y6K9 | S43 | EPSD|PSP | IKBKG FIP3 NEMO | DQDVLGEEsPLGKPAMLHLPsEQGAPETLQRCLEENQELRD |
| Q9Y6K9 | S8 | EPSD|PSP | IKBKG FIP3 NEMO | _____________MNRHLWKsQLCEMVQPsGGPAADQDVLG |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.391554e-12 | 11.857 | 1 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.085643e-12 | 11.511 | 1 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.950218e-11 | 10.225 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.018607e-09 | 8.396 | 0 | 0 |
| M Phase | R-HSA-68886 | 5.938140e-09 | 8.226 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.694464e-09 | 8.174 | 1 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 7.747662e-09 | 8.111 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.288678e-08 | 7.640 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.231978e-08 | 7.651 | 1 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.435282e-08 | 7.353 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.459370e-07 | 6.836 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.602600e-07 | 6.795 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.560128e-07 | 6.592 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.064662e-07 | 6.514 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.519564e-07 | 6.454 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.004896e-06 | 5.998 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.513521e-06 | 5.820 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.513521e-06 | 5.820 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.969172e-06 | 5.706 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.106802e-06 | 5.676 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.877691e-06 | 5.163 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.362229e-05 | 4.866 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.409762e-05 | 4.851 | 1 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.576032e-05 | 4.802 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.608281e-05 | 4.794 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.838253e-05 | 4.736 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.352217e-05 | 4.629 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.608001e-05 | 4.584 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.267261e-05 | 4.278 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 5.381793e-05 | 4.269 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.584197e-05 | 4.253 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.735728e-05 | 4.111 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.735728e-05 | 4.111 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 9.558439e-05 | 4.020 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.061667e-04 | 3.974 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.114515e-04 | 3.953 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.125658e-04 | 3.949 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.410704e-04 | 3.851 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.578594e-04 | 3.802 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.568553e-04 | 3.805 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.792863e-04 | 3.746 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.242862e-04 | 3.649 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.242862e-04 | 3.649 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.452171e-04 | 3.610 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.908799e-04 | 3.536 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.908799e-04 | 3.536 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.972347e-04 | 3.527 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.092460e-04 | 3.510 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.186486e-04 | 3.497 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.209062e-04 | 3.494 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.292125e-04 | 3.483 | 1 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.487247e-04 | 3.458 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.604089e-04 | 3.443 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.236409e-04 | 3.373 | 1 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.253028e-04 | 3.371 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.289679e-04 | 3.368 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.604852e-04 | 3.337 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.915962e-04 | 3.308 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 5.235188e-04 | 3.281 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.386560e-04 | 3.269 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.773011e-04 | 3.239 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.525876e-04 | 3.123 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.525876e-04 | 3.123 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 7.185896e-04 | 3.144 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 7.426247e-04 | 3.129 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 7.754771e-04 | 3.110 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 7.831200e-04 | 3.106 | 0 | 0 |
| Kinesins | R-HSA-983189 | 7.921252e-04 | 3.101 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 9.290006e-04 | 3.032 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 9.708287e-04 | 3.013 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.012364e-03 | 2.995 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.033333e-03 | 2.986 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.083206e-03 | 2.965 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.229200e-03 | 2.910 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.229200e-03 | 2.910 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.206514e-03 | 2.918 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.199843e-03 | 2.921 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.236649e-03 | 2.908 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.281209e-03 | 2.892 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.287567e-03 | 2.890 | 1 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.377012e-03 | 2.861 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.377012e-03 | 2.861 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.390367e-03 | 2.857 | 1 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.408047e-03 | 2.851 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.573413e-03 | 2.803 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.615122e-03 | 2.792 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.655581e-03 | 2.781 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.655581e-03 | 2.781 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.874357e-03 | 2.727 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.919377e-03 | 2.717 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.969933e-03 | 2.706 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.984055e-03 | 2.702 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.177446e-03 | 2.662 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.177446e-03 | 2.662 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.164646e-03 | 2.665 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.272959e-03 | 2.643 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.272959e-03 | 2.643 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.326002e-03 | 2.633 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.591266e-03 | 2.586 | 1 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.679312e-03 | 2.572 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.680793e-03 | 2.572 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.919029e-03 | 2.535 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.771377e-03 | 2.557 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.960375e-03 | 2.529 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.996323e-03 | 2.523 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.201156e-03 | 2.495 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.255113e-03 | 2.487 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.356192e-03 | 2.474 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.463502e-03 | 2.460 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.600169e-03 | 2.444 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.754708e-03 | 2.425 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.789830e-03 | 2.421 | 1 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.839366e-03 | 2.416 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.887235e-03 | 2.410 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.038084e-03 | 2.394 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 4.226665e-03 | 2.374 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.226665e-03 | 2.374 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.772645e-03 | 2.321 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.294091e-03 | 2.367 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.530234e-03 | 2.344 | 1 | 0 |
| Cell junction organization | R-HSA-446728 | 4.588829e-03 | 2.338 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.855116e-03 | 2.314 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.420682e-03 | 2.355 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.828396e-03 | 2.316 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.733754e-03 | 2.325 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.968801e-03 | 2.304 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.968801e-03 | 2.304 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.119904e-03 | 2.291 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.179690e-03 | 2.286 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.222667e-03 | 2.282 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.243186e-03 | 2.280 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.432566e-03 | 2.265 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.654864e-03 | 2.248 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.812065e-03 | 2.236 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.827377e-03 | 2.235 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.850975e-03 | 2.164 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.850975e-03 | 2.164 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.241775e-03 | 2.140 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.850975e-03 | 2.164 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.782754e-03 | 2.169 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.955871e-03 | 2.158 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.860140e-03 | 2.164 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.023258e-03 | 2.153 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.990831e-03 | 2.223 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 7.446268e-03 | 2.128 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 7.446268e-03 | 2.128 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.548716e-03 | 2.122 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.096306e-03 | 2.092 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.128961e-03 | 2.090 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.856986e-03 | 2.053 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.900547e-03 | 2.051 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 8.900547e-03 | 2.051 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.139256e-03 | 2.039 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 9.741940e-03 | 2.011 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.003054e-02 | 1.999 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.084431e-02 | 1.965 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.106652e-02 | 1.956 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.106652e-02 | 1.956 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.100842e-02 | 1.958 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.164490e-02 | 1.934 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.119197e-02 | 1.951 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.137628e-02 | 1.944 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.119197e-02 | 1.951 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.100893e-02 | 1.958 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.140276e-02 | 1.943 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.200339e-02 | 1.921 | 1 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.208988e-02 | 1.918 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.216776e-02 | 1.915 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.231400e-02 | 1.910 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.255463e-02 | 1.901 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.255463e-02 | 1.901 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.255463e-02 | 1.901 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.255463e-02 | 1.901 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.255463e-02 | 1.901 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 1.315997e-02 | 1.881 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.329379e-02 | 1.876 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.375206e-02 | 1.862 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.396277e-02 | 1.855 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.427843e-02 | 1.845 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.432573e-02 | 1.844 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.450462e-02 | 1.838 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.576786e-02 | 1.802 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.519665e-02 | 1.818 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.541699e-02 | 1.812 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.659600e-02 | 1.780 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.471047e-02 | 1.832 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.471529e-02 | 1.832 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.536250e-02 | 1.814 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.619331e-02 | 1.791 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.519665e-02 | 1.818 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.466733e-02 | 1.834 | 1 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.483557e-02 | 1.829 | 1 | 1 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.677372e-02 | 1.775 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.677372e-02 | 1.775 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.689786e-02 | 1.772 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.711634e-02 | 1.767 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.719324e-02 | 1.765 | 1 | 1 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.772425e-02 | 1.751 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.772425e-02 | 1.751 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.778610e-02 | 1.750 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.778610e-02 | 1.750 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.778610e-02 | 1.750 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.779530e-02 | 1.750 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.779530e-02 | 1.750 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.779530e-02 | 1.750 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.923281e-02 | 1.716 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.923281e-02 | 1.716 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.801493e-02 | 1.744 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.801493e-02 | 1.744 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.896312e-02 | 1.722 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.880077e-02 | 1.726 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.099325e-02 | 1.678 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.944419e-02 | 1.711 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.825705e-02 | 1.739 | 1 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.896312e-02 | 1.722 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.896312e-02 | 1.722 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.986064e-02 | 1.702 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.100666e-02 | 1.678 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.117334e-02 | 1.674 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.117334e-02 | 1.674 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.117334e-02 | 1.674 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.117334e-02 | 1.674 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.123222e-02 | 1.673 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.162650e-02 | 1.665 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.166277e-02 | 1.664 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.166277e-02 | 1.664 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.182940e-02 | 1.661 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.241644e-02 | 1.649 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.303509e-02 | 1.638 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.471059e-02 | 1.607 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.489375e-02 | 1.604 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.489375e-02 | 1.604 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.521202e-02 | 1.598 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.528192e-02 | 1.597 | 1 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.541898e-02 | 1.595 | 1 | 1 |
| Semaphorin interactions | R-HSA-373755 | 2.575134e-02 | 1.589 | 1 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.619145e-02 | 1.582 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.634874e-02 | 1.579 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.646965e-02 | 1.577 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.825721e-02 | 1.549 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.825721e-02 | 1.549 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.825721e-02 | 1.549 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.825721e-02 | 1.549 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.825721e-02 | 1.549 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.803274e-02 | 1.552 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.079589e-02 | 1.512 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.156893e-02 | 1.501 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.175417e-02 | 1.498 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.049447e-02 | 1.516 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.881580e-02 | 1.540 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.200562e-02 | 1.495 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.200562e-02 | 1.495 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.893373e-02 | 1.539 | 1 | 1 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.079589e-02 | 1.512 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.720311e-02 | 1.565 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.950550e-02 | 1.530 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.124842e-02 | 1.505 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.919757e-02 | 1.535 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.049447e-02 | 1.516 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.207817e-02 | 1.494 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.115846e-02 | 1.506 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.226275e-02 | 1.491 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.230608e-02 | 1.491 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.230608e-02 | 1.491 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.311786e-02 | 1.480 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.348526e-02 | 1.475 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.348526e-02 | 1.475 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.348526e-02 | 1.475 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.348526e-02 | 1.475 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.373407e-02 | 1.472 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.396051e-02 | 1.469 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.446620e-02 | 1.463 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.479367e-02 | 1.458 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.515766e-02 | 1.454 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.515766e-02 | 1.454 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.531168e-02 | 1.452 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.700750e-02 | 1.432 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.726261e-02 | 1.429 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.771697e-02 | 1.423 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.816547e-02 | 1.418 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.903057e-02 | 1.409 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.910131e-02 | 1.408 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 3.931259e-02 | 1.405 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.021633e-02 | 1.396 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.127423e-02 | 1.384 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.192439e-02 | 1.378 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.214142e-02 | 1.375 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.231279e-02 | 1.374 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.252479e-02 | 1.371 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.262350e-02 | 1.370 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.312258e-02 | 1.365 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.320006e-02 | 1.365 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.412370e-02 | 1.355 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.412370e-02 | 1.355 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.412370e-02 | 1.355 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.412370e-02 | 1.355 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.423484e-02 | 1.354 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.423484e-02 | 1.354 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.438733e-02 | 1.353 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.438733e-02 | 1.353 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.518822e-02 | 1.345 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.600449e-02 | 1.337 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.600449e-02 | 1.337 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.600449e-02 | 1.337 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 5.643770e-02 | 1.248 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 5.643770e-02 | 1.248 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 5.643770e-02 | 1.248 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.750595e-02 | 1.323 | 1 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.750595e-02 | 1.323 | 1 | 1 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.815412e-02 | 1.235 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.824019e-02 | 1.235 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.826285e-02 | 1.235 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.826285e-02 | 1.235 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.694526e-02 | 1.328 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.533348e-02 | 1.257 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.039917e-02 | 1.298 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.680068e-02 | 1.330 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.268055e-02 | 1.278 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 4.816545e-02 | 1.317 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.782134e-02 | 1.320 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.815412e-02 | 1.235 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.412558e-02 | 1.267 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.325407e-02 | 1.274 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.700697e-02 | 1.244 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.188039e-02 | 1.285 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.910337e-02 | 1.309 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.711088e-02 | 1.243 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.800728e-02 | 1.319 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 5.846371e-02 | 1.233 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.877168e-02 | 1.231 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.877364e-02 | 1.231 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.924247e-02 | 1.227 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.925767e-02 | 1.227 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.925767e-02 | 1.227 | 1 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.925767e-02 | 1.227 | 1 | 1 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.925767e-02 | 1.227 | 1 | 1 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.925767e-02 | 1.227 | 1 | 1 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.925767e-02 | 1.227 | 1 | 1 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.130451e-02 | 1.213 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 6.306288e-02 | 1.200 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.319456e-02 | 1.199 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.386760e-02 | 1.195 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.386760e-02 | 1.195 | 0 | 0 |
| IRS activation | R-HSA-74713 | 6.386760e-02 | 1.195 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 6.386760e-02 | 1.195 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.402236e-02 | 1.194 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.476573e-02 | 1.189 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.481344e-02 | 1.188 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.509450e-02 | 1.186 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.548122e-02 | 1.184 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.980495e-02 | 1.156 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.980495e-02 | 1.156 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.115436e-02 | 1.148 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.115436e-02 | 1.148 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.126953e-02 | 1.147 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 7.164583e-02 | 1.145 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 7.249725e-02 | 1.140 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.249725e-02 | 1.140 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.249725e-02 | 1.140 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.251709e-02 | 1.140 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.251709e-02 | 1.140 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 7.251709e-02 | 1.140 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.308430e-02 | 1.136 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.332654e-02 | 1.135 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.455676e-02 | 1.128 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.493196e-02 | 1.125 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 9.566661e-02 | 1.019 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 9.566661e-02 | 1.019 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 9.566661e-02 | 1.019 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 9.566661e-02 | 1.019 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 9.566661e-02 | 1.019 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 9.566661e-02 | 1.019 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 9.566661e-02 | 1.019 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 9.566661e-02 | 1.019 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 9.566661e-02 | 1.019 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 9.566661e-02 | 1.019 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 9.566661e-02 | 1.019 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 8.696333e-02 | 1.061 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.696333e-02 | 1.061 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 8.696333e-02 | 1.061 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 8.696333e-02 | 1.061 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 9.061798e-02 | 1.043 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.725923e-02 | 1.059 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.725923e-02 | 1.059 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 9.498886e-02 | 1.022 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.002243e-01 | 0.999 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.002243e-01 | 0.999 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.002243e-01 | 0.999 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.002243e-01 | 0.999 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.869562e-02 | 1.052 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.869562e-02 | 1.052 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.758692e-02 | 1.011 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.818443e-02 | 1.107 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.665230e-02 | 1.115 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 9.555954e-02 | 1.020 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.555954e-02 | 1.020 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.234402e-02 | 1.035 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.858158e-02 | 1.053 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.498886e-02 | 1.022 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.822313e-02 | 1.054 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 9.061798e-02 | 1.043 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.402332e-02 | 1.076 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.402332e-02 | 1.076 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 9.539553e-02 | 1.020 | 1 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 8.353245e-02 | 1.078 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 8.353245e-02 | 1.078 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.333924e-02 | 1.030 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 8.696333e-02 | 1.061 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 8.696333e-02 | 1.061 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.878368e-02 | 1.005 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.900064e-02 | 1.051 | 0 | 0 |
| Protein folding | R-HSA-391251 | 7.772193e-02 | 1.109 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.157429e-02 | 1.088 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.918076e-02 | 1.101 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.900064e-02 | 1.051 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.559983e-02 | 1.068 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 9.985031e-02 | 1.001 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.014285e-01 | 0.994 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.029208e-01 | 0.987 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.034370e-01 | 0.985 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.034370e-01 | 0.985 | 1 | 1 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.034370e-01 | 0.985 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.034370e-01 | 0.985 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.034370e-01 | 0.985 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.040478e-01 | 0.983 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.043082e-01 | 0.982 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.044608e-01 | 0.981 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.069899e-01 | 0.971 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.085875e-01 | 0.964 | 1 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.090181e-01 | 0.963 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.093459e-01 | 0.961 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.093459e-01 | 0.961 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.095067e-01 | 0.961 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.095067e-01 | 0.961 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.095067e-01 | 0.961 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.095067e-01 | 0.961 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.100126e-01 | 0.959 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.100126e-01 | 0.959 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.100126e-01 | 0.959 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.100126e-01 | 0.959 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.100126e-01 | 0.959 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.106748e-01 | 0.956 | 1 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.106748e-01 | 0.956 | 1 | 1 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.106748e-01 | 0.956 | 1 | 1 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.106748e-01 | 0.956 | 1 | 1 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.106748e-01 | 0.956 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.111836e-01 | 0.954 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.111836e-01 | 0.954 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.130292e-01 | 0.947 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 1.130292e-01 | 0.947 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.172566e-01 | 0.931 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.190119e-01 | 0.924 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.190252e-01 | 0.924 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.209837e-01 | 0.917 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.209837e-01 | 0.917 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.214505e-01 | 0.916 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.214505e-01 | 0.916 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.214505e-01 | 0.916 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.214505e-01 | 0.916 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.214505e-01 | 0.916 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.214505e-01 | 0.916 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.214505e-01 | 0.916 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.214505e-01 | 0.916 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.214505e-01 | 0.916 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.214505e-01 | 0.916 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.214505e-01 | 0.916 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.214505e-01 | 0.916 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.214505e-01 | 0.916 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.214505e-01 | 0.916 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.214505e-01 | 0.916 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.214505e-01 | 0.916 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.214505e-01 | 0.916 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.214505e-01 | 0.916 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.214505e-01 | 0.916 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.214505e-01 | 0.916 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.231773e-01 | 0.909 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.236613e-01 | 0.908 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.249227e-01 | 0.903 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.250881e-01 | 0.903 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.259303e-01 | 0.900 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.377225e-01 | 0.861 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.377225e-01 | 0.861 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.377225e-01 | 0.861 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.377225e-01 | 0.861 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.377225e-01 | 0.861 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.829052e-01 | 0.738 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.829052e-01 | 0.738 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.829052e-01 | 0.738 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.829052e-01 | 0.738 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 1.829052e-01 | 0.738 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.829052e-01 | 0.738 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.829052e-01 | 0.738 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.416390e-01 | 0.849 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.416390e-01 | 0.849 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.416390e-01 | 0.849 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.723492e-01 | 0.764 | 0 | 0 |
| RSK activation | R-HSA-444257 | 1.723492e-01 | 0.764 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.723492e-01 | 0.764 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.723492e-01 | 0.764 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.325113e-01 | 0.878 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.325113e-01 | 0.878 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.559480e-01 | 0.807 | 1 | 1 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.559480e-01 | 0.807 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.398157e-01 | 0.854 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.807893e-01 | 0.743 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.598356e-01 | 0.796 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.416827e-01 | 0.849 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.416827e-01 | 0.849 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.809346e-01 | 0.742 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.592309e-01 | 0.798 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.776650e-01 | 0.750 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.383598e-01 | 0.859 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.524886e-01 | 0.817 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.728335e-01 | 0.762 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.728335e-01 | 0.762 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.672780e-01 | 0.777 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.683386e-01 | 0.774 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.900005e-01 | 0.721 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.365301e-01 | 0.865 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.716053e-01 | 0.765 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.662179e-01 | 0.779 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.313275e-01 | 0.882 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.592151e-01 | 0.798 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.817379e-01 | 0.741 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.416827e-01 | 0.849 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.899442e-01 | 0.721 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.309614e-01 | 0.883 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.592309e-01 | 0.798 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.899442e-01 | 0.721 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.826929e-01 | 0.738 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 1.829052e-01 | 0.738 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.614197e-01 | 0.792 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.284226e-01 | 0.891 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 1.829052e-01 | 0.738 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.697019e-01 | 0.770 | 1 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.407791e-01 | 0.851 | 1 | 1 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.899442e-01 | 0.721 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.807893e-01 | 0.743 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.313275e-01 | 0.882 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 1.807893e-01 | 0.743 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.559480e-01 | 0.807 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.559480e-01 | 0.807 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.559480e-01 | 0.807 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.807893e-01 | 0.743 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.672780e-01 | 0.777 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.377225e-01 | 0.861 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.325113e-01 | 0.878 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.325113e-01 | 0.878 | 1 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.282869e-01 | 0.892 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.840084e-01 | 0.735 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.891568e-01 | 0.723 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.889413e-01 | 0.724 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.824821e-01 | 0.739 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.416390e-01 | 0.849 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.416827e-01 | 0.849 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 1.377225e-01 | 0.861 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.592309e-01 | 0.798 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.625082e-01 | 0.789 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.416390e-01 | 0.849 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.829052e-01 | 0.738 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.427751e-01 | 0.845 | 1 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.653188e-01 | 0.782 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.908385e-01 | 0.719 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.775194e-01 | 0.751 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.910291e-01 | 0.719 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.959809e-01 | 0.708 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.969108e-01 | 0.706 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.969108e-01 | 0.706 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.975669e-01 | 0.704 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.986944e-01 | 0.702 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.986944e-01 | 0.702 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.000364e-01 | 0.699 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.027829e-01 | 0.693 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.029956e-01 | 0.693 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 2.047184e-01 | 0.689 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.047184e-01 | 0.689 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.047184e-01 | 0.689 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.068303e-01 | 0.684 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.068303e-01 | 0.684 | 1 | 1 |
| DNA Damage Bypass | R-HSA-73893 | 2.097411e-01 | 0.678 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.097411e-01 | 0.678 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.097411e-01 | 0.678 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.131874e-01 | 0.671 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.131874e-01 | 0.671 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.157047e-01 | 0.666 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.168886e-01 | 0.664 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.168886e-01 | 0.664 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.168886e-01 | 0.664 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.258957e-01 | 0.646 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.260601e-01 | 0.646 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.260601e-01 | 0.646 | 1 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.260601e-01 | 0.646 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.281569e-01 | 0.642 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.281569e-01 | 0.642 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.281569e-01 | 0.642 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.281569e-01 | 0.642 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.281569e-01 | 0.642 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.281569e-01 | 0.642 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.281569e-01 | 0.642 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.281569e-01 | 0.642 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.282505e-01 | 0.642 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.298356e-01 | 0.639 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.298356e-01 | 0.639 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.298356e-01 | 0.639 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.298356e-01 | 0.639 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.298356e-01 | 0.639 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.299099e-01 | 0.638 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.219086e-01 | 0.492 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.219086e-01 | 0.492 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.219086e-01 | 0.492 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.219086e-01 | 0.492 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.219086e-01 | 0.492 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.219086e-01 | 0.492 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.219086e-01 | 0.492 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.219086e-01 | 0.492 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.219086e-01 | 0.492 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.219086e-01 | 0.492 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.219086e-01 | 0.492 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.219086e-01 | 0.492 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.219086e-01 | 0.492 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.219086e-01 | 0.492 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.774234e-01 | 0.557 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.774234e-01 | 0.557 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 2.774234e-01 | 0.557 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.774234e-01 | 0.557 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 2.774234e-01 | 0.557 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 2.774234e-01 | 0.557 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 4.042775e-01 | 0.393 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.042775e-01 | 0.393 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.042775e-01 | 0.393 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.042775e-01 | 0.393 | 0 | 0 |
| Defective visual phototransduction due to ABCA4 loss of function | R-HSA-9918454 | 4.042775e-01 | 0.393 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.042775e-01 | 0.393 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.042775e-01 | 0.393 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 4.042775e-01 | 0.393 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.042775e-01 | 0.393 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 2.383220e-01 | 0.623 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.383220e-01 | 0.623 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.248172e-01 | 0.488 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.727618e-01 | 0.564 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.727618e-01 | 0.564 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.338623e-01 | 0.631 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.338623e-01 | 0.631 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 3.076718e-01 | 0.512 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.713623e-01 | 0.430 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.713623e-01 | 0.430 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.713623e-01 | 0.430 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.495088e-01 | 0.603 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.900734e-01 | 0.537 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.375150e-01 | 0.624 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.427223e-01 | 0.465 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.427223e-01 | 0.465 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.188554e-01 | 0.496 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.165660e-01 | 0.380 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.165660e-01 | 0.380 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.165660e-01 | 0.380 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.165660e-01 | 0.380 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.165660e-01 | 0.380 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.803674e-01 | 0.552 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.803674e-01 | 0.552 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.478395e-01 | 0.459 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.478395e-01 | 0.459 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.478395e-01 | 0.459 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.478395e-01 | 0.459 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.840586e-01 | 0.547 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.840586e-01 | 0.547 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.676880e-01 | 0.572 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 2.413604e-01 | 0.617 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.413604e-01 | 0.617 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.485643e-01 | 0.458 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.768543e-01 | 0.424 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.600676e-01 | 0.337 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.600676e-01 | 0.337 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.600676e-01 | 0.337 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.866613e-01 | 0.543 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.473305e-01 | 0.459 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.865843e-01 | 0.543 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 4.057422e-01 | 0.392 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.057422e-01 | 0.392 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.849172e-01 | 0.545 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.215161e-01 | 0.493 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.459822e-01 | 0.351 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.459822e-01 | 0.351 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.689168e-01 | 0.570 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.835907e-01 | 0.547 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.193369e-01 | 0.496 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.927664e-01 | 0.406 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.243551e-01 | 0.372 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.243551e-01 | 0.372 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.243551e-01 | 0.372 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.751479e-01 | 0.426 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.074496e-01 | 0.390 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.074496e-01 | 0.390 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.932212e-01 | 0.405 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.932212e-01 | 0.405 | 1 | 1 |
| Transcription of the HIV genome | R-HSA-167172 | 3.969541e-01 | 0.401 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.131829e-01 | 0.384 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.489337e-01 | 0.348 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.489337e-01 | 0.348 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.489337e-01 | 0.348 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.800063e-01 | 0.553 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.553554e-01 | 0.342 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.458804e-01 | 0.461 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 3.427223e-01 | 0.465 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 3.045049e-01 | 0.516 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.614931e-01 | 0.442 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.614931e-01 | 0.442 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.193912e-01 | 0.377 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.705345e-01 | 0.568 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.383220e-01 | 0.623 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.478395e-01 | 0.459 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.977650e-01 | 0.526 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.616776e-01 | 0.582 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.188554e-01 | 0.496 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.485643e-01 | 0.458 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.329501e-01 | 0.478 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.140674e-01 | 0.383 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.365527e-01 | 0.626 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.900734e-01 | 0.537 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.768543e-01 | 0.424 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.328399e-01 | 0.364 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.932212e-01 | 0.405 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.700123e-01 | 0.432 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.057422e-01 | 0.392 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.600676e-01 | 0.337 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.698715e-01 | 0.569 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.900734e-01 | 0.537 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.713623e-01 | 0.430 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.322865e-01 | 0.634 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.497852e-01 | 0.602 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.600676e-01 | 0.337 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 4.600676e-01 | 0.337 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.807605e-01 | 0.419 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.991687e-01 | 0.399 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 4.165660e-01 | 0.380 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.643005e-01 | 0.578 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.245241e-01 | 0.489 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.245241e-01 | 0.489 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.076718e-01 | 0.512 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.165660e-01 | 0.380 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.165660e-01 | 0.380 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.449461e-01 | 0.611 | 0 | 0 |
| PKA activation | R-HSA-163615 | 3.478395e-01 | 0.459 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.287995e-01 | 0.368 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.616776e-01 | 0.582 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.991687e-01 | 0.399 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.282375e-01 | 0.368 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.431476e-01 | 0.614 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.046247e-01 | 0.516 | 1 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.529117e-01 | 0.597 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.343599e-01 | 0.362 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.031779e-01 | 0.518 | 1 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.233170e-01 | 0.490 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.038842e-01 | 0.394 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.444325e-01 | 0.463 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 2.727618e-01 | 0.564 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.431678e-01 | 0.614 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.927664e-01 | 0.406 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 4.343599e-01 | 0.362 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.154818e-01 | 0.381 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.525569e-01 | 0.453 | 1 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.294192e-01 | 0.367 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 3.412899e-01 | 0.467 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.490821e-01 | 0.457 | 1 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.807605e-01 | 0.419 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.294239e-01 | 0.367 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.900734e-01 | 0.537 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.768543e-01 | 0.424 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.057422e-01 | 0.392 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.427223e-01 | 0.465 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.554316e-01 | 0.593 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.980658e-01 | 0.526 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.338623e-01 | 0.631 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.776211e-01 | 0.423 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.719304e-01 | 0.430 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 2.383220e-01 | 0.623 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.121137e-01 | 0.385 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.991687e-01 | 0.399 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.380972e-01 | 0.358 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.596827e-01 | 0.444 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.478395e-01 | 0.459 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.298477e-01 | 0.367 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.383220e-01 | 0.623 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.248172e-01 | 0.488 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.041549e-01 | 0.517 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.427223e-01 | 0.465 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.478395e-01 | 0.459 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.836151e-01 | 0.416 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.328390e-01 | 0.633 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.765935e-01 | 0.558 | 1 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.798962e-01 | 0.553 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.630747e-01 | 0.440 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.219086e-01 | 0.492 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.219086e-01 | 0.492 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 3.219086e-01 | 0.492 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.219086e-01 | 0.492 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.219086e-01 | 0.492 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.219086e-01 | 0.492 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.042775e-01 | 0.393 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.042775e-01 | 0.393 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.042775e-01 | 0.393 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 4.042775e-01 | 0.393 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.616776e-01 | 0.582 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.713623e-01 | 0.430 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.165660e-01 | 0.380 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.165660e-01 | 0.380 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.478395e-01 | 0.459 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.451012e-01 | 0.462 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.751479e-01 | 0.426 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.697793e-01 | 0.432 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.343599e-01 | 0.362 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.932212e-01 | 0.405 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.700123e-01 | 0.432 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.698715e-01 | 0.569 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.368674e-01 | 0.473 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.456357e-01 | 0.351 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 4.459822e-01 | 0.351 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.039711e-01 | 0.517 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.305986e-01 | 0.366 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.020499e-01 | 0.396 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.248172e-01 | 0.488 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.983649e-01 | 0.525 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.713623e-01 | 0.430 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.495088e-01 | 0.603 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.600676e-01 | 0.337 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.459822e-01 | 0.351 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.489337e-01 | 0.348 | 1 | 1 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.489337e-01 | 0.348 | 1 | 1 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.269502e-01 | 0.486 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.357388e-01 | 0.474 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.383220e-01 | 0.623 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.478395e-01 | 0.459 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.423299e-01 | 0.466 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 4.343599e-01 | 0.362 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.219086e-01 | 0.492 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 3.219086e-01 | 0.492 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 4.042775e-01 | 0.393 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 4.042775e-01 | 0.393 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 2.495088e-01 | 0.603 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 3.485643e-01 | 0.458 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.121137e-01 | 0.385 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.692474e-01 | 0.570 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.625894e-01 | 0.441 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.000718e-01 | 0.398 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.143274e-01 | 0.503 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.696279e-01 | 0.569 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.121137e-01 | 0.385 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.474778e-01 | 0.349 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.614931e-01 | 0.442 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 3.991687e-01 | 0.399 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.586404e-01 | 0.339 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.600676e-01 | 0.337 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.459822e-01 | 0.351 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.427369e-01 | 0.615 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.449461e-01 | 0.611 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 4.121137e-01 | 0.385 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.605443e-01 | 0.337 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.625792e-01 | 0.335 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.678054e-01 | 0.330 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.678054e-01 | 0.330 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.694860e-01 | 0.328 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.720554e-01 | 0.326 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.740241e-01 | 0.324 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.766451e-01 | 0.322 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 4.766451e-01 | 0.322 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.766451e-01 | 0.322 | 0 | 0 |
| Defective gamma-carboxylation of F9 | R-HSA-9673240 | 4.766451e-01 | 0.322 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.766451e-01 | 0.322 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.766451e-01 | 0.322 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.766451e-01 | 0.322 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.766451e-01 | 0.322 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.766451e-01 | 0.322 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.766451e-01 | 0.322 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 4.766451e-01 | 0.322 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.768812e-01 | 0.322 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.790435e-01 | 0.320 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.790435e-01 | 0.320 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.790435e-01 | 0.320 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.790435e-01 | 0.320 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 4.790435e-01 | 0.320 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 4.790435e-01 | 0.320 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.790435e-01 | 0.320 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.827596e-01 | 0.316 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.827600e-01 | 0.316 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.833120e-01 | 0.316 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.898452e-01 | 0.310 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.939080e-01 | 0.306 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.963991e-01 | 0.304 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.016137e-01 | 0.300 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.016137e-01 | 0.300 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.016137e-01 | 0.300 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 5.016137e-01 | 0.300 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 5.016137e-01 | 0.300 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.016137e-01 | 0.300 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 5.016137e-01 | 0.300 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.046844e-01 | 0.297 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 5.046844e-01 | 0.297 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.070234e-01 | 0.295 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.099657e-01 | 0.292 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 5.111469e-01 | 0.291 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.111469e-01 | 0.291 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.131606e-01 | 0.290 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.173835e-01 | 0.286 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.173835e-01 | 0.286 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 5.173835e-01 | 0.286 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.173835e-01 | 0.286 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.173835e-01 | 0.286 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.173835e-01 | 0.286 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.222169e-01 | 0.282 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.222169e-01 | 0.282 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 5.233760e-01 | 0.281 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.255326e-01 | 0.279 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.262653e-01 | 0.279 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.262653e-01 | 0.279 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.298051e-01 | 0.276 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 5.298051e-01 | 0.276 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 5.298051e-01 | 0.276 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 5.329846e-01 | 0.273 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.358929e-01 | 0.271 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.402253e-01 | 0.267 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.402253e-01 | 0.267 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 5.402253e-01 | 0.267 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.402253e-01 | 0.267 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 5.402253e-01 | 0.267 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.402253e-01 | 0.267 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 5.402253e-01 | 0.267 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.402253e-01 | 0.267 | 0 | 0 |
| Vasopressin-like receptors | R-HSA-388479 | 5.402253e-01 | 0.267 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.410374e-01 | 0.267 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.410374e-01 | 0.267 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.410374e-01 | 0.267 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.410374e-01 | 0.267 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.421718e-01 | 0.266 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.421718e-01 | 0.266 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 5.421718e-01 | 0.266 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.421718e-01 | 0.266 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.421718e-01 | 0.266 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.421718e-01 | 0.266 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.421718e-01 | 0.266 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.421718e-01 | 0.266 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.434897e-01 | 0.265 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 5.437852e-01 | 0.265 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.474539e-01 | 0.262 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.474539e-01 | 0.262 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.493246e-01 | 0.260 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.529907e-01 | 0.257 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.565058e-01 | 0.255 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.565058e-01 | 0.255 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.682070e-01 | 0.245 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 5.682070e-01 | 0.245 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.682070e-01 | 0.245 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.682070e-01 | 0.245 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.684013e-01 | 0.245 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.684013e-01 | 0.245 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.684891e-01 | 0.245 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.684891e-01 | 0.245 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.694209e-01 | 0.245 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.695446e-01 | 0.244 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.698307e-01 | 0.244 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.707222e-01 | 0.244 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.720244e-01 | 0.243 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.720244e-01 | 0.243 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.760254e-01 | 0.240 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.782414e-01 | 0.238 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.782414e-01 | 0.238 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 5.782414e-01 | 0.238 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 5.782414e-01 | 0.238 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.782414e-01 | 0.238 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.782414e-01 | 0.238 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.782414e-01 | 0.238 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.782414e-01 | 0.238 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.782414e-01 | 0.238 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.782414e-01 | 0.238 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.782414e-01 | 0.238 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.782414e-01 | 0.238 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.875749e-01 | 0.231 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.884864e-01 | 0.230 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.884864e-01 | 0.230 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.901795e-01 | 0.229 | 1 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.906087e-01 | 0.229 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.942323e-01 | 0.226 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.942323e-01 | 0.226 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.942323e-01 | 0.226 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.942323e-01 | 0.226 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 5.960846e-01 | 0.225 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.960846e-01 | 0.225 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.960846e-01 | 0.225 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.960846e-01 | 0.225 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 5.960846e-01 | 0.225 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.960846e-01 | 0.225 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.960846e-01 | 0.225 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.960846e-01 | 0.225 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.960846e-01 | 0.225 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.960846e-01 | 0.225 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.960846e-01 | 0.225 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.960846e-01 | 0.225 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.960846e-01 | 0.225 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 5.960846e-01 | 0.225 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.006355e-01 | 0.221 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.006355e-01 | 0.221 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.006355e-01 | 0.221 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.011872e-01 | 0.221 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.121711e-01 | 0.213 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.121711e-01 | 0.213 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.121711e-01 | 0.213 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.121711e-01 | 0.213 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.131830e-01 | 0.212 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 6.131830e-01 | 0.212 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 6.131830e-01 | 0.212 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 6.131830e-01 | 0.212 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 6.131830e-01 | 0.212 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.170334e-01 | 0.210 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.181733e-01 | 0.209 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.181733e-01 | 0.209 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 6.181733e-01 | 0.209 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.235530e-01 | 0.205 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.235530e-01 | 0.205 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.274962e-01 | 0.202 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.279571e-01 | 0.202 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.279571e-01 | 0.202 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.279571e-01 | 0.202 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 6.330560e-01 | 0.199 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 6.330560e-01 | 0.199 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.330560e-01 | 0.199 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.382306e-01 | 0.195 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.410153e-01 | 0.193 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.410153e-01 | 0.193 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 6.412086e-01 | 0.193 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 6.412086e-01 | 0.193 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 6.412086e-01 | 0.193 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.412086e-01 | 0.193 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.412086e-01 | 0.193 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.421475e-01 | 0.192 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.451603e-01 | 0.190 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.451603e-01 | 0.190 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.451603e-01 | 0.190 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.451603e-01 | 0.190 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.451603e-01 | 0.190 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.451603e-01 | 0.190 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.451603e-01 | 0.190 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.451603e-01 | 0.190 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.451603e-01 | 0.190 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.451603e-01 | 0.190 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.451603e-01 | 0.190 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.458267e-01 | 0.190 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 6.458629e-01 | 0.190 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.458629e-01 | 0.190 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 6.458629e-01 | 0.190 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.458629e-01 | 0.190 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.464525e-01 | 0.189 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.532377e-01 | 0.185 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.532377e-01 | 0.185 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.539603e-01 | 0.184 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.539603e-01 | 0.184 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.539603e-01 | 0.184 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.545860e-01 | 0.184 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 6.579986e-01 | 0.182 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.633130e-01 | 0.178 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.633130e-01 | 0.178 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 6.642737e-01 | 0.178 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.688163e-01 | 0.175 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 6.744879e-01 | 0.171 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.744879e-01 | 0.171 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.763147e-01 | 0.170 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.763147e-01 | 0.170 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.763147e-01 | 0.170 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.763147e-01 | 0.170 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.763147e-01 | 0.170 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.763147e-01 | 0.170 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.763147e-01 | 0.170 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.786324e-01 | 0.168 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.786324e-01 | 0.168 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.786324e-01 | 0.168 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.788189e-01 | 0.168 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.817793e-01 | 0.166 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.817793e-01 | 0.166 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.817793e-01 | 0.166 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 6.844707e-01 | 0.165 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.846674e-01 | 0.165 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.881420e-01 | 0.162 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.882758e-01 | 0.162 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.882758e-01 | 0.162 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.882758e-01 | 0.162 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.882758e-01 | 0.162 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.882758e-01 | 0.162 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.882758e-01 | 0.162 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.882758e-01 | 0.162 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.882758e-01 | 0.162 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 6.882758e-01 | 0.162 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.968865e-01 | 0.157 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.986798e-01 | 0.156 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.019746e-01 | 0.154 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.019746e-01 | 0.154 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.019746e-01 | 0.154 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.019746e-01 | 0.154 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.045973e-01 | 0.152 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.045973e-01 | 0.152 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.045973e-01 | 0.152 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.045973e-01 | 0.152 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.045973e-01 | 0.152 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 7.045973e-01 | 0.152 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 7.045973e-01 | 0.152 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 7.045973e-01 | 0.152 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 7.045973e-01 | 0.152 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.045973e-01 | 0.152 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.046738e-01 | 0.152 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.046738e-01 | 0.152 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.046738e-01 | 0.152 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 7.093953e-01 | 0.149 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.093953e-01 | 0.149 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.095055e-01 | 0.149 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.130621e-01 | 0.147 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.130621e-01 | 0.147 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.142034e-01 | 0.146 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.239218e-01 | 0.140 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.240002e-01 | 0.140 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.240587e-01 | 0.140 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 7.261547e-01 | 0.139 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.261547e-01 | 0.139 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 7.261547e-01 | 0.139 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.261547e-01 | 0.139 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.261547e-01 | 0.139 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 7.261547e-01 | 0.139 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 7.261547e-01 | 0.139 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.261547e-01 | 0.139 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 7.261547e-01 | 0.139 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.261547e-01 | 0.139 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.261547e-01 | 0.139 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.261547e-01 | 0.139 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 7.261547e-01 | 0.139 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.261547e-01 | 0.139 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.261547e-01 | 0.139 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.261547e-01 | 0.139 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 7.261547e-01 | 0.139 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.261547e-01 | 0.139 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.266228e-01 | 0.139 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.266228e-01 | 0.139 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.269086e-01 | 0.139 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.269086e-01 | 0.139 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.290707e-01 | 0.137 | 1 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.306378e-01 | 0.136 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 7.306378e-01 | 0.136 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.307883e-01 | 0.136 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 7.307883e-01 | 0.136 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.307883e-01 | 0.136 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 7.307883e-01 | 0.136 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.331771e-01 | 0.135 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.349078e-01 | 0.134 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.349078e-01 | 0.134 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.353070e-01 | 0.134 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.422206e-01 | 0.129 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.422206e-01 | 0.129 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 7.422206e-01 | 0.129 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.454244e-01 | 0.128 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.475960e-01 | 0.126 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.505860e-01 | 0.125 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 7.549782e-01 | 0.122 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 7.549782e-01 | 0.122 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 7.549782e-01 | 0.122 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.588363e-01 | 0.120 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.588363e-01 | 0.120 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.594327e-01 | 0.120 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.594327e-01 | 0.120 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.594327e-01 | 0.120 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.594327e-01 | 0.120 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.594327e-01 | 0.120 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.594327e-01 | 0.120 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.594327e-01 | 0.120 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.594327e-01 | 0.120 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.594327e-01 | 0.120 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.594327e-01 | 0.120 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.594327e-01 | 0.120 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 7.594327e-01 | 0.120 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.594327e-01 | 0.120 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.595817e-01 | 0.119 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 7.595817e-01 | 0.119 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.625674e-01 | 0.118 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.642011e-01 | 0.117 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.686079e-01 | 0.114 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.731275e-01 | 0.112 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.739480e-01 | 0.111 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.754097e-01 | 0.110 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.760214e-01 | 0.110 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.760214e-01 | 0.110 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.760214e-01 | 0.110 | 1 | 1 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.772666e-01 | 0.109 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.772666e-01 | 0.109 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.772666e-01 | 0.109 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.805160e-01 | 0.108 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.809123e-01 | 0.107 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.824449e-01 | 0.107 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.824449e-01 | 0.107 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.824449e-01 | 0.107 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 7.824449e-01 | 0.107 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.824449e-01 | 0.107 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.846180e-01 | 0.105 | 1 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.871649e-01 | 0.104 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.871649e-01 | 0.104 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.871649e-01 | 0.104 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 7.881082e-01 | 0.103 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.886684e-01 | 0.103 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.886684e-01 | 0.103 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.886684e-01 | 0.103 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.886684e-01 | 0.103 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.886684e-01 | 0.103 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.886684e-01 | 0.103 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.886684e-01 | 0.103 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.886684e-01 | 0.103 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.886684e-01 | 0.103 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.886684e-01 | 0.103 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.886684e-01 | 0.103 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.886684e-01 | 0.103 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.886684e-01 | 0.103 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.886684e-01 | 0.103 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.899460e-01 | 0.102 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.915599e-01 | 0.102 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.967940e-01 | 0.099 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.977583e-01 | 0.098 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 7.977583e-01 | 0.098 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 7.977583e-01 | 0.098 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.977583e-01 | 0.098 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.977583e-01 | 0.098 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.995058e-01 | 0.097 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.995058e-01 | 0.097 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.995397e-01 | 0.097 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.003559e-01 | 0.097 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.016700e-01 | 0.096 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.062210e-01 | 0.094 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.062210e-01 | 0.094 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 8.143527e-01 | 0.089 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 8.143527e-01 | 0.089 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 8.143527e-01 | 0.089 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.143527e-01 | 0.089 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.143527e-01 | 0.089 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.143527e-01 | 0.089 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 8.143527e-01 | 0.089 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.143527e-01 | 0.089 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 8.143527e-01 | 0.089 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.143527e-01 | 0.089 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.143527e-01 | 0.089 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.143527e-01 | 0.089 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 8.145363e-01 | 0.089 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.145363e-01 | 0.089 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.145363e-01 | 0.089 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.153430e-01 | 0.089 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 8.154304e-01 | 0.089 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.165607e-01 | 0.088 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 8.165607e-01 | 0.088 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 8.165607e-01 | 0.088 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.165607e-01 | 0.088 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.165607e-01 | 0.088 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.200311e-01 | 0.086 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.200311e-01 | 0.086 | 1 | 1 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.216430e-01 | 0.085 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.216430e-01 | 0.085 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.267248e-01 | 0.083 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.302676e-01 | 0.081 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.302676e-01 | 0.081 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.315437e-01 | 0.080 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.325971e-01 | 0.080 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.337817e-01 | 0.079 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.337817e-01 | 0.079 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.346961e-01 | 0.078 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.369167e-01 | 0.077 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.369167e-01 | 0.077 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.369167e-01 | 0.077 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 8.369167e-01 | 0.077 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.369167e-01 | 0.077 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.369167e-01 | 0.077 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.369167e-01 | 0.077 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.369167e-01 | 0.077 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.369167e-01 | 0.077 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 8.369167e-01 | 0.077 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.369167e-01 | 0.077 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 8.369167e-01 | 0.077 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.369167e-01 | 0.077 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.369167e-01 | 0.077 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.445720e-01 | 0.073 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.462674e-01 | 0.072 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.491478e-01 | 0.071 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 8.495278e-01 | 0.071 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 8.495278e-01 | 0.071 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.495278e-01 | 0.071 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.495278e-01 | 0.071 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.511630e-01 | 0.070 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.566163e-01 | 0.067 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.566504e-01 | 0.067 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.566504e-01 | 0.067 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.566504e-01 | 0.067 | 0 | 0 |
| Gamma-carboxylation of protein precursors | R-HSA-159740 | 8.567394e-01 | 0.067 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 8.567394e-01 | 0.067 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.567394e-01 | 0.067 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 8.567394e-01 | 0.067 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.639031e-01 | 0.064 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.639031e-01 | 0.064 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.648581e-01 | 0.063 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.648581e-01 | 0.063 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.648581e-01 | 0.063 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.673581e-01 | 0.062 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.673581e-01 | 0.062 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.673581e-01 | 0.062 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.727878e-01 | 0.059 | 1 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.741536e-01 | 0.058 | 0 | 0 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | R-HSA-159854 | 8.741536e-01 | 0.058 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.741536e-01 | 0.058 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.741536e-01 | 0.058 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.741536e-01 | 0.058 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.741536e-01 | 0.058 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.741536e-01 | 0.058 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.741536e-01 | 0.058 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.741536e-01 | 0.058 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.741536e-01 | 0.058 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.741536e-01 | 0.058 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.741536e-01 | 0.058 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.767518e-01 | 0.057 | 1 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.770082e-01 | 0.057 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.770082e-01 | 0.057 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.770082e-01 | 0.057 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.770082e-01 | 0.057 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.770082e-01 | 0.057 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.770082e-01 | 0.057 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 8.782230e-01 | 0.056 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.797724e-01 | 0.056 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.867905e-01 | 0.052 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.867905e-01 | 0.052 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.889393e-01 | 0.051 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.889393e-01 | 0.051 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.889393e-01 | 0.051 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 8.894520e-01 | 0.051 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.894520e-01 | 0.051 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.894520e-01 | 0.051 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.894520e-01 | 0.051 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.894520e-01 | 0.051 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.894520e-01 | 0.051 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.894520e-01 | 0.051 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.895849e-01 | 0.051 | 1 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.899474e-01 | 0.051 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.899474e-01 | 0.051 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.906253e-01 | 0.050 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.954437e-01 | 0.048 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.993438e-01 | 0.046 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.997881e-01 | 0.046 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.997881e-01 | 0.046 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 8.997881e-01 | 0.046 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.012052e-01 | 0.045 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.023805e-01 | 0.045 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 9.028914e-01 | 0.044 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 9.028914e-01 | 0.044 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 9.028914e-01 | 0.044 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.028914e-01 | 0.044 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.035695e-01 | 0.044 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.062426e-01 | 0.043 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.062426e-01 | 0.043 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.080106e-01 | 0.042 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.083191e-01 | 0.042 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.083191e-01 | 0.042 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.083191e-01 | 0.042 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.096415e-01 | 0.041 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.096415e-01 | 0.041 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.096415e-01 | 0.041 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.096415e-01 | 0.041 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.096415e-01 | 0.041 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.096415e-01 | 0.041 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.100788e-01 | 0.041 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.100788e-01 | 0.041 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.111312e-01 | 0.040 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.111312e-01 | 0.040 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.127500e-01 | 0.040 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.146976e-01 | 0.039 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 9.146976e-01 | 0.039 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.146976e-01 | 0.039 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.146976e-01 | 0.039 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.146976e-01 | 0.039 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 9.146976e-01 | 0.039 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.146976e-01 | 0.039 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 9.146976e-01 | 0.039 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 9.146976e-01 | 0.039 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.146976e-01 | 0.039 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.148369e-01 | 0.039 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.159951e-01 | 0.038 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.160667e-01 | 0.038 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.160667e-01 | 0.038 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.185810e-01 | 0.037 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.233428e-01 | 0.035 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.250691e-01 | 0.034 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.250691e-01 | 0.034 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.250691e-01 | 0.034 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.250691e-01 | 0.034 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.250691e-01 | 0.034 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.266832e-01 | 0.033 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.266832e-01 | 0.033 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.300973e-01 | 0.031 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.307419e-01 | 0.031 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.310168e-01 | 0.031 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.314754e-01 | 0.031 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.334264e-01 | 0.030 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.340194e-01 | 0.030 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.340194e-01 | 0.030 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.340194e-01 | 0.030 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.340194e-01 | 0.030 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.341801e-01 | 0.030 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.341801e-01 | 0.030 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.341801e-01 | 0.030 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 9.341801e-01 | 0.030 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 9.341801e-01 | 0.030 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.341801e-01 | 0.030 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.341801e-01 | 0.030 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.341801e-01 | 0.030 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.341801e-01 | 0.030 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.341801e-01 | 0.030 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.363001e-01 | 0.029 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.406561e-01 | 0.027 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.406561e-01 | 0.027 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.411899e-01 | 0.026 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.419908e-01 | 0.026 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.419908e-01 | 0.026 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.421837e-01 | 0.026 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.421837e-01 | 0.026 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.421837e-01 | 0.026 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.421837e-01 | 0.026 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.421837e-01 | 0.026 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.431401e-01 | 0.025 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.431401e-01 | 0.025 | 1 | 1 |
| Cellular response to starvation | R-HSA-9711097 | 9.443643e-01 | 0.025 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.463531e-01 | 0.024 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.466550e-01 | 0.024 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.466550e-01 | 0.024 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.472067e-01 | 0.024 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.474850e-01 | 0.023 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.475005e-01 | 0.023 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.489737e-01 | 0.023 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.492145e-01 | 0.023 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.492145e-01 | 0.023 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.492145e-01 | 0.023 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.519833e-01 | 0.021 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.520244e-01 | 0.021 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.520244e-01 | 0.021 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.520729e-01 | 0.021 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.530483e-01 | 0.021 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.533722e-01 | 0.021 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.553907e-01 | 0.020 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.553907e-01 | 0.020 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.553907e-01 | 0.020 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.553907e-01 | 0.020 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.553907e-01 | 0.020 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.553907e-01 | 0.020 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.553907e-01 | 0.020 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.553907e-01 | 0.020 | 1 | 1 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.553907e-01 | 0.020 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.553907e-01 | 0.020 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.563537e-01 | 0.019 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.603492e-01 | 0.018 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.604846e-01 | 0.018 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.608161e-01 | 0.017 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.608161e-01 | 0.017 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.608161e-01 | 0.017 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.608161e-01 | 0.017 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.608637e-01 | 0.017 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.610330e-01 | 0.017 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.621660e-01 | 0.017 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.629236e-01 | 0.016 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.646791e-01 | 0.016 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.653458e-01 | 0.015 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.653458e-01 | 0.015 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.653789e-01 | 0.015 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.655819e-01 | 0.015 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.655819e-01 | 0.015 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.655819e-01 | 0.015 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.655819e-01 | 0.015 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.655819e-01 | 0.015 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.666248e-01 | 0.015 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.673307e-01 | 0.014 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.680839e-01 | 0.014 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.689247e-01 | 0.014 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.689247e-01 | 0.014 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.689247e-01 | 0.014 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.689247e-01 | 0.014 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.689247e-01 | 0.014 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.689247e-01 | 0.014 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.693486e-01 | 0.014 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.697684e-01 | 0.013 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.697684e-01 | 0.013 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.697684e-01 | 0.013 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.697684e-01 | 0.013 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.706894e-01 | 0.013 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.707366e-01 | 0.013 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.715727e-01 | 0.013 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.722043e-01 | 0.012 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.729580e-01 | 0.012 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.731393e-01 | 0.012 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.734458e-01 | 0.012 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.734458e-01 | 0.012 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.734458e-01 | 0.012 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.735568e-01 | 0.012 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.743749e-01 | 0.011 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.750437e-01 | 0.011 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.750437e-01 | 0.011 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.750437e-01 | 0.011 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.750437e-01 | 0.011 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.750437e-01 | 0.011 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.750437e-01 | 0.011 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.756623e-01 | 0.011 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.758534e-01 | 0.011 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.758534e-01 | 0.011 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.766761e-01 | 0.010 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.766761e-01 | 0.010 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.766761e-01 | 0.010 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.766761e-01 | 0.010 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.769830e-01 | 0.010 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.770816e-01 | 0.010 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.776488e-01 | 0.010 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.776488e-01 | 0.010 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.784306e-01 | 0.009 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.790284e-01 | 0.009 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.790284e-01 | 0.009 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.795136e-01 | 0.009 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.795136e-01 | 0.009 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.795136e-01 | 0.009 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.795136e-01 | 0.009 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.795136e-01 | 0.009 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.797801e-01 | 0.009 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.799896e-01 | 0.009 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.799896e-01 | 0.009 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.800215e-01 | 0.009 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.800480e-01 | 0.009 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.802770e-01 | 0.009 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.816681e-01 | 0.008 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.820060e-01 | 0.008 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.820060e-01 | 0.008 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.820060e-01 | 0.008 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.820060e-01 | 0.008 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.820060e-01 | 0.008 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.820060e-01 | 0.008 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.820060e-01 | 0.008 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.820060e-01 | 0.008 | 0 | 0 |
| Retinoid cycle disease events | R-HSA-2453864 | 9.820060e-01 | 0.008 | 0 | 0 |
| Diseases of the neuronal system | R-HSA-9675143 | 9.820060e-01 | 0.008 | 0 | 0 |
| Diseases associated with visual transduction | R-HSA-2474795 | 9.820060e-01 | 0.008 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.820060e-01 | 0.008 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.820918e-01 | 0.008 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.823042e-01 | 0.008 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.834391e-01 | 0.007 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.834391e-01 | 0.007 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.836729e-01 | 0.007 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.838206e-01 | 0.007 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.839789e-01 | 0.007 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.839789e-01 | 0.007 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.841953e-01 | 0.007 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.841953e-01 | 0.007 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.841953e-01 | 0.007 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.856430e-01 | 0.006 | 1 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.856720e-01 | 0.006 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.856720e-01 | 0.006 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.859573e-01 | 0.006 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.860548e-01 | 0.006 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.861184e-01 | 0.006 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.861184e-01 | 0.006 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.861184e-01 | 0.006 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.861184e-01 | 0.006 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.861184e-01 | 0.006 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.861184e-01 | 0.006 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.861184e-01 | 0.006 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.861184e-01 | 0.006 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.863928e-01 | 0.006 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.863928e-01 | 0.006 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.866621e-01 | 0.006 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.870830e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.871904e-01 | 0.006 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.878076e-01 | 0.005 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.878076e-01 | 0.005 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.878076e-01 | 0.005 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.879521e-01 | 0.005 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.885227e-01 | 0.005 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.885516e-01 | 0.005 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.885516e-01 | 0.005 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.885516e-01 | 0.005 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.885516e-01 | 0.005 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.885516e-01 | 0.005 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 9.892913e-01 | 0.005 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.892913e-01 | 0.005 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.892913e-01 | 0.005 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.892913e-01 | 0.005 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.892913e-01 | 0.005 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.892913e-01 | 0.005 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.899629e-01 | 0.004 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.905112e-01 | 0.004 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.905945e-01 | 0.004 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.905945e-01 | 0.004 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.905945e-01 | 0.004 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.907836e-01 | 0.004 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.908637e-01 | 0.004 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.908637e-01 | 0.004 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.911412e-01 | 0.004 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.911961e-01 | 0.004 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.917392e-01 | 0.004 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.917392e-01 | 0.004 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.917392e-01 | 0.004 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.918207e-01 | 0.004 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.920101e-01 | 0.003 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.927173e-01 | 0.003 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.927446e-01 | 0.003 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.927446e-01 | 0.003 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.927446e-01 | 0.003 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.928812e-01 | 0.003 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.934752e-01 | 0.003 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.934752e-01 | 0.003 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.936278e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.942011e-01 | 0.003 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.942627e-01 | 0.002 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.944034e-01 | 0.002 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.944034e-01 | 0.002 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.948274e-01 | 0.002 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.949688e-01 | 0.002 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.950847e-01 | 0.002 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.950847e-01 | 0.002 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.950847e-01 | 0.002 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.956338e-01 | 0.002 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.956338e-01 | 0.002 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.956831e-01 | 0.002 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.956831e-01 | 0.002 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.958875e-01 | 0.002 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.959713e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.961578e-01 | 0.002 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.961942e-01 | 0.002 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.963204e-01 | 0.002 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.964454e-01 | 0.002 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.966703e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.966703e-01 | 0.001 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.966703e-01 | 0.001 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.966703e-01 | 0.001 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.966703e-01 | 0.001 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.970757e-01 | 0.001 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.970757e-01 | 0.001 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.970757e-01 | 0.001 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.970757e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.973676e-01 | 0.001 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.974318e-01 | 0.001 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.974318e-01 | 0.001 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.975543e-01 | 0.001 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.976253e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.977432e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.977446e-01 | 0.001 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.978415e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.980099e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.982953e-01 | 0.001 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.983812e-01 | 0.001 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.985505e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.985505e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.986119e-01 | 0.001 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.986584e-01 | 0.001 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.987891e-01 | 0.001 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.988186e-01 | 0.001 | 1 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.988218e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.988218e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.988528e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.989231e-01 | 0.000 | 0 | 0 |
| The canonical retinoid cycle in rods (twilight vision) | R-HSA-2453902 | 9.989654e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.990035e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.990498e-01 | 0.000 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.990914e-01 | 0.000 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.990914e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.991129e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.992021e-01 | 0.000 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.992158e-01 | 0.000 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.992364e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.992929e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.993847e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.994597e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.994999e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.995255e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.995528e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.996028e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.996028e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.996341e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.997218e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.997262e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.997472e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.997825e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.997825e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.997937e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.998137e-01 | 0.000 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.998192e-01 | 0.000 | 1 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.998273e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.998323e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.998323e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.998390e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.998707e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.998707e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.998787e-01 | 0.000 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.998829e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998942e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.998970e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999125e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999139e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999147e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999266e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999347e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999407e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.999407e-01 | 0.000 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.999411e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999413e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999480e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.999480e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999503e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999522e-01 | 0.000 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.999595e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999599e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999600e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999648e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.999648e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999648e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999729e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999729e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999802e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999810e-01 | 0.000 | 1 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999830e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999881e-01 | 0.000 | 1 | 0 |
| Keratinization | R-HSA-6805567 | 9.999891e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999904e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999935e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999935e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999938e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999938e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999939e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999941e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999944e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999961e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999966e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999979e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999981e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999985e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999989e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999990e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999991e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999991e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999998e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999999e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999999e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999999e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 1.000000e+00 | 0.000 | 1 | 1 |
| Translation of Structural Proteins | R-HSA-9683701 | 1.000000e+00 | 0.000 | 1 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 7.233599e-08 | 7.141 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.828466e-07 | 6.234 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.431010e-07 | 6.025 | 1 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.969222e-06 | 5.224 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.373371e-05 | 4.625 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.314231e-05 | 4.636 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.877834e-05 | 4.726 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.712736e-05 | 4.766 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.968262e-05 | 4.527 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.111775e-05 | 4.507 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.258418e-05 | 4.487 | 1 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.164778e-05 | 4.500 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.411767e-05 | 4.355 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.560481e-05 | 4.341 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.158082e-05 | 4.211 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 9.529720e-05 | 4.021 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.089977e-04 | 3.963 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.089977e-04 | 3.963 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.398022e-04 | 3.854 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.494650e-04 | 3.825 | 1 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.851394e-04 | 3.733 | 1 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.051069e-04 | 3.688 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.088644e-04 | 3.680 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.208800e-04 | 3.656 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.472655e-04 | 3.607 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.548595e-04 | 3.594 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.946534e-04 | 3.531 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.063342e-04 | 3.514 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.285388e-04 | 3.483 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.415212e-04 | 3.467 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.666928e-04 | 3.436 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.072433e-04 | 3.390 | 1 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.461345e-04 | 3.351 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.633620e-04 | 3.334 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.751872e-04 | 3.323 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.484358e-04 | 3.261 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.766347e-04 | 3.239 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 6.802368e-04 | 3.167 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.078011e-04 | 3.150 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.848607e-04 | 3.164 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.904644e-04 | 3.161 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.466510e-04 | 3.189 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.441253e-04 | 3.128 | 0 | 0 |
| M Phase | R-HSA-68886 | 7.889172e-04 | 3.103 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.201961e-04 | 3.086 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.767926e-04 | 3.010 | 1 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.112268e-03 | 2.954 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.124896e-03 | 2.949 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.241974e-03 | 2.906 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.210139e-03 | 2.917 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.397067e-03 | 2.855 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.524367e-03 | 2.817 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.494758e-03 | 2.825 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.718617e-03 | 2.765 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.725203e-03 | 2.763 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.760302e-03 | 2.754 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.855523e-03 | 2.732 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.776710e-03 | 2.750 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.870634e-03 | 2.728 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.034782e-03 | 2.691 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.360361e-03 | 2.627 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.329394e-03 | 2.633 | 1 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.253666e-03 | 2.647 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.253666e-03 | 2.647 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.337741e-03 | 2.631 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.309255e-03 | 2.637 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.409690e-03 | 2.618 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.592702e-03 | 2.586 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.486027e-03 | 2.604 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.486027e-03 | 2.604 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.057481e-03 | 2.515 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.746454e-03 | 2.561 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.989833e-03 | 2.524 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.031982e-03 | 2.518 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.673950e-03 | 2.573 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.163018e-03 | 2.500 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.968454e-03 | 2.527 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.968454e-03 | 2.527 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.968454e-03 | 2.527 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.181431e-03 | 2.497 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.052254e-03 | 2.515 | 1 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.863537e-03 | 2.543 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.039282e-03 | 2.517 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.679973e-03 | 2.572 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.051255e-03 | 2.516 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.228116e-03 | 2.491 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.324791e-03 | 2.478 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.909491e-03 | 2.408 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.890191e-03 | 2.410 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.885797e-03 | 2.411 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.053980e-03 | 2.392 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.883657e-03 | 2.311 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.997154e-03 | 2.301 | 1 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.057653e-03 | 2.296 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.462163e-03 | 2.263 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.462163e-03 | 2.263 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.462163e-03 | 2.263 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.723469e-03 | 2.242 | 1 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.914056e-03 | 2.228 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 6.392053e-03 | 2.194 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 6.392053e-03 | 2.194 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.914056e-03 | 2.228 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.063127e-03 | 2.217 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.978580e-03 | 2.223 | 1 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.125782e-03 | 2.213 | 1 | 1 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.057629e-03 | 2.218 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.519333e-03 | 2.186 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.763828e-03 | 2.170 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 6.778861e-03 | 2.169 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 7.381059e-03 | 2.132 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.437189e-03 | 2.129 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.343936e-03 | 2.134 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.088222e-03 | 2.149 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.517170e-03 | 2.124 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.517170e-03 | 2.124 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 7.343936e-03 | 2.134 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.453485e-03 | 2.128 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.948144e-03 | 2.100 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.606017e-03 | 2.065 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.606017e-03 | 2.065 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 8.658038e-03 | 2.063 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.530328e-03 | 2.021 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 9.021608e-03 | 2.045 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 9.907016e-03 | 2.004 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 9.182048e-03 | 2.037 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.020416e-03 | 2.045 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 9.975853e-03 | 2.001 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 9.975853e-03 | 2.001 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.019087e-02 | 1.992 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.074583e-02 | 1.969 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.074583e-02 | 1.969 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.080618e-02 | 1.966 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.086950e-02 | 1.964 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.086950e-02 | 1.964 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.086950e-02 | 1.964 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.207860e-02 | 1.918 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.111666e-02 | 1.954 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.207860e-02 | 1.918 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.177571e-02 | 1.929 | 1 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.134864e-02 | 1.945 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.134864e-02 | 1.945 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.278079e-02 | 1.893 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.280932e-02 | 1.892 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.293929e-02 | 1.888 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.343821e-02 | 1.872 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.343821e-02 | 1.872 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.345671e-02 | 1.871 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.362945e-02 | 1.866 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.397016e-02 | 1.855 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.502297e-02 | 1.823 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.572940e-02 | 1.803 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.638723e-02 | 1.785 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.468724e-02 | 1.833 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.572940e-02 | 1.803 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.638723e-02 | 1.785 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.517207e-02 | 1.819 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.660062e-02 | 1.780 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.746049e-02 | 1.758 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.755131e-02 | 1.756 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.773960e-02 | 1.751 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.868733e-02 | 1.728 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.874014e-02 | 1.727 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.874014e-02 | 1.727 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.001444e-02 | 1.699 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.243081e-02 | 1.649 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.243081e-02 | 1.649 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.070501e-02 | 1.684 | 1 | 1 |
| Signaling by EGFR | R-HSA-177929 | 2.060552e-02 | 1.686 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.060552e-02 | 1.686 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.055750e-02 | 1.687 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.070501e-02 | 1.684 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.095503e-02 | 1.679 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.127541e-02 | 1.672 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.049340e-02 | 1.688 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.095503e-02 | 1.679 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.270889e-02 | 1.644 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.270889e-02 | 1.644 | 1 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.320554e-02 | 1.634 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.341111e-02 | 1.631 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.341111e-02 | 1.631 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.368149e-02 | 1.626 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.383520e-02 | 1.623 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.564381e-02 | 1.591 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.564381e-02 | 1.591 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.594449e-02 | 1.586 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.594449e-02 | 1.586 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.596183e-02 | 1.586 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.596183e-02 | 1.586 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.606260e-02 | 1.584 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.685708e-02 | 1.571 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.712553e-02 | 1.567 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.712553e-02 | 1.567 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.771269e-02 | 1.557 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.771269e-02 | 1.557 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.828578e-02 | 1.548 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 3.053397e-02 | 1.515 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.053397e-02 | 1.515 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.882775e-02 | 1.540 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.979447e-02 | 1.526 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.344883e-02 | 1.476 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.274292e-02 | 1.485 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.472534e-02 | 1.459 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.472534e-02 | 1.459 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 3.485746e-02 | 1.458 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.661542e-02 | 1.436 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 3.681552e-02 | 1.434 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 3.740354e-02 | 1.427 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.740354e-02 | 1.427 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.760653e-02 | 1.425 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.760653e-02 | 1.425 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.899437e-02 | 1.409 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.978677e-02 | 1.400 | 1 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.989497e-02 | 1.399 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.990220e-02 | 1.399 | 1 | 0 |
| RET signaling | R-HSA-8853659 | 3.994859e-02 | 1.398 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.999249e-02 | 1.398 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.026007e-02 | 1.395 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.026007e-02 | 1.395 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.476949e-02 | 1.349 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.999821e-02 | 1.301 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.385549e-02 | 1.358 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.722970e-02 | 1.326 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.419974e-02 | 1.355 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.202793e-02 | 1.376 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.378551e-02 | 1.359 | 1 | 1 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.351139e-02 | 1.361 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.246977e-02 | 1.372 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.641156e-02 | 1.333 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.911924e-02 | 1.309 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.246977e-02 | 1.372 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.725301e-02 | 1.326 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.727515e-02 | 1.325 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.641851e-02 | 1.333 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.727515e-02 | 1.325 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.112472e-02 | 1.291 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.112472e-02 | 1.291 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.144390e-02 | 1.289 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.144390e-02 | 1.289 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.144390e-02 | 1.289 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.294098e-02 | 1.276 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.326757e-02 | 1.274 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.449169e-02 | 1.264 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 5.824113e-02 | 1.235 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 5.824113e-02 | 1.235 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.865204e-02 | 1.232 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.865204e-02 | 1.232 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.967244e-02 | 1.224 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.978519e-02 | 1.223 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.978519e-02 | 1.223 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.056668e-02 | 1.218 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.056668e-02 | 1.218 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.153550e-02 | 1.211 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.245400e-02 | 1.204 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 7.008261e-02 | 1.154 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 7.141141e-02 | 1.146 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 7.141141e-02 | 1.146 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 7.141141e-02 | 1.146 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.031496e-02 | 1.153 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.265861e-02 | 1.203 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.452076e-02 | 1.128 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 6.388365e-02 | 1.195 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 7.574106e-02 | 1.121 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 7.031496e-02 | 1.153 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.113118e-02 | 1.148 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 6.670251e-02 | 1.176 | 1 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.574106e-02 | 1.121 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.818228e-02 | 1.166 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 7.570718e-02 | 1.121 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.404587e-02 | 1.194 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.973078e-02 | 1.157 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.784721e-02 | 1.168 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 7.141141e-02 | 1.146 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.879876e-02 | 1.162 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.452076e-02 | 1.128 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 6.854684e-02 | 1.164 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.091407e-02 | 1.149 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 7.809178e-02 | 1.107 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.546504e-02 | 1.122 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.784721e-02 | 1.168 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 7.570718e-02 | 1.121 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.879876e-02 | 1.162 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 7.182275e-02 | 1.144 | 1 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.341751e-02 | 1.134 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.846945e-02 | 1.105 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.846945e-02 | 1.105 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.907766e-02 | 1.102 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 8.053289e-02 | 1.094 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.071290e-02 | 1.093 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.158325e-02 | 1.088 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.341255e-02 | 1.079 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 8.550707e-02 | 1.068 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 8.650568e-02 | 1.063 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.853183e-02 | 1.053 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.894457e-02 | 1.051 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 9.066370e-02 | 1.043 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.066370e-02 | 1.043 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 9.279080e-02 | 1.032 | 0 | 0 |
| IRS activation | R-HSA-74713 | 9.279080e-02 | 1.032 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 9.279080e-02 | 1.032 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 9.279080e-02 | 1.032 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.377034e-02 | 1.028 | 1 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.157355e-01 | 0.937 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.157355e-01 | 0.937 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.157355e-01 | 0.937 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.157355e-01 | 0.937 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.157355e-01 | 0.937 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 1.157355e-01 | 0.937 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 9.746523e-02 | 1.011 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 9.746523e-02 | 1.011 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 9.746523e-02 | 1.011 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 9.746523e-02 | 1.011 | 1 | 1 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.123996e-01 | 0.949 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.123996e-01 | 0.949 | 1 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.123996e-01 | 0.949 | 1 | 1 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.123996e-01 | 0.949 | 1 | 1 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.123996e-01 | 0.949 | 1 | 1 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.123996e-01 | 0.949 | 1 | 1 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 9.970134e-02 | 1.001 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.112135e-01 | 0.954 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.232855e-01 | 0.909 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.668721e-02 | 1.015 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.245797e-01 | 0.905 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.025061e-01 | 0.989 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.099165e-01 | 0.959 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.198578e-01 | 0.921 | 1 | 1 |
| MET activates RAS signaling | R-HSA-8851805 | 1.123996e-01 | 0.949 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.121250e-01 | 0.950 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 9.537322e-02 | 1.021 | 1 | 1 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.025061e-01 | 0.989 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.025061e-01 | 0.989 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.561540e-02 | 1.019 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.132057e-01 | 0.946 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.970134e-02 | 1.001 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.922055e-02 | 1.003 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.123996e-01 | 0.949 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.025061e-01 | 0.989 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 9.746523e-02 | 1.011 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 9.568033e-02 | 1.019 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.157355e-01 | 0.937 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.047765e-01 | 0.980 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.157355e-01 | 0.937 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.035118e-01 | 0.985 | 1 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.144238e-01 | 0.941 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.046835e-01 | 0.980 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.254303e-01 | 0.902 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.000791e-01 | 1.000 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 9.705068e-02 | 1.013 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.212110e-01 | 0.916 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.157355e-01 | 0.937 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.232855e-01 | 0.909 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.123996e-01 | 0.949 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.046725e-01 | 0.980 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.157355e-01 | 0.937 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.195176e-01 | 0.923 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.195176e-01 | 0.923 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.213550e-01 | 0.916 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.070131e-01 | 0.971 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.232855e-01 | 0.909 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.240746e-01 | 0.906 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.025061e-01 | 0.989 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.265805e-01 | 0.898 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.268068e-01 | 0.897 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.281389e-01 | 0.892 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.281389e-01 | 0.892 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.281389e-01 | 0.892 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.286412e-01 | 0.891 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.310509e-01 | 0.883 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.315296e-01 | 0.881 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.334998e-01 | 0.875 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.343216e-01 | 0.872 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.351353e-01 | 0.869 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.352576e-01 | 0.869 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.352576e-01 | 0.869 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.352576e-01 | 0.869 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.352576e-01 | 0.869 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.352576e-01 | 0.869 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.352576e-01 | 0.869 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.358864e-01 | 0.867 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.358864e-01 | 0.867 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.383911e-01 | 0.859 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 1.958682e-01 | 0.708 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 1.958682e-01 | 0.708 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 1.958682e-01 | 0.708 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 1.958682e-01 | 0.708 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.958682e-01 | 0.708 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 1.958682e-01 | 0.708 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 1.958682e-01 | 0.708 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 1.958682e-01 | 0.708 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 1.399216e-01 | 0.854 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 1.399216e-01 | 0.854 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 1.650627e-01 | 0.782 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.650627e-01 | 0.782 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 1.650627e-01 | 0.782 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 1.650627e-01 | 0.782 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.650627e-01 | 0.782 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.909064e-01 | 0.719 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.909064e-01 | 0.719 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.446051e-01 | 0.840 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.446051e-01 | 0.840 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 1.617192e-01 | 0.791 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.617192e-01 | 0.791 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.617192e-01 | 0.791 | 1 | 1 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.975791e-01 | 0.704 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.501478e-01 | 0.823 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.501478e-01 | 0.823 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.509994e-01 | 0.821 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 2.082039e-01 | 0.682 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.709162e-01 | 0.767 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.809945e-01 | 0.742 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.617192e-01 | 0.791 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.650627e-01 | 0.782 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 1.909064e-01 | 0.719 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.826677e-01 | 0.738 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.056238e-01 | 0.687 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.460735e-01 | 0.835 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.975791e-01 | 0.704 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.445050e-01 | 0.840 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.445050e-01 | 0.840 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.446051e-01 | 0.840 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.909064e-01 | 0.719 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 1.975791e-01 | 0.704 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.601382e-01 | 0.796 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.536282e-01 | 0.814 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.056238e-01 | 0.687 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.056238e-01 | 0.687 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.690229e-01 | 0.772 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.404482e-01 | 0.852 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.765248e-01 | 0.753 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.642732e-01 | 0.784 | 1 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.617192e-01 | 0.791 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.794029e-01 | 0.746 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 1.958682e-01 | 0.708 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.399216e-01 | 0.854 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.975791e-01 | 0.704 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.765248e-01 | 0.753 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.573758e-01 | 0.803 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.932695e-01 | 0.714 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.685298e-01 | 0.773 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.008961e-01 | 0.697 | 1 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.435002e-01 | 0.843 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.425544e-01 | 0.846 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.899377e-01 | 0.721 | 1 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.420574e-01 | 0.848 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.489830e-01 | 0.827 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.642411e-01 | 0.785 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.704070e-01 | 0.769 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.462821e-01 | 0.835 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.032855e-01 | 0.692 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 1.958682e-01 | 0.708 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.446051e-01 | 0.840 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.399216e-01 | 0.854 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.968506e-01 | 0.706 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.650627e-01 | 0.782 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.650627e-01 | 0.782 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.794029e-01 | 0.746 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.573758e-01 | 0.803 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.554020e-01 | 0.809 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.871165e-01 | 0.728 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.625410e-01 | 0.789 | 1 | 1 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.882816e-01 | 0.725 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.908980e-01 | 0.719 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.112018e-01 | 0.675 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.112018e-01 | 0.675 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.126083e-01 | 0.672 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.161726e-01 | 0.665 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.161726e-01 | 0.665 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.161726e-01 | 0.665 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.161726e-01 | 0.665 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.172311e-01 | 0.663 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.172311e-01 | 0.663 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.172311e-01 | 0.663 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 2.172311e-01 | 0.663 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.172311e-01 | 0.663 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.172311e-01 | 0.663 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.172311e-01 | 0.663 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.172311e-01 | 0.663 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 2.172311e-01 | 0.663 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.184504e-01 | 0.661 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.242378e-01 | 0.649 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 2.522340e-01 | 0.598 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 2.522340e-01 | 0.598 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.522340e-01 | 0.598 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 2.522340e-01 | 0.598 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.522340e-01 | 0.598 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 3.046519e-01 | 0.516 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 3.046519e-01 | 0.516 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.046519e-01 | 0.516 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.046519e-01 | 0.516 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 3.046519e-01 | 0.516 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 3.533983e-01 | 0.452 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.533983e-01 | 0.452 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 3.533983e-01 | 0.452 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 3.533983e-01 | 0.452 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 3.533983e-01 | 0.452 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 3.533983e-01 | 0.452 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 3.533983e-01 | 0.452 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.533983e-01 | 0.452 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 2.438427e-01 | 0.613 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.705717e-01 | 0.568 | 1 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.705717e-01 | 0.568 | 1 | 1 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.705717e-01 | 0.568 | 1 | 1 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.705717e-01 | 0.568 | 1 | 1 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 3.987302e-01 | 0.399 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 3.987302e-01 | 0.399 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 3.987302e-01 | 0.399 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.351107e-01 | 0.629 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 2.543236e-01 | 0.595 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.543236e-01 | 0.595 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 3.238141e-01 | 0.490 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.238141e-01 | 0.490 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.238141e-01 | 0.490 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 3.238141e-01 | 0.490 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 4.408864e-01 | 0.356 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 4.408864e-01 | 0.356 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 4.408864e-01 | 0.356 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.408864e-01 | 0.356 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 4.408864e-01 | 0.356 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 4.408864e-01 | 0.356 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 4.408864e-01 | 0.356 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 4.408864e-01 | 0.356 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 4.408864e-01 | 0.356 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.408864e-01 | 0.356 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 3.500912e-01 | 0.456 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.933106e-01 | 0.533 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.933106e-01 | 0.533 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.515476e-01 | 0.599 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.129619e-01 | 0.505 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.129619e-01 | 0.505 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 3.760096e-01 | 0.425 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 3.760096e-01 | 0.425 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.326427e-01 | 0.478 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.993306e-01 | 0.524 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.288728e-01 | 0.640 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.288728e-01 | 0.640 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.288728e-01 | 0.640 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.288728e-01 | 0.640 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.288728e-01 | 0.640 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.609247e-01 | 0.583 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.718879e-01 | 0.430 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.264678e-01 | 0.370 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.853321e-01 | 0.545 | 1 | 1 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.480456e-01 | 0.458 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.578625e-01 | 0.589 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.106738e-01 | 0.387 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.561944e-01 | 0.448 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.704094e-01 | 0.431 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 4.297942e-01 | 0.367 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.297942e-01 | 0.367 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.297942e-01 | 0.367 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.486864e-01 | 0.348 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.486864e-01 | 0.348 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.486864e-01 | 0.348 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.486864e-01 | 0.348 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.450279e-01 | 0.352 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.917516e-01 | 0.535 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.119182e-01 | 0.385 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.411537e-01 | 0.355 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 3.795077e-01 | 0.421 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.452813e-01 | 0.351 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.660739e-01 | 0.436 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 2.954233e-01 | 0.530 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.106738e-01 | 0.387 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.933106e-01 | 0.533 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.933106e-01 | 0.533 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.361325e-01 | 0.627 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.608493e-01 | 0.443 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.385641e-01 | 0.358 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.385641e-01 | 0.358 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.385641e-01 | 0.358 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.351107e-01 | 0.629 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.673160e-01 | 0.573 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.673160e-01 | 0.573 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.438427e-01 | 0.613 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 2.972712e-01 | 0.527 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.450279e-01 | 0.352 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.718879e-01 | 0.430 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.533983e-01 | 0.452 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 3.987302e-01 | 0.399 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.972712e-01 | 0.527 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.238141e-01 | 0.490 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.977177e-01 | 0.526 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.106738e-01 | 0.387 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.721001e-01 | 0.565 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.811307e-01 | 0.551 | 1 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 2.705717e-01 | 0.568 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.987302e-01 | 0.399 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 3.987302e-01 | 0.399 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 2.972712e-01 | 0.527 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.130155e-01 | 0.384 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.832344e-01 | 0.548 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 3.500912e-01 | 0.456 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.635481e-01 | 0.439 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 3.863869e-01 | 0.413 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 2.972712e-01 | 0.527 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.933106e-01 | 0.533 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.326427e-01 | 0.478 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.264678e-01 | 0.370 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.102037e-01 | 0.508 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.357225e-01 | 0.628 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.287624e-01 | 0.641 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 2.858417e-01 | 0.544 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.972712e-01 | 0.527 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 4.014904e-01 | 0.396 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 4.014904e-01 | 0.396 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.850428e-01 | 0.414 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.543236e-01 | 0.595 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.543236e-01 | 0.595 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.522340e-01 | 0.598 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 2.522340e-01 | 0.598 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.046519e-01 | 0.516 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.046519e-01 | 0.516 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.046519e-01 | 0.516 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.438427e-01 | 0.613 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 3.987302e-01 | 0.399 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.972712e-01 | 0.527 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.972712e-01 | 0.527 | 1 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.972712e-01 | 0.527 | 1 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.351107e-01 | 0.629 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.238141e-01 | 0.490 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 4.408864e-01 | 0.356 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.500912e-01 | 0.456 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.254560e-01 | 0.647 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.014904e-01 | 0.396 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.394603e-01 | 0.621 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.718879e-01 | 0.430 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.297942e-01 | 0.367 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.660051e-01 | 0.575 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.450279e-01 | 0.352 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.754678e-01 | 0.425 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.411537e-01 | 0.355 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.420006e-01 | 0.466 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.613967e-01 | 0.442 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.212705e-01 | 0.493 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.302510e-01 | 0.638 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 3.987302e-01 | 0.399 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.238141e-01 | 0.490 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 4.264678e-01 | 0.370 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 4.264678e-01 | 0.370 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.543236e-01 | 0.595 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.480456e-01 | 0.458 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.411537e-01 | 0.355 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.436091e-01 | 0.464 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.821993e-01 | 0.549 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.737446e-01 | 0.563 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.820175e-01 | 0.550 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 3.533983e-01 | 0.452 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 2.438427e-01 | 0.613 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.238141e-01 | 0.490 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.238141e-01 | 0.490 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.238141e-01 | 0.490 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.297942e-01 | 0.367 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.393848e-01 | 0.621 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.338964e-01 | 0.631 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.355674e-01 | 0.474 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.961986e-01 | 0.402 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.961986e-01 | 0.402 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.961986e-01 | 0.402 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.119182e-01 | 0.385 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.119182e-01 | 0.385 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.515476e-01 | 0.599 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.832551e-01 | 0.548 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.492044e-01 | 0.603 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.236556e-01 | 0.490 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.718879e-01 | 0.430 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.718879e-01 | 0.430 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.225278e-01 | 0.491 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.736121e-01 | 0.428 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.278478e-01 | 0.484 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.449674e-01 | 0.611 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.610853e-01 | 0.583 | 1 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.438427e-01 | 0.613 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.351107e-01 | 0.629 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.155088e-01 | 0.501 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.399972e-01 | 0.620 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.297942e-01 | 0.367 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.203147e-01 | 0.376 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.297942e-01 | 0.367 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.498798e-01 | 0.602 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.747563e-01 | 0.426 | 1 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.014904e-01 | 0.396 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 3.046519e-01 | 0.516 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 3.533983e-01 | 0.452 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 3.987302e-01 | 0.399 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 2.972712e-01 | 0.527 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 4.408864e-01 | 0.356 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 4.408864e-01 | 0.356 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.760096e-01 | 0.425 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.853321e-01 | 0.545 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.806218e-01 | 0.420 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 3.986170e-01 | 0.399 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.717454e-01 | 0.566 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.238141e-01 | 0.490 | 1 | 1 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.975018e-01 | 0.527 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.326427e-01 | 0.478 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.500912e-01 | 0.456 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.155088e-01 | 0.501 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.498798e-01 | 0.602 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.659160e-01 | 0.437 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.438427e-01 | 0.613 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.264678e-01 | 0.370 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.297942e-01 | 0.367 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.705717e-01 | 0.568 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.395456e-01 | 0.357 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.129619e-01 | 0.505 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 3.238141e-01 | 0.490 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 4.368797e-01 | 0.360 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.438427e-01 | 0.613 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.563933e-01 | 0.448 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.867094e-01 | 0.413 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.326427e-01 | 0.478 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.486864e-01 | 0.348 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 4.508870e-01 | 0.346 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.508870e-01 | 0.346 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.508870e-01 | 0.346 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 4.508870e-01 | 0.346 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 4.508870e-01 | 0.346 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.508870e-01 | 0.346 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.517296e-01 | 0.345 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.521137e-01 | 0.345 | 1 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.522275e-01 | 0.345 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.551171e-01 | 0.342 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.551171e-01 | 0.342 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.560855e-01 | 0.341 | 1 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.624861e-01 | 0.335 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.625515e-01 | 0.335 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.673200e-01 | 0.330 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.673200e-01 | 0.330 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.673200e-01 | 0.330 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.727095e-01 | 0.325 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.727095e-01 | 0.325 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 4.747036e-01 | 0.324 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 4.747036e-01 | 0.324 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.747036e-01 | 0.324 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.747036e-01 | 0.324 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.764839e-01 | 0.322 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.772698e-01 | 0.321 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.781009e-01 | 0.320 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 4.800893e-01 | 0.319 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 4.800893e-01 | 0.319 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 4.800893e-01 | 0.319 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.808009e-01 | 0.318 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.827360e-01 | 0.316 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.856674e-01 | 0.314 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.856674e-01 | 0.314 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.874660e-01 | 0.312 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 4.912745e-01 | 0.309 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.953026e-01 | 0.305 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.963644e-01 | 0.304 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.963644e-01 | 0.304 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.978822e-01 | 0.303 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.978822e-01 | 0.303 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.978822e-01 | 0.303 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 4.978822e-01 | 0.303 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.978822e-01 | 0.303 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.978822e-01 | 0.303 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.978822e-01 | 0.303 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.978822e-01 | 0.303 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 4.978822e-01 | 0.303 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.978822e-01 | 0.303 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.997855e-01 | 0.301 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.026028e-01 | 0.299 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.037043e-01 | 0.298 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.071368e-01 | 0.295 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.072318e-01 | 0.295 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.120003e-01 | 0.291 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 5.165456e-01 | 0.287 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 5.165456e-01 | 0.287 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.165456e-01 | 0.287 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.165456e-01 | 0.287 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.165456e-01 | 0.287 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.165456e-01 | 0.287 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.165456e-01 | 0.287 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.165456e-01 | 0.287 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.165456e-01 | 0.287 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.165456e-01 | 0.287 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.169816e-01 | 0.287 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.189913e-01 | 0.285 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 5.203950e-01 | 0.284 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.203950e-01 | 0.284 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 5.203950e-01 | 0.284 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.203950e-01 | 0.284 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 5.222991e-01 | 0.282 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.222991e-01 | 0.282 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.241015e-01 | 0.281 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.267624e-01 | 0.278 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.267624e-01 | 0.278 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.283759e-01 | 0.277 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.363800e-01 | 0.271 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 5.371429e-01 | 0.270 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.386257e-01 | 0.269 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.387635e-01 | 0.269 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.387635e-01 | 0.269 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.396486e-01 | 0.268 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.422216e-01 | 0.266 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.422216e-01 | 0.266 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.422216e-01 | 0.266 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 5.422216e-01 | 0.266 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.422216e-01 | 0.266 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.422216e-01 | 0.266 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.424175e-01 | 0.266 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.479296e-01 | 0.261 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 5.504477e-01 | 0.259 | 0 | 0 |
| RSK activation | R-HSA-444257 | 5.504477e-01 | 0.259 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 5.504477e-01 | 0.259 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 5.504477e-01 | 0.259 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.504477e-01 | 0.259 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 5.504477e-01 | 0.259 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.504477e-01 | 0.259 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.504477e-01 | 0.259 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 5.504477e-01 | 0.259 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 5.504477e-01 | 0.259 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.504477e-01 | 0.259 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 5.504477e-01 | 0.259 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.517505e-01 | 0.258 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.556724e-01 | 0.255 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.565790e-01 | 0.254 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.633475e-01 | 0.249 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 5.633475e-01 | 0.249 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 5.633475e-01 | 0.249 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.712079e-01 | 0.243 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.723584e-01 | 0.242 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.723584e-01 | 0.242 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.748743e-01 | 0.240 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.748743e-01 | 0.240 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.761519e-01 | 0.239 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.791749e-01 | 0.237 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.802130e-01 | 0.236 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.802130e-01 | 0.236 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 5.819743e-01 | 0.235 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 5.819743e-01 | 0.235 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 5.819743e-01 | 0.235 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.819743e-01 | 0.235 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 5.819743e-01 | 0.235 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 5.819743e-01 | 0.235 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 5.819743e-01 | 0.235 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.819743e-01 | 0.235 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 5.819743e-01 | 0.235 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.837636e-01 | 0.234 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.837636e-01 | 0.234 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.837636e-01 | 0.234 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 5.885149e-01 | 0.230 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 5.885149e-01 | 0.230 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 5.885149e-01 | 0.230 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.885740e-01 | 0.230 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.885740e-01 | 0.230 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.885740e-01 | 0.230 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.938828e-01 | 0.226 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.995776e-01 | 0.222 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.034655e-01 | 0.219 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.034655e-01 | 0.219 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.034655e-01 | 0.219 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 6.043887e-01 | 0.219 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.043887e-01 | 0.219 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.043887e-01 | 0.219 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.099265e-01 | 0.215 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.109939e-01 | 0.214 | 1 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 6.112917e-01 | 0.214 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.112917e-01 | 0.214 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.112917e-01 | 0.214 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.112917e-01 | 0.214 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 6.112917e-01 | 0.214 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.112917e-01 | 0.214 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 6.112917e-01 | 0.214 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.112917e-01 | 0.214 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 6.112917e-01 | 0.214 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.112917e-01 | 0.214 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.116205e-01 | 0.214 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.159086e-01 | 0.210 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.182898e-01 | 0.209 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.197952e-01 | 0.208 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 6.197952e-01 | 0.208 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.200685e-01 | 0.208 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.224531e-01 | 0.206 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.224531e-01 | 0.206 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.224531e-01 | 0.206 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.224531e-01 | 0.206 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.224531e-01 | 0.206 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.224531e-01 | 0.206 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.288653e-01 | 0.201 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.288653e-01 | 0.201 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.338842e-01 | 0.198 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.377832e-01 | 0.195 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 6.385546e-01 | 0.195 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 6.385546e-01 | 0.195 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 6.385546e-01 | 0.195 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 6.385546e-01 | 0.195 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 6.385546e-01 | 0.195 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 6.385546e-01 | 0.195 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 6.385546e-01 | 0.195 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 6.385546e-01 | 0.195 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 6.385546e-01 | 0.195 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 6.385546e-01 | 0.195 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 6.385546e-01 | 0.195 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.407295e-01 | 0.193 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.407295e-01 | 0.193 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 6.407295e-01 | 0.193 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.461273e-01 | 0.190 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.464500e-01 | 0.189 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.465866e-01 | 0.189 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.481765e-01 | 0.188 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.493639e-01 | 0.188 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.493639e-01 | 0.188 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 6.493639e-01 | 0.188 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.545877e-01 | 0.184 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.545877e-01 | 0.184 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.583012e-01 | 0.182 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.583012e-01 | 0.182 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.583012e-01 | 0.182 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.583012e-01 | 0.182 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.590561e-01 | 0.181 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.635203e-01 | 0.178 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.635203e-01 | 0.178 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.635203e-01 | 0.178 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.635203e-01 | 0.178 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.635203e-01 | 0.178 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.639069e-01 | 0.178 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.639069e-01 | 0.178 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.678991e-01 | 0.175 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.685461e-01 | 0.175 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.685461e-01 | 0.175 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 6.751770e-01 | 0.171 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.751770e-01 | 0.171 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.752040e-01 | 0.171 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.772566e-01 | 0.169 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.792479e-01 | 0.168 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.792479e-01 | 0.168 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.792479e-01 | 0.168 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.873975e-01 | 0.163 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.874823e-01 | 0.163 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.874823e-01 | 0.163 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.874823e-01 | 0.163 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 6.874823e-01 | 0.163 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.874823e-01 | 0.163 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.874823e-01 | 0.163 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.905733e-01 | 0.161 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.905733e-01 | 0.161 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.905733e-01 | 0.161 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.905733e-01 | 0.161 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.905733e-01 | 0.161 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.913682e-01 | 0.160 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 6.913682e-01 | 0.160 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.913682e-01 | 0.160 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.944217e-01 | 0.158 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.958217e-01 | 0.158 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 7.034724e-01 | 0.153 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.040227e-01 | 0.152 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.092479e-01 | 0.149 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.094054e-01 | 0.149 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 7.094054e-01 | 0.149 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.094054e-01 | 0.149 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.094054e-01 | 0.149 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 7.094054e-01 | 0.149 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.099466e-01 | 0.149 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.108552e-01 | 0.148 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.159566e-01 | 0.145 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.159566e-01 | 0.145 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.159566e-01 | 0.145 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.165347e-01 | 0.145 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.165347e-01 | 0.145 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.188751e-01 | 0.143 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.197074e-01 | 0.143 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.217498e-01 | 0.142 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.217498e-01 | 0.142 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.217498e-01 | 0.142 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.217498e-01 | 0.142 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 7.280297e-01 | 0.138 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.280297e-01 | 0.138 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 7.280297e-01 | 0.138 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 7.280297e-01 | 0.138 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.297918e-01 | 0.137 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 7.297918e-01 | 0.137 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.297918e-01 | 0.137 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.297918e-01 | 0.137 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.297918e-01 | 0.137 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.297918e-01 | 0.137 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.297918e-01 | 0.137 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.297918e-01 | 0.137 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.342715e-01 | 0.134 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.359707e-01 | 0.133 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 7.359707e-01 | 0.133 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.374468e-01 | 0.132 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.396964e-01 | 0.131 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.396964e-01 | 0.131 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.396964e-01 | 0.131 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.396964e-01 | 0.131 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.396964e-01 | 0.131 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.417168e-01 | 0.130 | 1 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.474563e-01 | 0.126 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.474563e-01 | 0.126 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.475728e-01 | 0.126 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.487491e-01 | 0.126 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.487491e-01 | 0.126 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.487491e-01 | 0.126 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.487491e-01 | 0.126 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 7.487491e-01 | 0.126 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 7.487491e-01 | 0.126 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.487491e-01 | 0.126 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.487491e-01 | 0.126 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.487491e-01 | 0.126 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.487491e-01 | 0.126 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.495671e-01 | 0.125 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.495671e-01 | 0.125 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.495671e-01 | 0.125 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.509622e-01 | 0.124 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.618332e-01 | 0.118 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.618332e-01 | 0.118 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.642699e-01 | 0.117 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.663775e-01 | 0.116 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.663775e-01 | 0.116 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 7.663775e-01 | 0.116 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.663775e-01 | 0.116 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.663775e-01 | 0.116 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.663775e-01 | 0.116 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 7.663775e-01 | 0.116 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.665948e-01 | 0.115 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.723161e-01 | 0.112 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.733315e-01 | 0.112 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.749572e-01 | 0.111 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.749572e-01 | 0.111 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.749572e-01 | 0.111 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 7.749572e-01 | 0.111 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.824181e-01 | 0.107 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.824181e-01 | 0.107 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.824181e-01 | 0.107 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.824181e-01 | 0.107 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 7.827700e-01 | 0.106 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.827700e-01 | 0.106 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.827700e-01 | 0.106 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.827700e-01 | 0.106 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.867877e-01 | 0.104 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.867877e-01 | 0.104 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.867877e-01 | 0.104 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.867877e-01 | 0.104 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.921471e-01 | 0.101 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.931509e-01 | 0.101 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.931509e-01 | 0.101 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.952697e-01 | 0.099 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.980132e-01 | 0.098 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 7.980132e-01 | 0.098 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.980132e-01 | 0.098 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 7.980132e-01 | 0.098 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.980132e-01 | 0.098 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.980672e-01 | 0.098 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.980672e-01 | 0.098 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.980672e-01 | 0.098 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.980672e-01 | 0.098 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.980672e-01 | 0.098 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 7.980672e-01 | 0.098 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.980672e-01 | 0.098 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.015109e-01 | 0.096 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.080300e-01 | 0.093 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.080300e-01 | 0.093 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.088145e-01 | 0.092 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.088145e-01 | 0.092 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.088145e-01 | 0.092 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.105181e-01 | 0.091 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.105181e-01 | 0.091 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.105181e-01 | 0.091 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.117176e-01 | 0.091 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.121876e-01 | 0.090 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.121876e-01 | 0.090 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.121876e-01 | 0.090 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.154925e-01 | 0.089 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.172239e-01 | 0.088 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.190488e-01 | 0.087 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.190488e-01 | 0.087 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.190488e-01 | 0.087 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.190488e-01 | 0.087 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.190488e-01 | 0.087 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.190488e-01 | 0.087 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.191772e-01 | 0.087 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.252626e-01 | 0.083 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 8.253681e-01 | 0.083 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.253681e-01 | 0.083 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.253681e-01 | 0.083 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.253681e-01 | 0.083 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.253681e-01 | 0.083 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 8.253681e-01 | 0.083 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 8.253681e-01 | 0.083 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.287892e-01 | 0.082 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.287892e-01 | 0.082 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.308575e-01 | 0.080 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.321426e-01 | 0.080 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.354870e-01 | 0.078 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.376244e-01 | 0.077 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 8.376244e-01 | 0.077 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 8.376244e-01 | 0.077 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 8.376244e-01 | 0.077 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 8.376244e-01 | 0.077 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.376244e-01 | 0.077 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.376244e-01 | 0.077 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.376244e-01 | 0.077 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.376244e-01 | 0.077 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.380545e-01 | 0.077 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.380545e-01 | 0.077 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.380545e-01 | 0.077 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.401695e-01 | 0.076 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.414878e-01 | 0.075 | 1 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.431558e-01 | 0.074 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.468635e-01 | 0.072 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.468635e-01 | 0.072 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.490212e-01 | 0.071 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.490212e-01 | 0.071 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.490212e-01 | 0.071 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.501239e-01 | 0.071 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.552345e-01 | 0.068 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.552345e-01 | 0.068 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.552345e-01 | 0.068 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.552345e-01 | 0.068 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.552345e-01 | 0.068 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.552345e-01 | 0.068 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.552345e-01 | 0.068 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.575673e-01 | 0.067 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 8.596187e-01 | 0.066 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.596187e-01 | 0.066 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 8.596187e-01 | 0.066 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.596187e-01 | 0.066 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 8.596187e-01 | 0.066 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.596187e-01 | 0.066 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.621381e-01 | 0.064 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.631856e-01 | 0.064 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.631856e-01 | 0.064 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.631856e-01 | 0.064 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.631856e-01 | 0.064 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.631856e-01 | 0.064 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.658209e-01 | 0.063 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.680340e-01 | 0.061 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.694729e-01 | 0.061 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.694729e-01 | 0.061 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.694729e-01 | 0.061 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.694729e-01 | 0.061 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 8.759184e-01 | 0.058 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.767552e-01 | 0.057 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.770079e-01 | 0.057 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.770079e-01 | 0.057 | 1 | 1 |
| Collagen degradation | R-HSA-1442490 | 8.770079e-01 | 0.057 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.778792e-01 | 0.057 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.778983e-01 | 0.057 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.778983e-01 | 0.057 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.778983e-01 | 0.057 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.786359e-01 | 0.056 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.786359e-01 | 0.056 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 8.786359e-01 | 0.056 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.786359e-01 | 0.056 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.786359e-01 | 0.056 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.787538e-01 | 0.056 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.810111e-01 | 0.055 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.813096e-01 | 0.055 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.824787e-01 | 0.054 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.846940e-01 | 0.053 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.871562e-01 | 0.052 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.871562e-01 | 0.052 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.871562e-01 | 0.052 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.886242e-01 | 0.051 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.911379e-01 | 0.050 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.911379e-01 | 0.050 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.949734e-01 | 0.048 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.950788e-01 | 0.048 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.950788e-01 | 0.048 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.950788e-01 | 0.048 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.950788e-01 | 0.048 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 8.950788e-01 | 0.048 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.950788e-01 | 0.048 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.950788e-01 | 0.048 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.950788e-01 | 0.048 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.950788e-01 | 0.048 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.950788e-01 | 0.048 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.950804e-01 | 0.048 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.964541e-01 | 0.047 | 1 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.972460e-01 | 0.047 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.972460e-01 | 0.047 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.972460e-01 | 0.047 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.024457e-01 | 0.045 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.024457e-01 | 0.045 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 9.024457e-01 | 0.045 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 9.024457e-01 | 0.045 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.024457e-01 | 0.045 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.024457e-01 | 0.045 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.030335e-01 | 0.044 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.030335e-01 | 0.044 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.030335e-01 | 0.044 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.030335e-01 | 0.044 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.038981e-01 | 0.044 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.053109e-01 | 0.043 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.060425e-01 | 0.043 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.085154e-01 | 0.042 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.089514e-01 | 0.041 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.092957e-01 | 0.041 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.092957e-01 | 0.041 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.092957e-01 | 0.041 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.092957e-01 | 0.041 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.092957e-01 | 0.041 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.092957e-01 | 0.041 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.134779e-01 | 0.039 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.137060e-01 | 0.039 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.137060e-01 | 0.039 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.156650e-01 | 0.038 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.156650e-01 | 0.038 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.156650e-01 | 0.038 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.156650e-01 | 0.038 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.156650e-01 | 0.038 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.185453e-01 | 0.037 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.186192e-01 | 0.037 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.197388e-01 | 0.036 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.199901e-01 | 0.036 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.215875e-01 | 0.035 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.215875e-01 | 0.035 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.215875e-01 | 0.035 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.215875e-01 | 0.035 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.215875e-01 | 0.035 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.231331e-01 | 0.035 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.232684e-01 | 0.035 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.232684e-01 | 0.035 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.258376e-01 | 0.033 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.258550e-01 | 0.033 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.270944e-01 | 0.033 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.270944e-01 | 0.033 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.276663e-01 | 0.033 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.283011e-01 | 0.032 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.283617e-01 | 0.032 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.283617e-01 | 0.032 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.288563e-01 | 0.032 | 1 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.297700e-01 | 0.032 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.315648e-01 | 0.031 | 1 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.318253e-01 | 0.031 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.318253e-01 | 0.031 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.318253e-01 | 0.031 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.322149e-01 | 0.030 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.322149e-01 | 0.030 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.322149e-01 | 0.030 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.354705e-01 | 0.029 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.357573e-01 | 0.029 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.357573e-01 | 0.029 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.369760e-01 | 0.028 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.378744e-01 | 0.028 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.394736e-01 | 0.027 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.397020e-01 | 0.027 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.398347e-01 | 0.027 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.406774e-01 | 0.027 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.414029e-01 | 0.026 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.414029e-01 | 0.026 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.414029e-01 | 0.026 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.435626e-01 | 0.025 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.435626e-01 | 0.025 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.455192e-01 | 0.024 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.455192e-01 | 0.024 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.455192e-01 | 0.024 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.463023e-01 | 0.024 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.493465e-01 | 0.023 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.493465e-01 | 0.023 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.493465e-01 | 0.023 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.493465e-01 | 0.023 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.493465e-01 | 0.023 | 1 | 1 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.493465e-01 | 0.023 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.513602e-01 | 0.022 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.523929e-01 | 0.021 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.529052e-01 | 0.021 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.529052e-01 | 0.021 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.529052e-01 | 0.021 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.529052e-01 | 0.021 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.538758e-01 | 0.021 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.557618e-01 | 0.020 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.562140e-01 | 0.019 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.562140e-01 | 0.019 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.562140e-01 | 0.019 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.562140e-01 | 0.019 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.578200e-01 | 0.019 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.592906e-01 | 0.018 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.592906e-01 | 0.018 | 1 | 1 |
| NCAM1 interactions | R-HSA-419037 | 9.592906e-01 | 0.018 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.592906e-01 | 0.018 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.621511e-01 | 0.017 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.621511e-01 | 0.017 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.621511e-01 | 0.017 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.648108e-01 | 0.016 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.648108e-01 | 0.016 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.648108e-01 | 0.016 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.648633e-01 | 0.016 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.666761e-01 | 0.015 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.689151e-01 | 0.014 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.695831e-01 | 0.013 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.695831e-01 | 0.013 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.695831e-01 | 0.013 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.703576e-01 | 0.013 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.713338e-01 | 0.013 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.716249e-01 | 0.013 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.716249e-01 | 0.013 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.717209e-01 | 0.012 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.717209e-01 | 0.012 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.717209e-01 | 0.012 | 1 | 1 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.717209e-01 | 0.012 | 1 | 1 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.717209e-01 | 0.012 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.737086e-01 | 0.012 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.755567e-01 | 0.011 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.772750e-01 | 0.010 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.772750e-01 | 0.010 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.772750e-01 | 0.010 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.785453e-01 | 0.009 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.788726e-01 | 0.009 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.788726e-01 | 0.009 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.788726e-01 | 0.009 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.792594e-01 | 0.009 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.797637e-01 | 0.009 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.803580e-01 | 0.009 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.806778e-01 | 0.008 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.817390e-01 | 0.008 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.830230e-01 | 0.007 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.838502e-01 | 0.007 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.843007e-01 | 0.007 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.855847e-01 | 0.006 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.861553e-01 | 0.006 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.861553e-01 | 0.006 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.863583e-01 | 0.006 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.863587e-01 | 0.006 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.863587e-01 | 0.006 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.863587e-01 | 0.006 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.882101e-01 | 0.005 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.890394e-01 | 0.005 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.897801e-01 | 0.004 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.898191e-01 | 0.004 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.899073e-01 | 0.004 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.905272e-01 | 0.004 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.905272e-01 | 0.004 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.908546e-01 | 0.004 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.908589e-01 | 0.004 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.911936e-01 | 0.004 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.914091e-01 | 0.004 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.918941e-01 | 0.004 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.923892e-01 | 0.003 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.926600e-01 | 0.003 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.928318e-01 | 0.003 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.929248e-01 | 0.003 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.929248e-01 | 0.003 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.932817e-01 | 0.003 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.934226e-01 | 0.003 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.934226e-01 | 0.003 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.935420e-01 | 0.003 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.936041e-01 | 0.003 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.942399e-01 | 0.003 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.945479e-01 | 0.002 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.957534e-01 | 0.002 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.957534e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.957550e-01 | 0.002 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.957550e-01 | 0.002 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.957714e-01 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.959982e-01 | 0.002 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.960539e-01 | 0.002 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.961426e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.965900e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.967665e-01 | 0.001 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.968245e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.968301e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.968301e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.972117e-01 | 0.001 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.972608e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.973664e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.974537e-01 | 0.001 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.976399e-01 | 0.001 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.977334e-01 | 0.001 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.979305e-01 | 0.001 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.979547e-01 | 0.001 | 1 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.980035e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.980988e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.980988e-01 | 0.001 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.984519e-01 | 0.001 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.984519e-01 | 0.001 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.984519e-01 | 0.001 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.984719e-01 | 0.001 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.984730e-01 | 0.001 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.984730e-01 | 0.001 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.988101e-01 | 0.001 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.988101e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.990150e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.990238e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.991447e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.991447e-01 | 0.000 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.991490e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.992129e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.992550e-01 | 0.000 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.993166e-01 | 0.000 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.993648e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.993918e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.994023e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.994095e-01 | 0.000 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.994095e-01 | 0.000 | 1 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.995259e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.995593e-01 | 0.000 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.995593e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.995904e-01 | 0.000 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.996303e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.996527e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.996711e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.997159e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.997545e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.998017e-01 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.998494e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998633e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.998730e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.998746e-01 | 0.000 | 1 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999224e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999544e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999717e-01 | 0.000 | 1 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999727e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999799e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999849e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999853e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999897e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999942e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999953e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999960e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999969e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999977e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999979e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999983e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999986e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999987e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999992e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999992e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999994e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999995e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999999e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999999e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 1.000000e+00 | 0.000 | 1 | 1 |
| Translation of Structural Proteins | R-HSA-9683701 | 1.000000e+00 | 0.000 | 1 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 1.000000e+00 | 0.000 | 1 | 1 |